_unit_id,_created_at,_updated_at,gs,term,values,please_choose_one_of_the_reasons_below_gold,please_choose_one_of_the_reasons_below_gold_reason,which_category_does_this_term_belong_to_gold,which_category_does_this_term_belong_to_gold_reason
1229987731,5/3/2017 13:01:58,5/4/2017 11:42:00, time,incubation time (hours)  ,0,,,,
1229987732,5/3/2017 13:01:58,5/4/2017 11:36:05, time,time in meiosis (hr)  ,0,,,,
1229987733,5/3/2017 13:01:58,5/4/2017 11:34:26, time,time under flooding (h)  ,0,,,,
1229987734,5/3/2017 13:01:58,5/4/2017 11:27:09, disease,disease relapse (event)  ,1,,,,
1229987735,5/3/2017 13:01:58,5/4/2017 11:35:40, time,time_to_relapse (years)  ,1.3,,,,
1229987736,5/3/2017 13:01:58,5/4/2017 11:41:00, time,time pi (weeks)  ,3,,,,
1229987737,5/3/2017 13:01:58,5/4/2017 12:19:54, treatment,treatment_time[hr]  ,6,,,,
1229987738,5/3/2017 13:01:58,5/4/2017 11:33:08, disease,disease free survival (months)  ,12,,,,
1229987739,5/3/2017 13:01:58,5/4/2017 11:38:26, disease,disease free interval (months)  ,15,,,,
1229987740,5/3/2017 13:01:58,5/4/2017 11:40:21, time,time to recurrence (years)  ,15.75,,,,
1229987741,5/3/2017 13:01:58,5/4/2017 11:24:53, age,age (1#pfu_1) ,21,,,,
1229987742,5/3/2017 13:01:58,5/4/2017 11:39:21, time,induction time (h)  ,24,,,,
1229987743,5/3/2017 13:01:58,5/4/2017 11:47:47, age,age (1#pvu_1) ,26,,,,
1229987744,5/3/2017 13:01:58,5/4/2017 11:51:03, age,sampling age ,38,,,,
1229987745,5/3/2017 13:01:58,5/4/2017 11:30:14, age,gestational age at delivery ,40,,,,
1229987746,5/3/2017 13:01:58,5/4/2017 11:39:20, cell line,ips cell line  ,41,,,,
1229987747,5/3/2017 13:01:58,5/4/2017 11:44:42, age,age (1#pfu_2) ,42,,,,
1229987748,5/3/2017 13:01:58,5/4/2017 11:42:43, treatment,euthanasia day post treatment  ,42,,,,
1229987749,5/3/2017 13:01:58,5/4/2017 11:42:10, age,average age (days after birth) ,47,,,,
1229987750,5/3/2017 13:01:58,5/4/2017 11:32:42, age,age at rc ,51.33,,,,
1229987751,5/3/2017 13:01:58,5/4/2017 11:34:54, age,cell line source age ,56,,,,
1229987752,5/3/2017 13:01:58,5/4/2017 11:46:26, cell line,cell line source age  ,56,,,,
1229987753,5/3/2017 13:01:58,5/4/2017 11:44:19, age,age (at specimen collection) ,67.73,,,,
1229987754,5/3/2017 13:01:58,5/4/2017 11:32:48, age,age_dx ,68,,,,
1229987755,5/3/2017 13:01:58,5/4/2017 11:24:34, time,time to hcc recurrence (days)  ,1097,,,,
1229987756,5/3/2017 13:01:58,5/4/2017 11:22:16, age,sac age (wks) ,12/16/17,,,,
1229987757,5/3/2017 13:01:58,5/4/2017 11:34:26, treatment,dht treatment  ," ""-"", na, 1 nm, 100nm, ",,,,
1229987758,5/3/2017 13:01:58,5/4/2017 11:38:39, time,collection time  ," less than 72 hour after symptoms, 3 to 7 dys after symptoms, 2 to 5 weeks after symptoms, 0 hr, 24 hr",,,,
1229987759,5/3/2017 13:01:58,5/4/2017 11:40:21, tissue,tissue harvest ,", 9/24/03. 9/17/03, embryonic day 6 (h&h stage 26 -28)",,,,
1229987760,5/3/2017 13:01:58,5/4/2017 11:37:58, treatment,treatment adchem  ,": adchemanthracycline, : adhtamoxifen, : no treatment",,,,
1229987761,5/3/2017 13:01:58,5/4/2017 11:34:10, strain,transgenic strain  ,": fsp1-egfp, mmtv-wnt-1, mmtv-wnt/ilk",,,,
1229987762,5/3/2017 13:01:58,5/4/2017 11:35:16, strain,strain 3235 = scc1-pk3  ,:his,,,,
1229987763,5/3/2017 13:01:58,5/4/2017 11:27:27, strain,strain 379 = scc1-ha6  ,:his3,,,,
1229987764,5/3/2017 13:01:58,5/4/2017 11:40:25, strain,strain by4741 ptc2  ,:kanmx4,,,,
1229987765,5/3/2017 13:01:58,5/4/2017 11:29:48, strain,strain by4741 ptc4  ,:kanmx4,,,,
1229987766,5/3/2017 13:01:58,5/4/2017 11:28:30, strain,strain yjdi381 gal1-taf1  ,:kanmx6 + taf1 ts2,,,,
1229987767,5/3/2017 13:01:58,5/4/2017 11:41:12, strain,strain by4741 ptc1  ,:nat1,,,,
1229987768,5/3/2017 13:01:58,5/4/2017 11:35:40, time,time.to.recurrence (years)  ,"., 2.16, 0.83, 2.08, 1.82",,,,
1229987769,5/3/2017 13:01:58,5/4/2017 11:29:44, time,pfs time  ,"., 288, 178, 388, 104",,,,
1229987770,5/3/2017 13:01:58,5/4/2017 11:38:43, time,time.to.ok  ,"., 4.99, 5.3, 5.16, 5.07",,,,
1229987771,5/3/2017 13:01:58,5/4/2017 11:33:00, treatment,treatment time (rhgaa)  ,"""--"", 00 weeks, 12 weeks, 52 weeks",,,,
1229987772,5/3/2017 13:01:58,5/4/2017 11:39:32, time,treatment time (rhgaa)  ,"""--"", 00 weeks, 12 weeks, 52 weeks",,,,
1229987773,5/3/2017 13:01:58,5/4/2017 11:33:01, age,age of diagnosis (year) ,"""--"", 34, 57, 32, 35",,,,
1229987774,5/3/2017 13:01:58,5/4/2017 11:27:01, time,evolution time (years)  ,"""--"", 7, 13, 3, 8",,,,
1229987775,5/3/2017 13:01:58,5/4/2017 11:41:29, time,time until recurrence (years)  ,"""-"", 2.4",,,,
1229987776,5/3/2017 13:01:58,5/4/2017 11:21:16, time,dsn time  ,"""-"", 5h",,,,
1229987777,5/3/2017 13:01:58,5/4/2017 11:32:59, treatment,ms treatment  ,"""-"", copaxone, betaferon, tysabri, rebif44",,,,
1229987778,5/3/2017 13:01:58,5/4/2017 11:22:01, age,age at onset (years) ,"""-"", na, 47, 48, 78",,,,
1229987779,5/3/2017 13:01:58,5/4/2017 11:19:22, disease,other diseases  ,"""-"", positive lead test",,,,
1229987780,5/3/2017 13:01:58,5/4/2017 11:37:45, disease,chronic diseases  ,"""-"", yes",,,,
1229987781,5/3/2017 13:01:58,5/4/2017 11:38:26, genotype,il4r genotype  ,"""-/-"", +/+",,,,
1229987782,5/3/2017 13:01:58,5/4/2017 11:38:45, time,time (weeks of treatment)  ,"""-4"", 11, 27, 23, 17",,,,
1229987783,5/3/2017 13:01:58,5/4/2017 11:36:58, time,timepoint (wks)  ,"""-5"", 12, 4",,,,
1229987784,5/3/2017 13:01:58,5/4/2017 11:34:13, age,age of onset ,"""=-n/a"", 20yr, -, 17 yr, 25 yr",,,,
1229987785,5/3/2017 13:01:58,5/4/2017 11:29:33, treatment,response to tzd treatment  ,"""=+ (responder)"", ""=- (non responder)""",,,,
1229987786,5/3/2017 13:01:58,5/4/2017 11:37:58, strain,strain [background]  ,"(n>6)b6.129, b6129 hybrid, (n>>2)b6.129, b6",,,,
1229987787,5/3/2017 13:01:58,5/4/2017 11:53:48, treatment,treatment amount [c]  ,"(not applicable), 50 ug/ml",,,,
1229987788,5/3/2017 13:01:58,5/4/2017 11:36:57, treatment,treatment [c]  ,"(not applicable), oxidized ldl",,,,
1229987789,5/3/2017 13:01:58,5/4/2017 11:40:54, disease,disease subtype  ,"[er+/pr+]her2-, refractory anemia (ra), refractory anemia with ringed sideroblasts (rars), refractory anemia with excess blasts 2 (raeb2), refractory anemia with excess blasts 1 (raeb1)",,,,
1229987790,5/3/2017 13:01:58,5/4/2017 11:46:21, age,age at diagnosis (months) ,"<18m, 1, >18m, 6, 4",,,,
1229987791,5/3/2017 13:01:58,5/4/2017 11:31:08, time,time quit (@ initial consult)  ,">10yrs, 6-10yrs, 0, 1-6mos, unk",,,,
1229987792,5/3/2017 13:01:58,5/4/2017 11:33:31, age,age of trees ,">30, 3, 9, 2, 1",,,,
1229987793,5/3/2017 13:01:58,5/4/2017 11:40:55, treatment,days after treatment  ,"0 d, 1 d, 23 d, 3, 7",,,,
1229987794,5/3/2017 13:01:58,5/4/2017 11:25:40, age,infant age ,0 day,,,,
1229987795,5/3/2017 13:01:58,5/4/2017 11:38:17, tissue,tissue collection time ,"0 h (control), 18 h post pgf2_ administration, 6 h post pgf2_ administration, 3 h post pgf2_ administration",,,,
1229987796,5/3/2017 13:01:58,5/4/2017 11:36:25, time,tissue collection time  ,"0 h (control), 6 h post pgf2� administration, 18 h post pgf2� administration, 3 h post pgf2� administration",,,,
1229987797,5/3/2017 13:01:58,5/4/2017 11:50:16, treatment,duration of il-6 treatment  ,"0 h, 12 h, 1 h, 6 h, 3 h",,,,
1229987798,5/3/2017 13:01:58,5/4/2017 11:36:57, time,time before sampling  ,"0 h, 24 h, 72 h",,,,
1229987799,5/3/2017 13:01:58,5/4/2017 11:21:04, time,time of exercise  ,"0 hour (pre), 6 hour, 24 hour, 3 hour",,,,
1229987800,5/3/2017 13:01:58,5/4/2017 11:38:34, time,time post-perforation  ,"0 hours, 12 hours, 144 hours, 36 hours, 24 hours",,,,
1229987801,5/3/2017 13:01:58,5/4/2017 11:34:49, time,post serum time point  ,"0 hours, 6 hours",,,,
1229987802,5/3/2017 13:01:58,5/4/2017 11:33:24, time,time differentiated  ,"0 hr, 24 hr, 72 hr",,,,
1229987803,5/3/2017 13:01:58,5/4/2017 11:35:52, time,time in fr light  ,"0 hr, 3 hr, 1 hr, 24 hr",,,,
1229987804,5/3/2017 13:01:58,5/4/2017 11:42:11, time,hcg treatment time  ,"0 hr, 3 hr, 14 hr, 9 hr",,,,
1229987805,5/3/2017 13:01:58,5/4/2017 11:21:16, treatment,hcg treatment time  ,"0 hr, 3 hr, 9 hr, 14 hr",,,,
1229987806,5/3/2017 13:01:58,5/4/2017 11:38:50, time,time in constant white light  ,"0 hrs, 8 hrs, 32 hrs, 4 hrs, 12 hrs",,,,
1229987807,5/3/2017 13:01:58,5/4/2017 11:19:57, time,time(absolute)  ,"0 months, 1 months",,,,
1229987808,5/3/2017 13:01:58,5/4/2017 12:18:35, time,post-exposure time  ,0 weeks,,,,
1229987809,5/3/2017 13:01:58,5/4/2017 11:22:17, gender,female gender ,"0, 1",,,,
1229987810,5/3/2017 13:01:58,5/4/2017 11:27:13, treatment,treatment response in vivo  ,"0, 1",,,,
1229987811,5/3/2017 13:01:58,5/4/2017 11:39:29, disease,code disease-specific survival  ,"0, 1",,,,
1229987812,5/3/2017 13:01:58,5/4/2017 11:41:22, disease,disease_free_survival_years  ,"0, 1, na, 10, 0.67",,,,
1229987813,5/3/2017 13:01:58,5/4/2017 11:39:48, time,time_to_metastasis (years)  ,"0, 1.6, 2.1, 2.4, 1.7",,,,
1229987814,5/3/2017 13:01:58,5/4/2017 11:53:48, treatment,treatment_dose_u/ml  ,"0, 1000",,,,
1229987815,5/3/2017 13:01:58,5/4/2017 11:29:49, time,zt time  ,"0, 12, 18, 6, 3",,,,
1229987816,5/3/2017 13:01:58,5/4/2017 11:32:19, time,time (minutes)  ,"0, 12, 6, 15, 20",,,,
1229987817,5/3/2017 13:01:58,5/4/2017 11:59:07, time,time (days post-infection)  ,"0, 2",,,,
1229987818,5/3/2017 13:01:58,5/4/2017 11:34:47, time,timepoint (weeks)  ,"0, 2",,,,
1229987819,5/3/2017 13:01:58,5/4/2017 11:38:14, age,ageing at 29 c in days ,"0, 2, 14",,,,
1229987820,5/3/2017 13:01:58,5/4/2017 11:40:29, treatment,rai stage before treatment  ,"0, 2, 4, 3, 1",,,,
1229987821,5/3/2017 13:01:58,5/4/2017 11:29:49, time,induction time (hours)  ,"0, 24",,,,
1229987822,5/3/2017 13:01:58,5/4/2017 11:32:57, disease,disease-free interval (months)  ,"0, 24, 23, 37, 40",,,,
1229987823,5/3/2017 13:01:58,5/4/2017 11:41:02, time,time after injury (hours)  ,"0, 288, 528, 3, 6",,,,
1229987824,5/3/2017 13:01:58,5/4/2017 11:27:16, time,time (d)  ,"0, 3, 10, 1, 7",,,,
1229987825,5/3/2017 13:01:58,5/4/2017 11:34:54, time,time in spo (hours)  ,"0, 3, 5",,,,
1229987826,5/3/2017 13:01:58,5/4/2017 11:29:16, time,time (h)  ,"0, 4, 6, 24, 8",,,,
1229987827,5/3/2017 13:01:58,5/4/2017 11:31:08, age,culture age (days) ,"0, 40, 20, 7, 42",,,,
1229987828,5/3/2017 13:01:58,5/4/2017 11:36:42, disease,disease free interval (days)  ,"0, 462, 122, 546, na",,,,
1229987829,5/3/2017 13:01:58,5/4/2017 11:35:19, age,age (year) ,"0, 68, 55, 59, 54",,,,
1229987830,5/3/2017 13:01:58,5/4/2017 11:34:26, time,time point (hours)  ,"0, 72, 2, 4, 12",,,,
1229987833,5/3/2017 13:01:59,5/4/2017 11:27:01, strain,strain dba2(%)  ,"0, 75, 100, 50",,,,
1229987834,5/3/2017 13:01:59,5/4/2017 11:25:46, time,time post surgery  ,"0, 8 weeks, 2 weeks, 4 weeks, 12h",,,,
1229987835,5/3/2017 13:01:59,5/4/2017 11:33:08, time,dfs time (months)  ,"0, 8.51, 54.7, 20.7, 91.93",,,,
1229987836,5/3/2017 13:01:59,5/4/2017 11:34:31, strain,strain sjl(%)  ,"0, 9, 37.5, 84, 69",,,,
1229987837,5/3/2017 13:01:59,5/4/2017 11:36:58, time,time since sample1 months  ,"0, 9.93, 21.41, 19.21, 35.74",,,,
1229987838,5/3/2017 13:01:59,5/4/2017 11:39:15, disease,duration of disease (month)  ,"0, unknown, 1",,,,
1229987839,5/3/2017 13:01:59,5/4/2017 11:30:23, time,time period of attachment  ,"0.25 h, 1 h, logarithmic aerobic growing cells",,,,
1229987840,5/3/2017 13:01:59,5/4/2017 11:38:10, time,time pre_post surgery (years)  ,"0.28, 0.15, 0.53, 0.25, 0.14",,,,
1229987841,5/3/2017 13:01:59,5/4/2017 11:40:22, age,donor age (years) ,"0.35, 54, 50, 82, 92",,,,
1229987842,5/3/2017 13:01:59,5/4/2017 11:25:40, time,time after injury  ,"0.5 h, 72 h, 7 d, 24 h, 28 d",,,,
1229987843,5/3/2017 13:01:59,5/4/2017 11:41:39, treatment,hours treatment  ,"0.5, 4, 0",,,,
1229987844,5/3/2017 13:01:59,5/4/2017 11:29:33, time,time (hours after pollination)  ,"0.5, 8, 3.5",,,,
1229987845,5/3/2017 13:01:59,5/4/2017 11:54:57, age,host age (yr) ,"0.50-0.66, 24, 26, 25, 55",,,,
1229987846,5/3/2017 13:01:59,5/4/2017 11:35:40, time,post-infection time points  ,"0.5hpi, 16hpi, 18hpi, 1hpi, 2hpi",,,,
1229987847,5/3/2017 13:01:59,5/4/2017 11:34:47, time,rna degradation time  ,"000 h, 315 h, 145 h, 230 h",,,,
1229987848,5/3/2017 13:01:59,5/4/2017 11:42:45, time,time post-stimulation  ,"008hr, 024hr, 072hr, 000min, 720min",,,,
1229987849,5/3/2017 13:01:59,5/4/2017 11:34:26, time,extraction time  ,"0h after bru labeling, 6h after bru labeling",,,,
1229987850,5/3/2017 13:01:59,5/4/2017 11:36:34, time,time (post amputation)  ,"0h, 12h, 48h, 24h",,,,
1229987851,5/3/2017 13:01:59,5/4/2017 11:35:52, time,time after induction  ,"0h, 24 hours, 1 days, 5 days, 0 days",,,,
1229987852,5/3/2017 13:01:59,5/4/2017 11:35:03, age,age in vitro ,"0h, 24h, 48h, 72h",,,,
1229987853,5/3/2017 13:01:59,5/4/2017 11:33:43, time,pos-harvest time  ,"0h, 24h, 5h",,,,
1229987854,5/3/2017 13:01:59,5/4/2017 11:40:52, time,differentiation timepoint  ,"0h, 72h, 48h, 24h, t0",,,,
1229987855,5/3/2017 13:01:59,5/4/2017 11:39:18, treatment,h2o2 treatment level  ,"0mm, 1mm, 50mm, 5mm, 25mm",,,,
1229987856,5/3/2017 13:01:59,5/4/2017 11:37:45, treatment,b12 treatment  ,"0nm, 500nm, 50um",,,,
1229987857,5/3/2017 13:01:59,5/4/2017 11:37:30, treatment,folate treatment  ,"0nm, 6um, 30um, 60um",,,,
1229987858,5/3/2017 13:01:59,5/4/2017 11:34:10, time,time  ,"1 d, 3 d, 5 d, 24h, 0.25 d",,,,
1229987859,5/3/2017 13:01:59,5/4/2017 11:42:43, treatment,days of treatment  ,"1 day, 3 days",,,,
1229987860,5/3/2017 13:01:59,5/4/2017 11:40:44, treatment,time after treatment  ,"1 day, 6h, 12h, 24h, 48h",,,,
1229987861,5/3/2017 13:01:59,5/4/2017 11:34:02, time,time after treatment  ,"1 day, 6h, 12h, 24h, 72h",,,,
1229987862,5/3/2017 13:01:59,5/4/2017 11:43:49, treatment,treatment duration  ,"1 days, 3 days, 5 days, .25 days, 24h",,,,
1229987863,5/3/2017 13:01:59,5/4/2017 11:44:20, time,4-thiouracil labeling time  ,"1 h, fourth h post-n-addition, first h post-n-addition",,,,
1229987864,5/3/2017 13:01:59,5/4/2017 11:40:54, age,age of the mice ,1 month old,,,,
1229987865,5/3/2017 13:01:59,5/4/2017 11:28:14, age,age at vaccination ,"1 month, newborn",,,,
1229987866,5/3/2017 13:01:59,5/4/2017 11:40:44, sex,sex (0-female 1-male)  ,"1, 0",,,,
1229987867,5/3/2017 13:01:59,5/4/2017 11:40:28, sex,sex (0-male 1-female)  ,"1, 0",,,,
1229987868,5/3/2017 13:01:59,5/4/2017 11:42:00, disease,disease progression (event)  ,"1, 0",,,,
1229987869,5/3/2017 13:01:59,5/4/2017 11:29:24, age,age (bin) ,"1, 0, na",,,,
1229987870,5/3/2017 13:01:59,5/4/2017 11:38:09, age,age bin ,"1, 0, na",,,,
1229987871,5/3/2017 13:01:59,5/4/2017 11:37:49, age,agebin ,"1, 0, na",,,,
1229987872,5/3/2017 13:01:59,5/4/2017 11:38:09, time,post radiation time (hour)  ,"1, 12, 24, 4, 0",,,,
1229987873,5/3/2017 13:01:59,5/4/2017 11:28:35, age,age (postnatal days) ,"1, 14, 7",,,,
1229987874,5/3/2017 13:01:59,5/4/2017 11:35:53, age,age (day) ,"1, 15, 5, 50, 30",,,,
1229987875,5/3/2017 13:01:59,5/4/2017 11:31:03, age,agegrp ,"1, 2",,,,
1229987876,5/3/2017 13:01:59,5/4/2017 11:33:29, treatment,order of treatment  ,"1, 2",,,,
1229987877,5/3/2017 13:01:59,5/4/2017 11:42:53, disease,stage of disease  ,"1, 2",,,,
1229987878,5/3/2017 13:01:59,5/4/2017 12:03:40, age,agestatus ,"1, 2, na",,,,
1229987879,5/3/2017 13:01:59,5/4/2017 11:36:57, sex,sex (male.1_female.2)  ,"1, 2, na",,,,
1229987880,5/3/2017 13:01:59,5/4/2017 11:43:54, disease,diseasestatus  ,"1, 2, nafld, nash, normal control",,,,
1229987881,5/3/2017 13:01:59,5/4/2017 11:38:08, time,time point (day)  ,"1, 28, 0, 3, 4",,,,
1229987882,5/3/2017 13:01:59,5/4/2017 11:41:13, time,lps exposure time  ,"1, 3, 0, 5",,,,
1229987883,5/3/2017 13:01:59,5/4/2017 11:41:38, disease,stage of disease (inss)  ,"1, 4, 2, 4s, 3",,,,
1229987884,5/3/2017 13:01:59,5/4/2017 12:18:36, tissue,number of pooled tissues ,"1, 4, 3",,,,
1229987885,5/3/2017 13:01:59,5/4/2017 11:32:22, treatment,treatment repeat  ,"1, 5, 6",,,,
1229987886,5/3/2017 13:01:59,5/4/2017 11:26:36, time,time after es/ga (days)  ,"1, 7, 3, n/a",,,,
1229987887,5/3/2017 13:01:59,5/4/2017 11:35:48, treatment,weeks after treatment  ,"1, 8",,,,
1229987888,5/3/2017 13:01:59,5/4/2017 11:32:38, disease,residual disease (cm)  ,"1, not evaluated, 6, 3, 0",,,,
1229987889,5/3/2017 13:01:59,5/4/2017 11:37:06, time,follow up time (months)  ,"1.2, 29.9, 48.7, 68.8, 51",,,,
1229987890,5/3/2017 13:01:59,5/4/2017 11:33:25, time,pfs time (years)  ,"1.33881, 3.96715, 0.780287",,,,
1229987891,5/3/2017 13:01:59,5/4/2017 11:37:45, time,time_rec (years)  ,"1.58, 2.08, 2.3, 0.92, 5.17",,,,
1229987892,5/3/2017 13:01:59,5/4/2017 11:32:01, time,time to outcome  ,"1.624 years, 0.035 years, 0.684 years, 2.315 years, 2.846 years",,,,
1229987893,5/3/2017 13:01:59,5/4/2017 11:41:30, time,developmental time  ,"1.75 - 2.75 hrs, 2 - 3 hrs, 0 h, 2 h, 1 h",,,,
1229987894,5/3/2017 13:01:59,5/4/2017 11:34:03, disease,mean disease duration  ,1.7yrs.,,,,
1229987895,5/3/2017 13:01:59,5/4/2017 11:41:54, strain,strain serotype  ,1/2a,,,,
1229987896,5/3/2017 13:01:59,5/4/2017 11:47:47, tissue,age and tissue ,10 days-old seedlings.,,,,
1229987897,5/3/2017 13:01:59,5/4/2017 11:44:42, age,age and tissue ,10 days-old seedlings.,,,,
1229987898,5/3/2017 13:01:59,5/4/2017 11:41:23, time,time (hpi)  ,"10 hr, 20 hr, control, 72, 96",,,,
1229987899,5/3/2017 13:01:59,5/4/2017 11:35:03, time,time(weeks)  ,10 weeks,,,,
1229987900,5/3/2017 13:01:59,5/4/2017 11:33:19, age,age at start of experiment ,"10 wks, 8 wks",,,,
1229987901,5/3/2017 13:01:59,5/4/2017 11:36:23, time,dfs time (yrs)  ,"10, 10.66666667, 10.5, 10.75, 9.91666667",,,,
1229987902,5/3/2017 13:01:59,5/4/2017 11:37:27, tissue,day of tissue dissection ,"10, 15, 12, 18",,,,
1229987903,5/3/2017 13:01:59,5/4/2017 11:32:19, age,age (days old) ,"10, 52, 66, 68, 57",,,,
1229987904,5/3/2017 13:01:59,5/4/2017 11:44:20, disease,disease_free_survival_event  ,"10, na, 0.42,1, 3",,,,
1229987905,5/3/2017 13:01:59,5/4/2017 11:32:42, treatment,testosterone treatment  ,"100 nm testosterone, none",,,,
1229987906,5/3/2017 13:01:59,5/4/2017 11:25:46, treatment,treatment dose u/ml  ,"100, 0",,,,
1229987907,5/3/2017 13:01:59,5/4/2017 11:40:22, treatment,treatment_dose  ,"1000 u/ml, none",,,,
1229987908,5/3/2017 13:01:59,5/4/2017 11:42:01, disease,disease-free survival (dfs)  ,"107 months, 28 months, 32 months, 2 months, 3 months",,,,
1229987909,5/3/2017 13:01:59,5/4/2017 11:36:27, age,age of ffpe block (years) ,"11, 10, 12, 13",,,,
1229987910,5/3/2017 13:01:59,5/4/2017 11:37:49, age,age of ffpe tissue ,"11, 10, 12, 21, 19",,,,
1229987911,5/3/2017 13:01:59,5/4/2017 11:39:20, tissue,age of ffpe tissue ,"11, 10, 12, 21, 34",,,,
1229987912,5/3/2017 13:01:59,5/4/2017 11:38:26, treatment,time (weeks of treatment)  ,"11, 27, -4, 23, 17",,,,
1229987913,5/3/2017 13:01:59,5/4/2017 11:36:56, time,time sacrificed  ,"1130, 1505, 1230, 1439, 1105",,,,
1229987914,5/3/2017 13:01:59,5/4/2017 11:41:01, time,time to meta or recurrence  ,"1175, 446",,,,
1229987915,5/3/2017 13:01:59,5/4/2017 11:37:09, age,conidial age ,12 days,,,,
1229987916,5/3/2017 13:01:59,5/4/2017 11:38:45, time,transfection time  ,"12 hrs, 48h, 7 hours, 12 hours, 25 hours",,,,
1229987917,5/3/2017 13:01:59,5/4/2017 11:29:44, time,time on diet  ,"12 weeks, 11 weeks",,,,
1229987918,5/3/2017 13:01:59,5/4/2017 11:30:08, treatment,period of treatment  ,"12 weeks, 4 weeks",,,,
1229987919,5/3/2017 13:01:59,5/4/2017 11:38:30, time,feeding time  ,"12 weeks, 9 weeks",,,,
1229987920,5/3/2017 13:01:59,5/4/2017 11:45:29, age,age months ,"12, 1.5, 6, 3, 20",,,,
1229987921,5/3/2017 13:01:59,5/4/2017 11:22:00, time,circadian time (ct)  ,"12, 18, 0, 6",,,,
1229987922,5/3/2017 13:01:59,5/4/2017 11:54:57, time,time in hrs  ,"12, 24, 3, 0.5, 6",,,,
1229987923,5/3/2017 13:01:59,5/4/2017 11:41:02, time,time (hrs)  ,"12, 24, 8, 4, 0.5",,,,
1229987924,5/3/2017 13:01:59,5/4/2017 11:43:50, treatment,treatment time(minutes)  ,"120, 480, 0, 20, 40",,,,
1229987925,5/3/2017 13:01:59,5/4/2017 11:38:18, time,treatment time(minutes)  ,"120, 480, 0, 20, 40",,,,
1229987926,5/3/2017 13:01:59,5/4/2017 11:42:58, time,10years followup time (months)  ,"120, 51.49, 50.48, 52.51, 73.48",,,,
1229987927,5/3/2017 13:01:59,5/4/2017 11:37:30, time,time inject  ,"1230, 1110, 1100, 1130, 1200",,,,
1229987928,5/3/2017 13:01:59,5/4/2017 11:48:15, strain,strain (genetic background)  ,"129svjae/c57b6 f1, c57bl/6 x b6129 ola",,,,
1229987929,5/3/2017 13:01:59,5/4/2017 11:36:21, time,time post infection  ,"12h, 24h, 14 days, n/a, 3 day dpi",,,,
1229987930,5/3/2017 13:01:59,5/4/2017 11:40:10, time,stress time  ,"12h, 24h, 48h",,,,
1229987931,5/3/2017 13:01:59,5/4/2017 11:47:47, treatment,sirna treatment time point  ,"12hr, 4hr, 8hr, 18hr",,,,
1229987932,5/3/2017 13:01:59,5/4/2017 11:48:15, time,time of pseudo-pregnancy  ,"13 days, 15 days",,,,
1229987933,5/3/2017 13:01:59,5/4/2017 11:31:32, age,vitis (41528 population) - age ,13 month,,,,
1229987934,5/3/2017 13:01:59,5/4/2017 11:38:01, age,age (at the end of treatment) ,13 wks,,,,
1229987935,5/3/2017 13:01:59,5/4/2017 11:30:42, treatment,age (at the end of treatment)  ,13 wks,,,,
1229987936,5/3/2017 13:01:59,5/4/2017 11:29:33, time,survival time (month)  ,"13.86138614, 29.07590759, 16.46864686, 12.07920792, 18.15181518",,,,
1229987937,5/3/2017 13:01:59,5/4/2017 11:38:52, age,estimated age ,130 days gestation,,,,
1229987938,5/3/2017 13:01:59,5/4/2017 11:37:14, time,collected time  ,14 days after inoculation,,,,
1229987939,5/3/2017 13:01:59,5/4/2017 11:27:17, treatment,treatment-time  ,"14 days, none, 24 hours, 3 hours, 9 hours",,,,
1229987940,5/3/2017 13:01:59,5/4/2017 12:03:29, time,time after lights on  ,"14 hr;, 6 hr;, 11 hr;, 23.75 hr;, 18 hr;",,,,
1229987941,5/3/2017 13:01:59,5/4/2017 11:27:27, age,age harvested (days) ,"14, 12, 16, 17, 24",,,,
1229987942,5/3/2017 13:01:59,5/4/2017 11:30:24, age,age of mice (wk) ,"14, 15, 12",,,,
1229987943,5/3/2017 13:01:59,5/4/2017 11:38:10, time,time point (months)  ,"14, 2, 0, 12, 0.5",,,,
1229987944,5/3/2017 13:01:59,5/4/2017 11:37:55, age,age at surgery ,"14, 8, 6-8 weeks, 71, 65",,,,
1229987945,5/3/2017 13:01:59,5/4/2017 11:36:27, time,survival time (months)  ,"14, 88, 25, 108, 19",,,,
1229987946,5/3/2017 13:01:59,5/4/2017 11:38:08, age,age in days at diagnosis ,"1429, 6306, 6733",,,,
1229987947,5/3/2017 13:01:59,5/4/2017 11:35:51, time,time after vaccination  ,"14d, 0h, 2h, 24h, 4h",,,,
1229987948,5/3/2017 13:01:59,5/4/2017 11:44:36, time,fermentation time  ,"15 hours of fermentation, 17h, 21h, 30h, 12 hours of fermentation",,,,
1229987949,5/3/2017 13:01:59,5/4/2017 11:44:20, treatment,duration of treatment  ,"15 min, 5 days, 30 min, 60 min, 6 hr",,,,
1229987950,5/3/2017 13:01:59,5/4/2017 11:49:01, age,age of sampling ,15 years,,,,
1229987951,5/3/2017 13:01:59,5/4/2017 11:39:53, genotype,genotype of ecat15-1  ,"15-1+/+, 15-1ct/ct, 15-1flox/flox",,,,
1229987952,5/3/2017 13:01:59,5/4/2017 11:39:50, genotype,genotype of ecat15-2  ,"15-2-/-, 15-2+/+",,,,
1229987953,5/3/2017 13:01:59,5/4/2017 11:31:29, time,time post-copulation  ,"15-minutes, 2-hours, 6-hours",,,,
1229987954,5/3/2017 13:01:59,5/4/2017 11:40:38, time,time point (minutes)  ,"15, 30, 60, 5, 45",,,,
1229987955,5/3/2017 13:01:59,5/4/2017 11:42:45, age,mean age in days ,"150, 141.5, 77.25",,,,
1229987956,5/3/2017 13:01:59,5/4/2017 11:40:57, time,time (post-protocol)  ,"16 weeks, 4 weeks, 8 weeks, 2 weeks, baseline",,,,
1229987957,5/3/2017 13:01:59,5/4/2017 11:37:05, strain,strain b6(%)  ,"16, 0, 62.5, 31, 100",,,,
1229987958,5/3/2017 13:01:59,5/4/2017 11:39:24, age,fetus age ,"16.1 weeks, 13.6 weeks, 13.9 weeks, 11 weeks, 9.6 weeks",,,,
1229987959,5/3/2017 13:01:59,5/4/2017 11:36:23, time,time stimulated with anti-igm  ,"16h, 8h, unstimulated, 3h",,,,
1229987960,5/3/2017 13:01:59,5/4/2017 11:33:29, time,post-infection time  ,"16hr, 1hr",,,,
1229987961,5/3/2017 13:01:59,5/4/2017 11:36:20, age,age (weeks of gestation) ,"17, 16, 19",,,,
1229987962,5/3/2017 13:01:59,5/4/2017 11:31:31, time,time os (months)  ,"17, 35, 13, 14, 21",,,,
1229987963,5/3/2017 13:01:59,5/4/2017 11:39:27, time,time_to_dod_(months)  ,"17.68767123, 55.03561644, 6.575342466, 69.50136986, 67.92328767",,,,
1229987964,5/3/2017 13:01:59,5/4/2017 11:47:54, age,age/weight ,170g,,,,
1229987965,5/3/2017 13:01:59,5/4/2017 11:29:35, time,hybridization time  ,"18 hours, 16 hrs, 65 hours, 140 hours, 40 hrs",,,,
1229987966,5/3/2017 13:01:59,5/4/2017 11:43:10, age,gestional age ,"18 weeks, 17 weeks",,,,
1229987967,5/3/2017 13:01:59,5/4/2017 11:31:26, time,time (hours)  ,"18, 24, 4, 0, 6",,,,
1229987968,5/3/2017 13:01:59,5/4/2017 11:36:05, age,serum culture age ,"180 days, 40 days, 60 days",,,,
1229987969,5/3/2017 13:01:59,5/4/2017 11:35:58, time,timesampletaken  ,"1815, 1745, 1515, 1700, 2115",,,,
1229987970,5/3/2017 13:01:59,5/4/2017 11:37:42, time,sirna treatment time point  ,"18hr, 8hr, 4hr, 12hr",,,,
1229987971,5/3/2017 13:01:59,5/4/2017 11:41:05, age,age post partum ,"19 days + 24 hrs, 8 days, 3 days, 19 days, 13 days",,,,
1229987972,5/3/2017 13:01:59,5/4/2017 11:36:42, age,age at sacrifice ,19 weeks old,,,,
1229987973,5/3/2017 13:01:59,5/4/2017 11:23:54, time,cold ischemia time (hours)  ,"19, 16, 20, 30, 24",,,,
1229987974,5/3/2017 13:01:59,5/4/2017 11:48:50, age,mother's age (years) ,"19, 18, 20, 22, 26",,,,
1229987975,5/3/2017 13:01:59,5/4/2017 11:41:22, time,time of embryo collection  ,"196 hpf (hours post-in-vitro fertilization), 7 dpi (days post-in-vivo insemination), 7 dpscnt (days post-somatic cell nuclear transfer), 170 hpf (hours post-in-vitro fertilization), 180 hpf (hours post-in-vitro fertilization)",,,,
1229987976,5/3/2017 13:01:59,5/4/2017 11:34:54, cell line,cell line initiation date  ,"1982, 1988, 1980, 1981",,,,
1229987977,5/3/2017 13:01:59,5/4/2017 11:42:00, time,time post mcao before sample  ,"1h, 6h",,,,
1229987978,5/3/2017 13:01:59,5/4/2017 11:23:37, time,sampling timepoint  ,"1hr after glucose ingestion, before glucose ingestion (baseline), 2hr after glucose ingesion, 8 h, 72 h",,,,
1229987979,5/3/2017 13:01:59,5/4/2017 11:32:52, treatment,tnfa treatment time point  ,"1hr, 2hr, 3hr, 6hr, untreatment",,,,
1229987980,5/3/2017 13:01:59,5/4/2017 11:30:08, time,tnfa treatment time point  ,"1hr, 2hr, 3hr, 6hr, untreatment",,,,
1229987981,5/3/2017 13:01:59,5/4/2017 11:41:25, strain,infrequent clonal strain code  ,"1mel, 5mel",,,,
1229987982,5/3/2017 13:01:59,5/4/2017 11:37:05, treatment,chloride treatment  ,"1mm, none",,,,
1229987983,5/3/2017 13:01:59,5/4/2017 11:38:10, treatment,bl treatment level  ,"1um, 0um",,,,
1229987984,5/3/2017 13:01:59,5/4/2017 11:29:48, time,time extraction  ,"2 days post graft, 7 days post graft, na",,,,
1229987985,5/3/2017 13:01:59,5/4/2017 11:32:44, time,time in continuous light  ,"2 days, 3 days, 4 hrs, 8 hrs, 12 hrs",,,,
1229987986,5/3/2017 13:01:59,5/4/2017 11:19:22, treatment,specific treatments  ,"2 h exposure to 12.5 _ｵg/ml gentamicin, 2h exposure to combined gentamicin ans surface acoustic waves, 2 h exposure to surface acoustic waves generated by a piezo element directly attached to the cathter. the frequency of the vibrations generated on the piezo element is 100 khz _ｱ 10% and at on/off frequency of 30hz, none",,,,
1229987987,5/3/2017 13:01:59,5/4/2017 11:37:02, time,ex vivo challenge time  ,2 hours,,,,
1229987988,5/3/2017 13:01:59,5/4/2017 11:40:38, time,time_after_resection  ,2 hours,,,,
1229987989,5/3/2017 13:01:59,5/4/2017 11:36:08, age,postnatal age ,"2 months, 17 days, 20-38 years, 25 years, 31 years",,,,
1229987990,5/3/2017 13:01:59,5/4/2017 11:41:37, gender,gender and age ,2 year old caucasian female,,,,
1229987991,5/3/2017 13:01:59,5/4/2017 11:41:25, age,gender and age ,2 year old caucasian female,,,,
1229987992,5/3/2017 13:01:59,5/4/2017 11:40:55, time,injected timepoint  ,2-cell stage,,,,
1229987993,5/3/2017 13:01:59,5/4/2017 12:18:36, time,injection timepoint  ,2-cell stage,,,,
1229987994,5/3/2017 13:01:59,5/4/2017 11:39:24, age,plant age ,"2-year old vine, 19 days, 28 days old, 20 days, 30 days",,,,
1229987995,5/3/2017 13:01:59,5/4/2017 11:41:23, time,time after infection (h)  ,"2, 0, 24, 12, 6",,,,
1229987996,5/3/2017 13:01:59,5/4/2017 11:42:00, treatment,time (days of dss treatment)  ,"2, 0, 7",,,,
1229987997,5/3/2017 13:01:59,5/4/2017 11:34:26, time,time (days of dss treatment)  ,"2, 0, 7",,,,
1229987998,5/3/2017 13:01:59,5/4/2017 11:29:49, time,time point (hrs)  ,"2, 10, 14, 18, 22",,,,
1229987999,5/3/2017 13:01:59,5/4/2017 11:41:30, time,time [hours]  ,"2, 24, 12, 6, 0.5",,,,
1229988000,5/3/2017 13:01:59,5/4/2017 12:39:11, treatment,weeks of treatment  ,"2, 3, 5/6, 1, 4",,,,
1229988001,5/3/2017 13:01:59,5/4/2017 11:32:48, time,time point (week end)  ,"2, 4, 6, 8, 20",,,,
1229988002,5/3/2017 13:01:59,5/4/2017 11:27:01, time,ischemic time (days)  ,"2, 5, 1207, 1886, 9",,,,
1229988003,5/3/2017 13:01:59,5/4/2017 11:34:17, treatment,kcl treatment time (hours)  ,"2, 6, 1",,,,
1229988004,5/3/2017 13:01:59,5/4/2017 11:36:01, time,kcl treatment time (hours)  ,"2, 6, 1",,,,
1229988005,5/3/2017 13:01:59,5/4/2017 11:33:31, disease,disease stage  ,"2, cancer, benign, relapse, remission",,,,
1229988006,5/3/2017 13:01:59,5/4/2017 11:29:49, age,age (in days post-partum) ,"20 dpp, 17 dpp",,,,
1229988007,5/3/2017 13:01:59,5/4/2017 11:38:17, age,age at harvest ,20 weeks,,,,
1229988008,5/3/2017 13:01:59,5/4/2017 11:32:07, age,proband age ,"20-38 years, 25 years, 31 years, 22 years",,,,
1229988009,5/3/2017 13:01:59,5/4/2017 11:33:31, time,time (min.)  ,"20, 10, 5, 40, 0",,,,
1229988010,5/3/2017 13:01:59,5/4/2017 11:36:10, age,age_at_blooddraw ,"20, 19, 18, 21, 22",,,,
1229988011,5/3/2017 13:01:59,5/4/2017 11:37:30, time,sporulation timepoint  ,20h,,,,
1229988012,5/3/2017 13:01:59,5/4/2017 11:40:24, time,time post transfection  ,"20h, 120h",,,,
1229988013,5/3/2017 13:01:59,5/4/2017 11:40:21, time,time to harvest  ,21 days,,,,
1229988014,5/3/2017 13:01:59,5/4/2017 11:31:52, treatment,treatment length  ,"21 days, 48 hours, 96 hours, 14 days, 1 hour",,,,
1229988015,5/3/2017 13:01:59,5/4/2017 11:27:09, age,cell culture age ,"21 days, week 27, week 53, week 4, week 8",,,,
1229988016,5/3/2017 13:01:59,5/4/2017 11:21:19, age,culture age ,"21 days, week 27, week 53, week 4, week 8",,,,
1229988017,5/3/2017 13:01:59,5/4/2017 11:30:14, age,biofilm age ,"21 hours, 30 hours, 34 hours, 24 hours",,,,
1229988018,5/3/2017 13:01:59,5/4/2017 11:49:30, treatment,day of dox treatment  ,"21, 14, 27, 0, 2",,,,
1229988019,5/3/2017 13:01:59,5/4/2017 11:59:30, disease,disease free survival (month)  ,"21, 23, 22, 1, 9",,,,
1229988020,5/3/2017 13:01:59,5/4/2017 11:30:24, age,age of epilepsy duration (yr) ,"21, 29",,,,
1229988021,5/3/2017 13:01:59,5/4/2017 11:33:59, time,time (days)  ,"21, 9, 7, 0, 14",,,,
1229988022,5/3/2017 13:01:59,5/4/2017 11:38:50, time,time sac  ,"210, 200, 100, 240, 330",,,,
1229988023,5/3/2017 13:01:59,5/4/2017 11:43:55, strain,b.breve strain  ,210b,,,,
1229988024,5/3/2017 13:01:59,5/4/2017 11:36:15, time,time sample taken  ,"2110, 1710, 1845, 910, 2215",,,,
1229988025,5/3/2017 13:01:59,5/4/2017 11:38:30, time,time rfs  ,"2189, 2280, 5029, 3162, 3648",,,,
1229988026,5/3/2017 13:01:59,5/4/2017 11:37:43, age,hoechst- (viable) cells. age ,22 days of age,,,,
1229988027,5/3/2017 13:01:59,5/4/2017 11:31:08, time,time post bloodmeal  ,22-26 hrs,,,,
1229988028,5/3/2017 13:01:59,5/4/2017 11:29:03, treatment,treatment 2  ,"22mm glucose, 5mm glucose, 20 nm insulin, equine chorionic gonadotropin, i.p.  injection with scriptaid",,,,
1229988029,5/3/2017 13:01:59,5/4/2017 11:33:43, age,age of plants ,"23 months, 3 years",,,,
1229988030,5/3/2017 13:01:59,5/4/2017 11:42:45, age,age of mouse ,"23 weeks, 35 days, na",,,,
1229988031,5/3/2017 13:01:59,5/4/2017 11:25:46, age,age (in years) ,"23, 26, 28, 21, 25",,,,
1229988032,5/3/2017 13:01:59,5/4/2017 11:33:49, treatment,treatment pairs  ,"23, 61, 94, 19, 20",,,,
1229988033,5/3/2017 13:02:00,5/4/2017 11:27:27, time,harvested at what time  ,"24 h, 96 h, 192 h",,,,
1229988034,5/3/2017 13:02:00,5/4/2017 11:41:39, time,time after stimulation  ,"24 h, t30 (minutes), 0 hours, t0 (minutes)",,,,
1229988035,5/3/2017 13:02:00,5/4/2017 11:40:10, time,time post injury  ,24 hours after injury,,,,
1229988036,5/3/2017 13:02:00,5/4/2017 11:29:35, time,culture time  ,"24 hours, 3 days, 32 days, 18 h, 2 days",,,,
1229988037,5/3/2017 13:02:00,5/4/2017 11:37:42, treatment,time post treatment  ,"24 hours, 4 hours, 2 hours, 6 hours, 0 hour",,,,
1229988038,5/3/2017 13:02:00,5/4/2017 11:29:35, time,time post treatment  ,"24 hours, 4 hours, 2 hours, 6 hours, 0 hour",,,,
1229988039,5/3/2017 13:02:00,5/4/2017 11:34:47, time,time of exposure  ,"24 hours, 6 hours, 48 hours, 3 day, 24hrs",,,,
1229988040,5/3/2017 13:02:00,5/4/2017 11:50:51, treatment,length of treatment  ,"24 hours, 6w, 3w, 14hrs",,,,
1229988041,5/3/2017 13:02:00,5/4/2017 11:39:32, treatment,secondary treatment duration  ,"24 hours, 6w, 3w, 14hrs",,,,
1229988042,5/3/2017 13:02:00,5/4/2017 11:43:50, treatment,treatment time point  ,"24 hr, 3 hr, 10 minutes, 30 minutes, 350h",,,,
1229988043,5/3/2017 13:02:00,5/4/2017 11:35:51, time,time after isolation  ,"24 hr, 48 hr, 0 hr",,,,
1229988044,5/3/2017 13:02:00,5/4/2017 11:32:52, time,time point (h)  ,"24, 1, 0, 8, 0.5",,,,
1229988045,5/3/2017 13:02:00,5/4/2017 11:39:37, time,time point (hr)  ,"24, 1, 3, 6, 0.25",,,,
1229988046,5/3/2017 13:02:00,5/4/2017 11:31:23, age,age at collection months ,"24, 13, 12, 49, 37",,,,
1229988047,5/3/2017 13:02:00,5/4/2017 11:29:34, age,donor age (y) ,"24, 28, 23, 30",,,,
1229988048,5/3/2017 13:02:00,5/4/2017 11:36:59, time,sampling time (hours)  ,"24, 336",,,,
1229988049,5/3/2017 13:02:00,5/4/2017 11:32:43, time,time recovery (hour)  ,"24, 48, 72",,,,
1229988050,5/3/2017 13:02:00,5/4/2017 12:18:36, time,time [h]  ,"24, 6, 2, 0, 8",,,,
1229988051,5/3/2017 13:02:00,5/4/2017 11:42:28, treatment,treatment duration (hours)  ,"24, 6, 72",,,,
1229988052,5/3/2017 13:02:00,5/4/2017 11:53:48, treatment,duration of treatment (hours)  ,"24, 8",,,,
1229988053,5/3/2017 13:02:00,5/4/2017 11:37:28, time,harvest time after exposure  ,"24h, 0h, 4h, 1h",,,,
1229988054,5/3/2017 13:02:00,5/4/2017 11:38:26, time,exposure time  ,"24h, 24 h, 96 hours, 24 hrs, 72h",,,,
1229988055,5/3/2017 13:02:00,5/4/2017 11:45:09, treatment,treatment_time  ,"24h, 4 h, 4h, 24 h, 0 hrs",,,,
1229988056,5/3/2017 13:02:00,5/4/2017 11:39:17, time,time point  ,"24h, 6h, 12h, 0h, 0",,,,
1229988057,5/3/2017 13:02:00,5/4/2017 11:35:53, treatment,treatment time-point  ,"24h, 8h, ctrl, 15h, 2h",,,,
1229988058,5/3/2017 13:02:00,5/4/2017 11:33:01, time,treatment time-point  ,"24h, 8h, ctrl, 15h, 2h",,,,
1229988059,5/3/2017 13:02:00,5/4/2017 11:31:14, time,time post-injection  ,"24hr, 48hr",,,,
1229988060,5/3/2017 13:02:00,5/4/2017 11:33:24, time,time of harvest  ,"24hr, 6hr, 2hr",,,,
1229988061,5/3/2017 13:02:00,5/4/2017 11:37:55, time,cell collection time  ,"24hrs after last dose, control, 6hrs after last dose, 2hrs after last dose",,,,
1229988062,5/3/2017 13:02:00,5/4/2017 11:28:14, time,time exposure  ,"24hrs, 2 h, 24+8hrs, 24+6hrs, 32hrs",,,,
1229988063,5/3/2017 13:02:00,5/4/2017 11:41:30, treatment,treatment time (hours)  ,"24hrs, 8, 6hrs, 4, control",,,,
1229988064,5/3/2017 13:02:00,5/4/2017 11:42:05, time,treatment time (hours)  ,"24hrs, 8, 6hrs, 4, control",,,,
1229988065,5/3/2017 13:02:00,5/4/2017 11:36:05, time,time point in batch cycle  ,"254 hrs after the addition of tce, 313 days after the addition of tce, 127 hrs after the addition of tce",,,,
1229988066,5/3/2017 13:02:00,5/4/2017 11:19:57, time,time period  ,"25d, 8h, 3d, 1d, 38d",,,,
1229988067,5/3/2017 13:02:00,5/4/2017 11:38:26, treatment,growth factor treatment  ,"25ng/ml egf, 50ng/ml ngf, no treatment",,,,
1229988068,5/3/2017 13:02:00,5/4/2017 11:39:44, age,age (weeks) ,"26, 12, 6, 8/12/2017, 9",,,,
1229988069,5/3/2017 13:02:00,5/4/2017 11:40:38, age,age at examination ,"26, 29, 46, 30, 28",,,,
1229988070,5/3/2017 13:02:00,5/4/2017 11:41:51, time,harvested time after dose  ,"26hr, 2hr",,,,
1229988071,5/3/2017 13:02:00,5/4/2017 11:44:42, age,maternal age (year) ,"27, 22, 23, 24, 32",,,,
1229988072,5/3/2017 13:02:00,5/4/2017 11:41:48, age,age of gestation ,"28 weeks, 25 weeks",,,,
1229988073,5/3/2017 13:02:00,5/4/2017 11:41:29, age,ageatdraw ,"28, 27, 38, 29, 36",,,,
1229988074,5/3/2017 13:02:00,5/4/2017 11:35:03, age,age of the clone ,"29 months, 24 months",,,,
1229988075,5/3/2017 13:02:00,5/4/2017 11:40:51, age,paternal age ,"29, 32, n/a, 31, 26",,,,
1229988076,5/3/2017 13:02:00,5/4/2017 11:38:14, time,doubling time (hrs)  ,"29.5, 32.3, 35.1, 34.7, 39",,,,
1229988077,5/3/2017 13:02:00,5/4/2017 11:29:42, age,gestational age (w+d) ,"29+6, 29+2, 40+2",,,,
1229988078,5/3/2017 13:02:00,5/4/2017 11:39:27, time,time since lif removal  ,"2d, 0d, 6d, 4d, 8d",,,,
1229988079,5/3/2017 13:02:00,5/4/2017 11:42:43, strain,toxoplasma strain  ,"2f, pru, ctg",,,,
1229988080,5/3/2017 13:02:00,5/4/2017 11:40:14, time,timepoints  ,"2h, 8h, 24h after induction of sexual development, 72h after induction of sexual development, 144h  induction of sexual development",,,,
1229988081,5/3/2017 13:02:00,5/4/2017 11:37:35, time,diet intervention time  ,2wks,,,,
1229988082,5/3/2017 13:02:00,5/4/2017 11:39:29, age,age group (years) ,"3 (>15 yrs), 2 (5-14 yrs), 1 (0-4 yrs), n/a",,,,
1229988083,5/3/2017 13:02:00,5/4/2017 11:34:26, time,time post-mrsa infection  ,"3 day, 1 day",,,,
1229988084,5/3/2017 13:02:00,5/4/2017 11:29:49, time,cell sorting time  ,"3 days after transfection, 7 days after transfection",,,,
1229988085,5/3/2017 13:02:00,5/4/2017 11:28:30, age,treatment age ,3 days post-germination,,,,
1229988086,5/3/2017 13:02:00,5/4/2017 11:42:11, treatment,treatment age  ,3 days post-germination,,,,
1229988087,5/3/2017 13:02:00,5/4/2017 11:42:43, time,time post-wound  ,"3 days, 10 days, 6 hrs, 12 hrs, 24 hrs",,,,
1229988088,5/3/2017 13:02:00,5/4/2017 11:38:45, time,time post-infection  ,"3 days, 2 days, 1 day, 10 days, day 1",,,,
1229988089,5/3/2017 13:02:00,5/4/2017 11:34:49, time,time post exposure  ,"3 days, 4 h, 5 days, 3 h, 24 h",,,,
1229988090,5/3/2017 13:02:00,5/4/2017 11:32:42, treatment,treatment period  ,"3 h, 3 days, 7 days, 0, none",,,,
1229988091,5/3/2017 13:02:00,5/4/2017 11:31:30, time,virus replication time  ,"3 hours, 7 hours, none",,,,
1229988092,5/3/2017 13:02:00,5/4/2017 11:38:39, time,induction time  ,"3 hours, 8 hours, 7 hours, 0 hours, 6 hours",,,,
1229988093,5/3/2017 13:02:00,5/4/2017 11:36:24, time,time in meiosis  ,"3 hr  in meiosis, 2.5 hr  in meiosis, 0 hr  in meiosis, 2 hr  in meiosis, 3.5 hr  in meiosis",,,,
1229988094,5/3/2017 13:02:00,5/4/2017 11:31:26, time,treatment time point  ,"3 hr, 24 hr, 10 minutes, 30 minutes, 350h",,,,
1229988095,5/3/2017 13:02:00,5/4/2017 11:29:03, time,elapsed time  ,"3 hr, 6 hr, 1 hr, 15 min, 30 min",,,,
1229988096,5/3/2017 13:02:00,5/4/2017 11:24:52, age,age of rat ,"3 months, 30 months",,,,
1229988097,5/3/2017 13:02:00,5/4/2017 11:21:04, time,time post-immunization  ,3 weeks,,,,
1229988098,5/3/2017 13:02:00,5/4/2017 11:37:06, age,mouse age ,"3 weeks, p56, 2 days, xenograft cells injected at 6-10 weeks, 8 weeks",,,,
1229988099,5/3/2017 13:02:00,5/4/2017 11:41:01, age,age at biopsy ,"3 years, 42, 52, 76, 7 years",,,,
1229988100,5/3/2017 13:02:00,5/4/2017 11:54:57, treatment,5-aza-c treatment  ,"3_m at 18 hrs post infection for 12 hrs, 5_m at 32 hrs post infection for 24 hrs",,,,
1229988101,5/3/2017 13:02:00,5/4/2017 11:34:10, disease,trg disease state  ,"3, 2, 4, 1",,,,
1229988102,5/3/2017 13:02:00,5/4/2017 11:27:41, time,time point (days)  ,"3, 28, 1, 2, 0",,,,
1229988103,5/3/2017 13:02:00,5/4/2017 11:45:54, time,timepoint (dpa)  ,"3, 28, 35, 7, 21",,,,
1229988104,5/3/2017 13:02:00,5/4/2017 12:10:27, treatment,length of treatment (days)  ,"3, 5, 7, 1.5, 9",,,,
1229988105,5/3/2017 13:02:00,5/4/2017 11:32:02, time,time after induction [days]  ,"3, 6, 12, 9, n/a",,,,
1229988106,5/3/2017 13:02:00,5/4/2017 11:35:58, treatment,days of ddc treatment  ,"3, 7, 14, 0",,,,
1229988107,5/3/2017 13:02:00,5/4/2017 11:36:21, genotype,apoe genotype  ,"3,4, 3,3, 4,4, 3/3, 2,4",,,,
1229988108,5/3/2017 13:02:00,5/4/2017 11:38:09, time,time since meiosis started  ,"3.5 hours, 5 hours",,,,
1229988109,5/3/2017 13:02:00,5/4/2017 11:36:06, time,time post transplant  ,"3.5 years, 9 years, 4 years, 3 years",,,,
1229988110,5/3/2017 13:02:00,5/4/2017 11:58:29, age,animal age ,"30 days embryo, 2 yr, 8-12 weeks, 2-months",,,,
1229988111,5/3/2017 13:02:00,5/4/2017 11:39:24, time,time (days post-treatment)  ,"30 days, 1 day, 15 days, 7 days, 3 days",,,,
1229988112,5/3/2017 13:02:00,5/4/2017 11:41:05, time,cell harvest time  ,"30 hrs post infection, 56 hrs post infection",,,,
1229988113,5/3/2017 13:02:00,5/4/2017 11:42:58, time,post-injury time  ,"30 minutes, 3 days, 7 days, no injury",,,,
1229988114,5/3/2017 13:02:00,5/4/2017 11:39:44, time,time (min)  ,"30, 0, 60, 75, 45",,,,
1229988115,5/3/2017 13:02:00,5/4/2017 11:39:50, time,infection time (min)  ,"30, 120, 60, 0",,,,
1229988116,5/3/2017 13:02:00,5/4/2017 11:39:48, age,age in years ,"30, 25, 23, 43, 32",,,,
1229988117,5/3/2017 13:02:00,5/4/2017 11:34:58, age,current age (2007) ,"30, 40, 24, 29, 66",,,,
1229988118,5/3/2017 13:02:00,5/4/2017 11:24:34, time,time (dpi)  ,"30, 6, 15, 8, 0",,,,
1229988119,5/3/2017 13:02:00,5/4/2017 11:36:59, genotype,hla-dqb1 genotype  ,"302, 02, 0302, 2",,,,
1229988120,5/3/2017 13:02:00,5/4/2017 11:59:08, tissue,tissue_mg ,"31, 33, 26",,,,
1229988121,5/3/2017 13:02:00,5/4/2017 11:32:07, time,time biopsy to surgery (days)  ,"31, 35, 18, 23, 42",,,,
1229988122,5/3/2017 13:02:00,5/4/2017 11:33:05, time,survival time (days)  ,"3183, 3309, 1680, 1604, 5128",,,,
1229988123,5/3/2017 13:02:00,5/4/2017 11:19:57, time,time post-induction  ,"32 hours, 48 hours, 24 hours, 6h, 0h",,,,
1229988124,5/3/2017 13:02:00,5/4/2017 11:35:58, age,maternal age (yrs) ,"32, 29, 28, 35, 33",,,,
1229988125,5/3/2017 13:02:00,5/4/2017 11:33:24, time,time_in_freezer  ,"3277, 3892, 3618, 3365, 3001",,,,
1229988126,5/3/2017 13:02:00,5/4/2017 11:33:52, genotype,genotype icsbp1  ,"33, 13, 11",,,,
1229988127,5/3/2017 13:02:00,5/4/2017 12:10:12, strain,bxd strain  ,"33, 28, 21, 40, 12",,,,
1229988128,5/3/2017 13:02:00,5/4/2017 11:33:43, time,time pfs (months)  ,"35, 25, 14, 16, 12",,,,
1229988129,5/3/2017 13:02:00,5/4/2017 11:27:12, age,age at sacrifice (days) ,"35, 50",,,,
1229988130,5/3/2017 13:02:00,5/4/2017 11:40:22, time,cultivated time  ,36h,,,,
1229988131,5/3/2017 13:02:00,5/4/2017 11:32:43, time,time after plating  ,36h,,,,
1229988132,5/3/2017 13:02:00,5/4/2017 11:38:09, age,gestational age (wk) ,"37, 38, 36, 34, 32",,,,
1229988133,5/3/2017 13:02:00,5/4/2017 11:42:28, age,gestational age ,"37, 38, 39, 14wk, e16",,,,
1229988134,5/3/2017 13:02:00,5/4/2017 11:32:44, age,age at collection ,"38 weeks, 53, 58, 65, 54",,,,
1229988135,5/3/2017 13:02:00,5/4/2017 11:42:43, age,age of woman [years] ,"38, 34, 35, 27, 32",,,,
1229988136,5/3/2017 13:02:00,5/4/2017 11:36:27, treatment,stress treatment  ,"38c for 3hrs, 100 mm nacl for 3hrs, 800 _ｵm photons m-2s-1 for 3hrs, 10c for 3hrs, 100 mm nacl + 38c for 3hrs",,,,
1229988137,5/3/2017 13:02:00,5/4/2017 11:39:27, age,gestational age (wks) ,"39, 39, 38, 39.43, 39.71",,,,
1229988138,5/3/2017 13:02:00,5/4/2017 11:41:14, age,age at 1st diagnosis ,"39, 44, 52, 47, 36",,,,
1229988139,5/3/2017 13:02:00,5/4/2017 11:36:22, age,diagnosis age ,"39, 45, 47, 49, 54",,,,
1229988140,5/3/2017 13:02:00,5/4/2017 11:36:37, time,post-mixing time  ,3h,,,,
1229988141,5/3/2017 13:02:00,5/4/2017 11:41:05, time,time (post-treatment)  ,"3h, 6h, 0h, 21h, 18h",,,,
1229988142,5/3/2017 13:02:00,5/4/2017 11:36:54, time,timepoint/developmental stage  ,"3hr after lights are on, 0hr, 4hr, 2hr",,,,
1229988143,5/3/2017 13:02:00,5/4/2017 11:35:29, time,time (post-infection)  ,"4 day, 2 day, 1 day, 7 day, day 14",,,,
1229988144,5/3/2017 13:02:00,5/4/2017 11:29:42, time,stimulation time  ,"4 days, 24h, 2h, 0h, 120 minutes",,,,
1229988145,5/3/2017 13:02:00,5/4/2017 11:30:14, time,time (duration)  ,4 h,,,,
1229988146,5/3/2017 13:02:00,5/4/2017 11:30:19, time,time after media shift  ,"4 hours, 1 hour",,,,
1229988147,5/3/2017 13:02:00,5/4/2017 11:37:35, age,age time point ,"4 hours, 12 hours, 2 hours, 28 hours after nutrient removal, 14h timepoint",,,,
1229988148,5/3/2017 13:02:00,5/4/2017 11:23:37, time,age time point  ,"4 hours, 12 hours, 2 hours, 28 hours after nutrient removal, 14h timepoint",,,,
1229988149,5/3/2017 13:02:00,5/4/2017 11:37:58, time,incubation time  ,"4 hours, 280-288 degree days post fertilisation, 24, 8 hours, 2 hours",,,,
1229988150,5/3/2017 13:02:00,5/4/2017 11:34:21, time,meiotic timepoint  ,"4 hours, 3 hours, 6 hours",,,,
1229988151,5/3/2017 13:02:00,5/4/2017 11:29:49, time,treatement time  ,"4 hours, 40 hours, 10, 0, 40",,,,
1229988152,5/3/2017 13:02:00,5/4/2017 11:41:22, time,infection time  ,"4 hours, 48h, 4h, 18h, 6hr",,,,
1229988153,5/3/2017 13:02:00,5/4/2017 11:32:01, time,time after infection  ,"4 hours, 7 days, 10 days, 14 days, 21 days",,,,
1229988154,5/3/2017 13:02:00,5/4/2017 11:36:23, time,time of euthanasia  ,"4 hr, 12 hr, 20 hr, 0 hr, 8 hr",,,,
1229988155,5/3/2017 13:02:00,5/4/2017 11:19:57, time,stimulation time and condition  ,"4 hrs bcg stimulated, 4 hrs unstimulated, 12 hrs bcg stimulated, 12 hrs unstimulated",,,,
1229988156,5/3/2017 13:02:00,5/4/2017 11:30:22, age,mouse model age ,4 weeks,,,,
1229988157,5/3/2017 13:02:00,5/4/2017 11:34:49, time,time after exposure  ,"4 weeks, 1 hour, 12 weeks, 3 weeks, 6 weeks",,,,
1229988158,5/3/2017 13:02:00,5/4/2017 11:40:19, treatment,vernalization treatment  ,"4_皇, short day (8 hours light/16 hours dark)",,,,
1229988159,5/3/2017 13:02:00,5/4/2017 11:40:10, time,differentiation time days  ,"4, 0",,,,
1229988160,5/3/2017 13:02:00,5/4/2017 11:35:51, time,time class  ,"4, 0, 24",,,,
1229988161,5/3/2017 13:02:00,5/4/2017 11:38:39, time,time trial  ,"4, 1, 2, 3, 0",,,,
1229988162,5/3/2017 13:02:00,5/4/2017 11:42:58, tissue,tissue/treatment id ,"4, 2, 3, 1, 7",,,,
1229988163,5/3/2017 13:02:00,5/4/2017 11:39:47, age,taqman pool by age ,"4, 5, 2, 6, 3",,,,
1229988164,5/3/2017 13:02:00,5/4/2017 11:29:03, age,age of epilepsy onset (yr) ,"4, 7, 13, 14, 2",,,,
1229988165,5/3/2017 13:02:00,5/4/2017 11:27:33, time,time (wpi)  ,"4, 8, 2, 9, 10",,,,
1229988166,5/3/2017 13:02:00,5/4/2017 11:34:17, disease,disease duration (yrs)  ,"4, 9, 7, 1",,,,
1229988167,5/3/2017 13:02:00,5/4/2017 11:31:29, time,survival time (year)  ,"4.5, 4.25, 4.58, 4.17, 4.33",,,,
1229988168,5/3/2017 13:02:00,5/4/2017 11:42:00, age,age at infection ,"4.6, 11.5, 8.1, 5 weeks, 9.5",,,,
1229988169,5/3/2017 13:02:00,5/4/2017 11:35:04, genotype,per3 genotype  ,"4\4, 5\5",,,,
1229988170,5/3/2017 13:02:00,5/4/2017 11:36:11, age,age at tumor ,40 days,,,,
1229988171,5/3/2017 13:02:00,5/4/2017 11:23:54, age,gestational age (weeks) ,"40, 39, 38, 41, 26",,,,
1229988172,5/3/2017 13:02:00,5/4/2017 11:40:38, age,age diagnosis ,"405, 348, 188, 709, 231",,,,
1229988173,5/3/2017 13:02:00,5/4/2017 11:39:22, age,age at disease onset ,"41, 35, 30, 37, 32",,,,
1229988174,5/3/2017 13:02:00,5/4/2017 11:43:50, disease,age at disease onset  ,"41, 35, 30, 37, 32",,,,
1229988175,5/3/2017 13:02:00,5/4/2017 11:37:42, age,average age ,"41.42 _ｱ 9.72, 43.17 _ｱ 8.66, 64.7, 49, 29.7",,,,
1229988176,5/3/2017 13:02:00,5/4/2017 11:37:49, time,time of gut bacteria  ,"42 days prior, 1 day prior, 2 days prior, 14 days prior, 35 days prior",,,,
1229988177,5/3/2017 13:02:00,5/4/2017 11:40:57, age,age (postnatal day) ,"42, 3, 10, pnd 0 (<24 hrs), 0",,,,
1229988178,5/3/2017 13:02:00,5/4/2017 11:34:11, time,time after feeding  ,42h,,,,
1229988179,5/3/2017 13:02:00,5/4/2017 11:37:58, age,donor's age ,"43 years old, 53 years old, 56 years old, 16 years old, 6 years old",,,,
1229988180,5/3/2017 13:02:00,5/4/2017 11:41:25, age,age_tx ,"43, 26, 41, 42, 55.2",,,,
1229988181,5/3/2017 13:02:00,5/4/2017 11:38:52, age,age at sample (months) ,"43, 67, 19, 22, 37",,,,
1229988182,5/3/2017 13:02:00,5/4/2017 11:30:40, time,time (post-injection)  ,"44 hours, 20 hours",,,,
1229988183,5/3/2017 13:02:00,5/4/2017 11:44:35, age,agedx ,"44, 34",,,,
1229988184,5/3/2017 13:02:00,5/4/2017 11:41:31, age,cell age ,"44, 50, 31, 34",,,,
1229988185,5/3/2017 13:02:00,5/4/2017 11:25:46, time,4su labeling time  ,45 min,,,,
1229988186,5/3/2017 13:02:00,5/4/2017 11:37:56, time,doubling time  ,"45.5, 39, 29.5, 23.8, 32.3",,,,
1229988187,5/3/2017 13:02:00,5/4/2017 11:39:53, age,age_years ,"46, 51, 42, 47, 58",,,,
1229988188,5/3/2017 13:02:00,5/4/2017 11:39:38, cell line,cell line karyotype  ,"46,xx, 46,xy, 49,xxxxy, 47,xxx",,,,
1229988189,5/3/2017 13:02:00,5/4/2017 11:35:19, age,age range ,"48-92 years old, 18-25 yr old, pediatric patient",,,,
1229988190,5/3/2017 13:02:00,5/4/2017 11:40:10, time,developmental time point  ,"48, 15 days of age, 6 weeks of age, gestational day 15, 19 days of age",,,,
1229988191,5/3/2017 13:02:00,5/4/2017 11:41:02, age,patient age (yrs) ,"48, 46, 56, 53, 50",,,,
1229988192,5/3/2017 13:02:00,5/4/2017 11:42:11, age,age at blood sample collection ,"48, 49, 55, 47, 46",,,,
1229988193,5/3/2017 13:02:00,5/4/2017 11:29:36, time,time_hr_post_hypoxia  ,"48, 6, 168, 1, 12",,,,
1229988194,5/3/2017 13:02:00,5/4/2017 11:40:19, time,time_point  ,"48h, 24h, early, late, 16h",,,,
1229988195,5/3/2017 13:02:00,5/4/2017 11:37:03, time,collection timepoint  ,"48hr, 10hr",,,,
1229988196,5/3/2017 13:02:00,5/4/2017 11:37:30, cell line,cell line passage  ,"49-50, 40, 7",,,,
1229988197,5/3/2017 13:02:00,5/4/2017 11:54:57, age,age-at-biopsy-years ,"49, 39, 41",,,,
1229988198,5/3/2017 13:02:00,5/4/2017 11:28:13, age,subject age ,"49, 9, na, 4, 52",,,,
1229988199,5/3/2017 13:02:00,5/4/2017 11:38:08, treatment,time after h2o2 treatment  ,4h,,,,
1229988200,5/3/2017 13:02:00,5/4/2017 11:40:59, time,time after h2o2 treatment  ,4h,,,,
1229988201,5/3/2017 13:02:00,5/4/2017 11:41:01, time,sk-mel-103 time  ,"4h, 10h",,,,
1229988202,5/3/2017 13:02:00,5/4/2017 11:38:43, time,il4 stimulation time  ,"4h, 18h, none",,,,
1229988203,5/3/2017 13:02:00,5/4/2017 11:38:39, time,recovery time  ,"4h, 28 days, 28d, 16 weeks, 0 hours",,,,
1229988204,5/3/2017 13:02:00,5/4/2017 11:37:56, time,reperfusion time  ,4hr,,,,
1229988205,5/3/2017 13:02:00,5/4/2017 11:32:57, age,age of ipi (yr/mo) ,"4yr, 2yr, 13yr, 3yr",,,,
1229988206,5/3/2017 13:02:00,5/4/2017 11:40:44, age,age at sampling ,"4yr, 6yr, 3yr, 8yr, 5yr",,,,
1229988207,5/3/2017 13:02:00,5/4/2017 11:39:25, time,sample time after surgery  ,5 days,,,,
1229988208,5/3/2017 13:02:00,5/4/2017 11:41:29, time,mnase digestion time  ,"5 min, 25 min",,,,
1229988209,5/3/2017 13:02:00,5/4/2017 11:37:30, treatment,h2o2 treatment  ,5 mm,,,,
1229988210,5/3/2017 13:02:00,5/4/2017 11:29:49, treatment,treatment dose  ,"5 ng/ml, 10 _ｵm, 10 u/ml, 3 um, 5 _ｵm",,,,
1229988211,5/3/2017 13:02:00,5/4/2017 11:44:36, age,mutant age ,"5 week-old tissue48 hpi with pst dc3000(avrrpt2) leaves, 5 week-old tissueuninoculated leaves",,,,
1229988212,5/3/2017 13:02:00,5/4/2017 11:32:19, age,wild-type (col-0) age ,"5 week-old tissueuninoculated leaves, 5 week-old tissue48 hpi with pst dc3000(avrrpt2) leaves",,,,
1229988213,5/3/2017 13:02:00,5/4/2017 11:41:00, age,in a diurnal environment. age ,5 weeks old,,,,
1229988214,5/3/2017 13:02:00,5/4/2017 11:33:02, age,age (month) ,"5, 10, 3, 17, 2",,,,
1229988215,5/3/2017 13:02:00,5/4/2017 11:30:49, treatment,treatment batch  ,"5, 2, 1, 3, 4",,,,
1229988216,5/3/2017 13:02:00,5/4/2017 12:03:29, age,age at diagonosis (years) ,"5.2, 5.6, 15.7, 5.3, 6.4",,,,
1229988217,5/3/2017 13:02:00,5/4/2017 11:22:00, time,time.to.death (years)  ,"5.36, 3.93",,,,
1229988218,5/3/2017 13:02:00,5/4/2017 11:27:16, time,dmfs time  ,"5.58, 5.83, 4, na, 4.83",,,,
1229988219,5/3/2017 13:02:00,5/4/2017 11:27:01, treatment,treatment concentration  ,"500nm, 10 mm, 0.3mm h2o2, --",,,,
1229988220,5/3/2017 13:02:00,5/4/2017 11:43:42, age,median age ,"51, 33, 42, 30",,,,
1229988221,5/3/2017 13:02:00,5/4/2017 11:34:47, age,age on study ,"51, 33, 59, 38, 22",,,,
1229988222,5/3/2017 13:02:00,5/4/2017 11:40:54, age,age at surgery (yrs) ,"51, 75, 78, 39, 40",,,,
1229988223,5/3/2017 13:02:00,5/4/2017 11:39:37, age,donor age ,"52, 40, 53, 23, adult",,,,
1229988224,5/3/2017 13:02:00,5/4/2017 11:29:03, age,recipient age ,"52, 50, 48, 43, 30",,,,
1229988225,5/3/2017 13:02:00,5/4/2017 11:31:27, age,age at death ,"52, 87 years, 44, 57, 61",,,,
1229988226,5/3/2017 13:02:00,5/4/2017 11:46:57, age,age of patient ,"53, 45, 47 years, 34 years, 40 years",,,,
1229988227,5/3/2017 13:02:00,5/4/2017 11:53:29, age,age in 1986 ,"54, 17, 22, 15, 24",,,,
1229988228,5/3/2017 13:02:00,5/4/2017 12:03:29, age,age at 2nd diagnosis ,"54, 57, 49, 44, 42",,,,
1229988229,5/3/2017 13:02:00,5/4/2017 11:54:51, age,age(yrs.) ,"54, 76, 55, 81, 39",,,,
1229988230,5/3/2017 13:02:00,5/4/2017 11:36:34, treatment,co2 treatment  ,"540 ppm co2, 1020 ppm co2,",,,,
1229988231,5/3/2017 13:02:00,5/4/2017 11:48:50, age,gallus gallus  - age ,"55 week dev. stage (boyes et al. plant cell 2001), 55weekdev.stage (boyes et al",,,,
1229988232,5/3/2017 13:02:00,5/4/2017 11:38:46, age,age at excision (years) ,"55, 52, 69, 56, 64",,,,
1229988234,5/3/2017 13:02:00,5/4/2017 11:41:22, age,age(years) ,"55, 56, 58, na, 61",,,,
1229988235,5/3/2017 13:02:00,5/4/2017 11:59:07, strain,strains  ,"5500 yeast mutants, pcc 9802 and fgp-2, 200-800 zebrafish from ab*,ab2o2,ab2o2 golden and ab2o2 leo, bd11, bn, bd11, sprd-cu3",,,,
1229988236,5/3/2017 13:02:00,5/4/2017 11:42:11, age,age of human sera ,"56, 44, 54, 58, 63",,,,
1229988237,5/3/2017 13:02:00,5/4/2017 11:38:29, time,survival time  ,"56, 726, 173, 302, 71",,,,
1229988238,5/3/2017 13:02:00,5/4/2017 11:31:23, age,age at dx ,"57, 49, 61, 54, 73",,,,
1229988239,5/3/2017 13:02:00,5/4/2017 11:40:32, age,age (at diagnosis) ,"58, 61, 65, 46, 50",,,,
1229988240,5/3/2017 13:02:00,5/4/2017 11:39:21, age,mean age ,"58.5 years, 38.25yrs., 31.5 years old, 41.3, 29.68yrs",,,,
1229988241,5/3/2017 13:02:00,5/4/2017 11:35:53, age,ageatrecruitment ,"59, 73, 63, 70, 58",,,,
1229988242,5/3/2017 13:02:00,5/4/2017 11:41:22, time,bddm followup time (months)  ,"59.9917864, 60, 39.3264887, 38.8336756, 59.5975359",,,,
1229988243,5/3/2017 13:02:00,5/4/2017 11:40:25, time,differentiation time  ,"6 days, 4 weeks, 0 days, 2 days, day 3.5",,,,
1229988244,5/3/2017 13:02:00,5/4/2017 11:33:08, time,sulfur deprivation time  ,6 hours,,,,
1229988245,5/3/2017 13:02:00,5/4/2017 11:41:22, time,time post injection  ,"6 hours post infection, 10 days post infection",,,,
1229988246,5/3/2017 13:02:00,5/4/2017 11:54:51, treatment,period of salt treatment  ,"6 hours, 1 hour, 3 hours, 12 hours, 0 hour",,,,
1229988247,5/3/2017 13:02:00,5/4/2017 11:37:43, treatment,treatment exposure  ,"6 hours, 1 hours",,,,
1229988248,5/3/2017 13:02:00,5/4/2017 11:32:01, time,sacrifice time  ,"6 hours, 1344, 1300, 1326, 1629",,,,
1229988249,5/3/2017 13:02:00,5/4/2017 11:33:49, time,growth time  ,"6 hours, 2 hours, 16 hour culture, three days, 4hr",,,,
1229988250,5/3/2017 13:02:00,5/4/2017 11:31:49, time,time point [c]  ,"6 hours, 2 hours, 24 hours, 12 hours, 0 hours",,,,
1229988251,5/3/2017 13:02:00,5/4/2017 11:26:10, time,time of progression  ,"6 wks, 7 wks, 9 wks, 13 wks, 12 wks",,,,
1229988252,5/3/2017 13:02:00,5/4/2017 11:40:55, time,time(wpi)  ,"6 wpi, 2 wpi, 4 wpi, 8 wpi, 10 wpi",,,,
1229988253,5/3/2017 13:02:00,5/4/2017 13:25:13, age,age at start of treatment ,"6-8 d, 2 d",,,,
1229988254,5/3/2017 13:02:00,5/4/2017 11:35:48, treatment,age at start of treatment  ,"6-8 d, 2 d",,,,
1229988255,5/3/2017 13:02:00,5/4/2017 11:34:58, age,age of plant ,6-leaf-old,,,,
1229988256,5/3/2017 13:02:00,5/4/2017 11:39:35, time,time after induction[days]  ,"6, 0, 9, 12, 3",,,,
1229988257,5/3/2017 13:02:00,5/4/2017 11:31:31, time,time-to-progession (months)  ,"6, 11, 8, 3, 10",,,,
1229988258,5/3/2017 13:02:00,5/4/2017 11:37:05, time,time (hr)  ,"6, 48, 0, 30, 24",,,,
1229988259,5/3/2017 13:02:00,5/4/2017 11:37:58, tissue,tissue ph ,"6.46, 6.43, 6.28, 6.38, 6.06",,,,
1229988260,5/3/2017 13:02:00,5/4/2017 11:29:35, time,brain ph at time of freezing  ,"6.6, 6.76, 6.3, 6.93, 6.59",,,,
1229988261,5/3/2017 13:02:00,5/4/2017 11:35:58, age,agedecade ,"60-69, n/a, 70-79, 68, 78",,,,
1229988262,5/3/2017 13:02:00,5/4/2017 11:27:09, age,age at death (in years) ,"60, 53, 57, 62, 55",,,,
1229988263,5/3/2017 13:02:00,5/4/2017 11:58:56, age,age (yr-old) ,"60, 65, 74, 58, 67",,,,
1229988264,5/3/2017 13:02:00,5/4/2017 11:19:57, age,age of blood draw ,"60, 66, 71, 63, 75",,,,
1229988265,5/3/2017 13:02:00,5/4/2017 11:29:44, age,age at time of resection ,"60y 5m, 34y 2m, 59y 7m, 31y 3m, 57y 11m",,,,
1229988266,5/3/2017 13:02:00,5/4/2017 11:41:14, time,age at time of resection  ,"60y 5m, 34y 2m, 59y 7m, 73y 4m, 31y 3m",,,,
1229988267,5/3/2017 13:02:00,5/4/2017 12:10:12, age,patient age ,"61, 60, 57, 37, 54",,,,
1229988268,5/3/2017 13:02:00,5/4/2017 11:58:29, age,age at op ,"61, 64, 63, 65, 67",,,,
1229988269,5/3/2017 13:02:00,5/4/2017 11:21:16, age,age(yrs) ,"62, 26.6, 30, 64, 72",,,,
1229988270,5/3/2017 13:02:00,5/4/2017 11:21:04, age,age quit smoking ,"62, 40, 65, 56, 68",,,,
1229988271,5/3/2017 13:02:00,5/4/2017 11:29:44, age,age@dx ,"62, 58, 44, 75, 65",,,,
1229988272,5/3/2017 13:02:00,5/4/2017 11:29:33, age,ageatdiagnosis ,"63, 67, 59, 12, 52",,,,
1229988273,5/3/2017 13:02:00,5/4/2017 11:21:19, age,age_diag ,"63, 78, 74, 66, 71",,,,
1229988274,5/3/2017 13:02:00,5/4/2017 11:48:55, age,ageofoperation ,"64, 54, 60, 27, 48",,,,
1229988275,5/3/2017 13:02:00,5/4/2017 11:37:49, age,age of diagnosis ,"65, 57, 49, 59, 46",,,,
1229988276,5/3/2017 13:02:00,5/4/2017 11:31:27, age,age [y] ,"65, 66, 61, 76, 70",,,,
1229988277,5/3/2017 13:02:00,5/4/2017 11:37:55, age,age (yrs) at dasatinib start ,"65, 66, 63, 59, 39",,,,
1229988278,5/3/2017 13:02:00,5/4/2017 11:44:36, age,age.at.surgery ,"65, 67, 69, 63, 70",,,,
1229988279,5/3/2017 13:02:00,5/4/2017 11:41:30, age,age at radiation ,"66, 57, 47, 65, 54",,,,
1229988280,5/3/2017 13:02:00,5/4/2017 11:36:21, age,age_at_diagnosis ,"66, 58, 62, 73, 64",,,,
1229988281,5/3/2017 13:02:00,5/4/2017 11:25:52, age,age at the time of surgery ,"67, 76, 71, 72, 63",,,,
1229988282,5/3/2017 13:02:00,5/4/2017 12:04:28, age,age at time of surgery ,"67, 76, 71, 72, 63",,,,
1229988283,5/3/2017 13:02:00,5/4/2017 11:37:49, time,age at time of surgery  ,"67, 76, 71, 72, 63",,,,
1229988284,5/3/2017 13:02:00,5/4/2017 11:41:29, age,age.year ,"67.5, 75.3, 74.5, 71.3",,,,
1229988285,5/3/2017 13:02:00,5/4/2017 11:38:01, age,ctl bone age ,"68 years  sexfemale, 72 years  sexfemale, 83 years  sexfemale, 71 years  sexmale",,,,
1229988286,5/3/2017 13:02:00,5/4/2017 11:36:42, age,age at onset ,"68 years, 60 years, 48 years, 71 years, 62 years",,,,
1229988287,5/3/2017 13:02:00,5/4/2017 11:38:46, age,age-at-examination ,"68, 47, 48, 54, 69",,,,
1229988288,5/3/2017 13:02:00,5/4/2017 11:33:49, age,age at primary diagnosis ,"68, 54, 49, 58, 72",,,,
1229988289,5/3/2017 13:02:00,5/4/2017 11:41:25, age,age at metastases ,"68, 61, 59, 76, 74",,,,
1229988290,5/3/2017 13:02:00,5/4/2017 11:35:47, age,age at diagnosis ,"68, 61, 71, 73, 51",,,,
1229988291,5/3/2017 13:02:00,5/4/2017 11:33:06, age,age (yrs) at rrp ,"68, 66, 67, 70, 71",,,,
1229988292,5/3/2017 13:02:00,5/4/2017 11:29:36, age,age_at_prostatectomy_(years) ,"68, 67, 64, 58, 59",,,,
1229988293,5/3/2017 13:02:00,5/4/2017 11:30:08, age,age at diagnosis (y) ,"68, 73, 64, 72, 82",,,,
1229988294,5/3/2017 13:02:00,5/4/2017 11:34:10, age,age_enroll ,"68.4, 59.9, 69.9, 65.4, 66.3",,,,
1229988295,5/3/2017 13:02:00,5/4/2017 11:54:57, time,culture doubling time  ,"69 hours, 4.6 hours",,,,
1229988296,5/3/2017 13:02:00,5/4/2017 11:41:01, cell line,cell line number  ,"69, 11, 64, 71, 12",,,,
1229988297,5/3/2017 13:02:00,5/4/2017 11:36:34, age,age (yrs) ,"69, 66, na, 67, 51, 50",,,,
1229988298,5/3/2017 13:02:00,5/4/2017 11:52:16, age,age (years at surgery) ,"69, 70, 56, 67, 59",,,,
1229988299,5/3/2017 13:02:00,5/4/2017 11:36:10, age,age (days) ,"69, 70, 56, 9, 74",,,,
1229988300,5/3/2017 13:02:00,5/4/2017 11:31:52, time,time submerged  ,"6d, 1d",,,,
1229988301,5/3/2017 13:02:00,5/4/2017 11:34:21, treatment,post-dac treatment  ,"6h etoh treatment, 6h e2 treatment",,,,
1229988302,5/3/2017 13:02:00,5/4/2017 11:29:49, treatment,treatment time  ,"6hr, 2hr, 0hr, 24h, 14 days",,,,
1229988303,5/3/2017 13:02:00,5/4/2017 11:37:55, time,treatment time  ,"6hr, 2hr, 0hr, 24h, 14 days",,,,
1229988304,5/3/2017 13:02:00,5/4/2017 11:42:45, time,time (doxorubicin)  ,"6hrs, 1hrs, 9hrs, 0hrs, 3hrs",,,,
1229988305,5/3/2017 13:02:00,5/4/2017 11:28:59, time,time in entraining conditions  ,7 d,,,,
1229988306,5/3/2017 13:02:00,5/4/2017 11:39:53, time,time of biopsy  ,"7 days after the putative luteinizing hormone surge, biopsy at baseline, 6 days after the putative luteinizing hormone surge, biopsy at 3 months after inclusion, 8 days after the putative luteinizing hormone surge",,,,
1229988307,5/3/2017 13:02:00,5/4/2017 11:25:46, time,time in culture  ,"7 days, 14 days, 48 hours, 6, 72",,,,
1229988308,5/3/2017 13:02:00,5/4/2017 11:31:27, time,time (incubation)  ,"7 hrs, control, 24 hrs",,,,
1229988309,5/3/2017 13:02:00,5/4/2017 11:43:11, treatment,time of tamoxifen treatment  ,"7 months of tamoxifen treatment in vivo, 8 months of tamoxifen treatment in vivo, from 7 to 8 months of tamoxifen treatment in vivo, 9 months of tamoxifen treatment in vivo, 10 months of tamoxifen treatment in vivo",,,,
1229988310,5/3/2017 13:02:00,5/4/2017 11:43:12, time,time of tamoxifen treatment  ,"7 months of tamoxifen treatment in vivo, 8 months of tamoxifen treatment in vivo, from, 7 to 8 months of tamoxifen treatment in vivo, 9 months of tamoxifen treatment in vivo, 10 months of tamoxifen treatment in vivo",,,,
1229988311,5/3/2017 13:02:00,5/4/2017 11:32:32, age,age diet commenced ,7 weeks,,,,
1229988312,5/3/2017 13:02:00,5/4/2017 11:29:03, age,age high salt diet commenced ,7 weeks,,,,
1229988313,5/3/2017 13:02:00,5/4/2017 11:27:50, age,age put on diet ,7 weeks,,,,
1229988314,5/3/2017 13:02:00,5/4/2017 11:44:42, age,age at irradiation ,"7 weeks, 3 weeks, non-irradiated",,,,
1229988315,5/3/2017 13:02:00,5/4/2017 11:35:51, age,age at start ,"7 weeks, 9 weeks, 10 weeks",,,,
1229988316,5/3/2017 13:02:00,5/4/2017 12:02:25, treatment,day of dss treatment  ,"7, 0",,,,
1229988317,5/3/2017 13:02:00,5/4/2017 11:30:13, time,expression time hours  ,"7, 10",,,,
1229988318,5/3/2017 13:02:00,5/4/2017 11:41:13, time,time after lesion (days)  ,"7, 3, 21, 40, 0",,,,
1229988319,5/3/2017 13:02:00,5/4/2017 11:19:57, age,age (month) at surgery ,"7, 8, 6, 3, 23",,,,
1229988320,5/3/2017 13:02:00,5/4/2017 11:42:43, age,age induced (days) ,"7, 8, 9, 5",,,,
1229988321,5/3/2017 13:02:00,5/4/2017 11:35:54, time,metastasis time (month)  ,"7.121661721, 26.50840752, 11.53972964, 27.4975272, 1.153972964",,,,
1229988322,5/3/2017 13:02:00,5/4/2017 11:39:54, time,os time  ,"7.94, 2.86, 271, 1.18, 7.43",,,,
1229988323,5/3/2017 13:02:00,5/4/2017 11:29:16, age,agegroupatsampledraw ,"70 to 75, 55 to 60, 60 to 65, 65 to 70, over 75",,,,
1229988324,5/3/2017 13:02:00,5/4/2017 11:23:37, time,fu time  ,"70.08, 62.85, 6.54",,,,
1229988325,5/3/2017 13:02:00,5/4/2017 11:46:21, age,onset of age ,"71, 65, 64, 76, 60",,,,
1229988326,5/3/2017 13:02:00,5/4/2017 11:41:30, age,age at operation (yrs) ,"71.1, 70.5, 69.8, 56, 68.1",,,,
1229988327,5/3/2017 13:02:00,5/4/2017 11:23:11, genotype,backgroud genotype  ,717-1b4,,,,
1229988328,5/3/2017 13:02:00,5/4/2017 11:44:16, age,age seedlings ,"72 hag, 78 hag, 74 hag",,,,
1229988329,5/3/2017 13:02:00,5/4/2017 11:40:25, time,culture time (hrs)  ,"72, 12, 6, 192, 0",,,,
1229988330,5/3/2017 13:02:00,5/4/2017 11:28:32, time,time after transfection (hr)  ,"72, 48, 96, 24",,,,
1229988331,5/3/2017 13:02:00,5/4/2017 11:33:31, age,age at presentation ,"72, 50, 70, 69, 66",,,,
1229988332,5/3/2017 13:02:00,5/4/2017 11:37:45, age,baseline age (years) ,"72, 67, 57, 76, 50",,,,
1229988333,5/3/2017 13:02:00,5/4/2017 11:41:01, treatment,dac treatment  ,"72h no treatment, 72h 1__m dac treatment",,,,
1229988334,5/3/2017 13:02:01,5/4/2017 11:38:26, time,time since wetting  ,"73.9 hr, 35.5 hr, 11.5 hr, 9 hr, 22 hr",,,,
1229988335,5/3/2017 13:02:01,5/4/2017 11:49:05, age,age (years) ,"74, 62, 76, 83, 45",,,,
1229988336,5/3/2017 13:02:01,5/4/2017 11:43:22, age,age [years / days] ,76 / 197,,,,
1229988337,5/3/2017 13:02:01,5/4/2017 11:37:42, age,age at start therapy ,"76, 54, 64, 80, 51",,,,
1229988338,5/3/2017 13:02:01,5/4/2017 11:48:50, age,age (yr) ,"76, 74, 75, 28, 77",,,,
1229988339,5/3/2017 13:02:01,5/4/2017 11:31:29, time,time (post-inoculation)  ,"78 h, 174 h, 198 h, 6 h, 102 h",,,,
1229988340,5/3/2017 13:02:01,5/4/2017 11:31:32, age,op bone age ,"78 years  sexfemale, 74 years  sexfemale, 87 years  sexfemale",,,,
1229988341,5/3/2017 13:02:01,5/4/2017 11:41:00, age,subject age (years) ,"78, 68, 73, 48, 80",,,,
1229988342,5/3/2017 13:02:01,5/4/2017 11:31:32, age,age at death (years) ,"78, 70, 69, 88, 81",,,,
1229988343,5/3/2017 13:02:01,5/4/2017 11:33:04, age,age at enrollment (years) ,"79, 83, 73, 71, 77",,,,
1229988344,5/3/2017 13:02:01,5/4/2017 11:29:49, time,harvest time point  ,"7d post-surgery, 12, at the end of the 6 hour exposure period, 18 hours after the 6 hour exposure period on the 2nd day, at the end of the of the 2nd day 6 hour exposure period",,,,
1229988345,5/3/2017 13:02:01,5/4/2017 11:39:24, time,time post-surgery  ,"7d, 4d, 14d, 1d, 0h",,,,
1229988346,5/3/2017 13:02:01,5/4/2017 11:41:30, age,age at baseline ,"7m, 6.9m, 5m, 4m, 5.9m",,,,
1229988347,5/3/2017 13:02:01,5/4/2017 11:35:58, time,handling time  ,8 hours,,,,
1229988348,5/3/2017 13:02:01,5/4/2017 11:31:31, time,cross-linking time  ,"8 min, 12 min",,,,
1229988349,5/3/2017 13:02:01,5/4/2017 11:32:42, time,timesincemating  ,"8 weeks, 1 weeks",,,,
1229988350,5/3/2017 13:02:01,5/4/2017 12:03:29, time,time after surgery  ,"8 weeks, 2 weeks, 10 weeks",,,,
1229988351,5/3/2017 13:02:01,5/4/2017 11:36:05, age,age ,"8 weeks, approximately 14 days, 6 to 8 weeks, 6-8 weeks, adult",,,,
1229988352,5/3/2017 13:02:01,5/4/2017 11:31:52, age,age (y) ,"8 weeks, na, 48, 53, 49",,,,
1229988353,5/3/2017 13:02:01,5/4/2017 11:22:16, age,starting age ,8-week old,,,,
1229988354,5/3/2017 13:02:01,5/4/2017 11:40:04, age,patient age at diagnosis ,"8-yrs, 8, 2-yrs, 9, 9-yrs",,,,
1229988355,5/3/2017 13:02:01,5/4/2017 11:36:04, time,time (h) post-infection  ,"8, 1, 2, 4, 0",,,,
1229988356,5/3/2017 13:02:01,5/4/2017 11:37:55, age,age(weeks) ,"8, 32, 16, 72, 15",,,,
1229988357,5/3/2017 13:02:01,5/4/2017 11:27:17, age,age at infection (yrs) ,"8.1, 9.5, 6.1, 10.1, 12",,,,
1229988358,5/3/2017 13:02:01,5/4/2017 11:31:33, age,age (mos) ,"8.5, 10.5",,,,
1229988359,5/3/2017 13:02:01,5/4/2017 11:37:06, time,fermentation time point  ,"80hr, 60hr, 102hr, 8hr, 30hr",,,,
1229988360,5/3/2017 13:02:01,5/4/2017 11:40:59, age,age at collection (months) ,"87, 71, 140, 97, 161",,,,
1229988361,5/3/2017 13:02:01,5/4/2017 11:35:54, age,age at death (y) ,"89, 80, 81, 87, 76",,,,
1229988362,5/3/2017 13:02:01,5/4/2017 11:26:12, time,time [days of culture]  ,"9, 0",,,,
1229988363,5/3/2017 13:02:01,5/4/2017 11:38:19, time,event time (years)  ,"9.4, 9.483333333, 9.45, 14.43333333, 7.133333333",,,,
1229988364,5/3/2017 13:02:01,5/4/2017 11:37:35, time,post-treatment time  ,"90 hours, 1 week",,,,
1229988365,5/3/2017 13:02:01,5/4/2017 11:28:30, time,time after actd  ,"90 min, 45 min, 0 min",,,,
1229988366,5/3/2017 13:02:01,5/4/2017 11:38:01, time,time point after stress  ,"90 min, 7 min, 45 min",,,,
1229988367,5/3/2017 13:02:01,5/4/2017 11:38:09, time,seizure time  ,"917, 1021, 1123, 1106, 1104",,,,
1229988368,5/3/2017 13:02:01,5/4/2017 11:31:51, age,age at sacrafice ,92-114 weeks postinoculation,,,,
1229988369,5/3/2017 13:02:01,5/4/2017 11:35:19, time,time injected  ,"931, 1017, 1355, 954, 1050",,,,
1229988370,5/3/2017 13:02:01,5/4/2017 11:30:08, time,time aed  ,"96 hrs, 60 hrs, 72 hrs",,,,
1229988371,5/3/2017 13:02:01,5/4/2017 11:28:37, age,age(month) ,"96, 60, 48, 72, 13",,,,
1229988372,5/3/2017 13:02:01,5/4/2017 11:34:47, age,age at blood drawing (months) ,"96, 72, 36, 60, 84",,,,
1229988373,5/3/2017 13:02:01,5/4/2017 11:32:45, time,relapse free survival time  ,"96.82 month, 36.10 month, 36.36 month",,,,
1229988374,5/3/2017 13:02:01,5/4/2017 11:36:36, time,time (after crossing)  ,"96hr, 72hr, 24hr, 120hr, 144hr",,,,
1229988375,5/3/2017 13:02:01,5/4/2017 11:30:40, time,meiotic time point  ,"9h, 0h, 5h, 11h, 7h",,,,
1229988376,5/3/2017 13:02:01,5/4/2017 11:31:26, time,growth time points  ,"9h, 2h, start control, 7h",,,,
1229988377,5/3/2017 13:02:01,5/4/2017 11:35:40, genotype,genotype/varat  ,"垣asc1, wt",,,,
1229988378,5/3/2017 13:02:01,5/4/2017 11:35:51, treatment,treatment name  ,"a_euteiches_6dpi - inoculation - pathogen infection,ae 6dpi, a_euteiches_1dpi - time course study - pathogen infection,ae 1dpi, water_a_euteiches - with euteiches,inoculation - mock infiltration,ae 6d, water - inoculation - mock infiltration,mock_water",,,,
1229988379,5/3/2017 13:02:01,5/4/2017 11:39:44, strain,strain duplicate (a or b)  ,"a, b",,,,
1229988380,5/3/2017 13:02:01,5/4/2017 11:29:33, treatment,treatment_schedule  ,"a, b, c, untreated",,,,
1229988381,5/3/2017 13:02:01,5/4/2017 11:43:50, strain,infection (virus strain)  ,"a/california/07/2009 (h1n1), n/a, influenza a/h1n1 virus isolated from a patient with fatal, pneumonia during the first outbreak in mexico city in april 2009., influenza seasonal virus a/pr/8/34 strain",,,,
1229988382,5/3/2017 13:02:01,5/4/2017 11:25:46, strain,inbred strain  ,"a/j, b6by.c.132.54, c57bl/6byj, balb/cj",,,,
1229988383,5/3/2017 13:02:01,5/4/2017 11:28:14, cell line,es cell line  ,"a2lox, r1 esc, otx2-/- esc, ky1.1, e14 esc",,,,
1229988384,5/3/2017 13:02:01,5/4/2017 11:32:25, cell line,cell line background  ,"a549, beas-2b, cfpac1, pc3, imr90",,,,
1229988385,5/3/2017 13:02:01,5/4/2017 11:36:05, genotype,14q22 genotype rs11623717  ,"aa, ag, gg",,,,
1229988386,5/3/2017 13:02:01,5/4/2017 11:40:29, genotype,9q24 genotype rs10975552  ,"aa, ag, gg",,,,
1229988387,5/3/2017 13:02:01,5/4/2017 11:35:51, genotype,hemoglobin genotype  ,"aa, as, ac",,,,
1229988388,5/3/2017 13:02:01,5/4/2017 11:41:21, genotype,18q21 genotype rs7226855  ,"aa, gg",,,,
1229988389,5/3/2017 13:02:01,5/4/2017 11:38:09, disease,disease causing mutation  ,"aav-mediated insertional mutagenesis, h22y, heterozygous for d303n, t50m, a230t",,,,
1229988390,5/3/2017 13:02:01,5/4/2017 11:36:24, age,age of subjects ,"about 60 years, about 25 years",,,,
1229988391,5/3/2017 13:02:01,5/4/2017 11:39:22, treatment,post surgical treatment  ,"act, obs",,,,
1229988392,5/3/2017 13:02:01,5/4/2017 11:34:49, time,time graft  ,"acute, delayed, na",,,,
1229988393,5/3/2017 13:02:01,5/4/2017 11:36:11, treatment,hygromycin treatment  ,"added, added, then removed",,,,
1229988394,5/3/2017 13:02:01,5/4/2017 11:42:45, tissue,tissue diagnosis ,"adenocarcinoma, carcinoma large cell, carcinoma squamous cell, carcinoma non-small cell",,,,
1229988395,5/3/2017 13:02:01,5/4/2017 11:38:52, tissue,tissue derivation ,"adenoid cystic carinoma of the parotid gland, pancreatic tumor, tongue, breast cancer, hodgkin lymphoma",,,,
1229988396,5/3/2017 13:02:01,5/4/2017 11:29:03, time,postnatal time-point  ,adult,,,,
1229988397,5/3/2017 13:02:01,5/4/2017 11:45:29, age,age description ,"adult 8 weeks, immortal cells, embryonic day 0 (stem cell), embryonic day 14.5, embryonic day 11.5",,,,
1229988398,5/3/2017 13:02:01,5/4/2017 11:41:29, tissue,original tissue ,"adult dermal fidroblast, breast, peripheral blood",,,,
1229988399,5/3/2017 13:02:01,5/4/2017 11:35:19, age,age/gender ,"adult male, 77/m, 60/m, 54/f, 2-3 month old males",,,,
1229988400,5/3/2017 13:02:01,5/4/2017 11:46:56, cell type,pancreatic cell type  ,"adult pancreatic endocrine cells, adult pancreatic exocrine-duct cells",,,,
1229988401,5/3/2017 13:02:01,5/4/2017 11:33:01, tissue,fetal vs adult tissue ,"adult, fetal",,,,
1229988402,5/3/2017 13:02:01,5/4/2017 11:31:32, age,agegroup ,"adult, old, young, [53,58), [58,63]",,,,
1229988403,5/3/2017 13:02:01,5/4/2017 11:33:31, time,donation time  ,"after brain death, after cardiac death",,,,
1229988404,5/3/2017 13:02:01,5/4/2017 11:49:13, treatment,time of treatment  ,"after disease establishment, zt24, zt36, 6h, time of grafting",,,,
1229988405,5/3/2017 13:02:01,5/4/2017 11:35:16, time,time of treatment  ,"after disease establishment, zt24, zt36, 6h, time of grafting",,,,
1229988406,5/3/2017 13:02:01,5/4/2017 11:35:51, time,time of specimen collection  ,"after transplant, before transplant",,,,
1229988407,5/3/2017 13:02:01,5/4/2017 11:33:43, genotype,rs5995355 genotype  ,"ag, gg, aa",,,,
1229988408,5/3/2017 13:02:01,5/4/2017 11:33:29, genotype,12q13 genotype rs7136702  ,"ag, gg, aa, ",,,,
1229988409,5/3/2017 13:02:01,5/4/2017 11:31:47, cell type,cancer cell type  ,"aggressive, non-aggressive, metastatic, parental",,,,
1229988410,5/3/2017 13:02:01,5/4/2017 11:37:40, treatment,cactus host treatment  ,"agria, organpipe",,,,
1229988411,5/3/2017 13:02:01,5/4/2017 11:24:34, tissue,tissue provider ,"alberta-pacific, alberta, canada, agriculture and agri-food canada, prairie farm, rehabilitation administration (aafc-pfra), shelterbelt centre, indian head, sk, alberta- pacific forest industries inc., al-pac, grasslands, ab, l.a. quality products ltd., portage la prairie, mb",,,,
1229988412,5/3/2017 13:02:01,5/4/2017 11:38:30, genotype,individual genotype  ,"alcohol preferring (p), alcohol non-preferring (np)",,,,
1229988413,5/3/2017 13:02:01,5/4/2017 11:35:52, treatment,bioremediation treatment  ,alert (ex situ),,,,
1229988414,5/3/2017 13:02:01,5/4/2017 11:38:34, disease,disease outcome  ,"alive, dead",,,,
1229988415,5/3/2017 13:02:01,5/4/2017 11:34:21, cell type,cell type(s)  ,"all, keratinocytes and fibroblasts, neurons (neun+), non-neurons (neun-, predominantly glia), bmsc, nrvcm",,,,
1229988416,5/3/2017 13:02:01,5/4/2017 11:34:26, disease,twin's disease state  ,"allergic, healthy",,,,
1229988417,5/3/2017 13:02:01,5/4/2017 11:28:31, tissue,tissue preserve method ,"allprotect, frozen, n/a, rnalater",,,,
1229988418,5/3/2017 13:02:01,5/4/2017 11:35:19, disease,chief disease  ,als,,,,
1229988419,5/3/2017 13:02:01,5/4/2017 11:40:51, time,time of collection  ,"am, day 7.5 of culture (post fertilization), pm, 48 hour, day 7.0 post insemination",,,,
1229988420,5/3/2017 13:02:01,5/4/2017 11:40:28, tissue,tissue/source ,"amniotic fluid, blastocyst-derived embryonic stem cells",,,,
1229988421,5/3/2017 13:02:01,5/4/2017 11:48:50, treatment,treatment type  ,"anastrozole, tamoxifen, lps, letrozole, none",,,,
1229988422,5/3/2017 13:02:01,5/4/2017 11:34:49, cell line,cell line reference  ,"andrews pw (1984) retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. dev biol 103285-293, brown et al. 1997, sugarman bj, et al. (1985) recombinant human tumor necrosis factor-alphaeffects on proliferation of normal and transformed cells in vitro. science 230943-945. pubmed3933111",,,,
1229988423,5/3/2017 13:02:01,5/4/2017 11:32:01, treatment,inducer treatment  ,"ap21967, vehicle",,,,
1229988424,5/3/2017 13:02:01,5/4/2017 11:36:52, genotype,genotype/variation (offspring)  ,apoe-/+,,,,
1229988425,5/3/2017 13:02:01,5/4/2017 11:35:03, age,final age at death ,approximately 18 weeks old,,,,
1229988426,5/3/2017 13:02:01,5/4/2017 11:27:33, disease,disease severity/outcome  ,"asymptomatic, encephalitis, meningitis",,,,
1229988427,5/3/2017 13:02:01,5/4/2017 11:37:42, time,sampling time  ,"at diagnosis, at remission, daytime 1200, nighttime 2400, 30 minutes after oda600 0.75",,,,
1229988428,5/3/2017 13:02:01,5/4/2017 11:39:24, genotype,20p12 genotype rs50005940  ,"at, aa, tt",,,,
1229988429,5/3/2017 13:02:01,5/4/2017 11:38:52, strain,strain/accession  ,atcc 200175,,,,
1229988430,5/3/2017 13:02:01,5/4/2017 11:37:35, cell type,targeted cell type  ,b cell,,,,
1229988431,5/3/2017 13:02:01,5/4/2017 11:39:21, strain,t cell strain  ,b10.br,,,,
1229988432,5/3/2017 13:02:01,5/4/2017 11:36:16, strain,strain of ooplasm  ,b6,,,,
1229988433,5/3/2017 13:02:01,5/4/2017 11:27:16, strain,strain of paternal pronucleus  ,b6,,,,
1229988434,5/3/2017 13:02:02,5/4/2017 11:37:14, strain,maternal strain  ,"b6, f1, his2av-mrfp iii.1 (bloomington 23650), c57bl6/j (b6), castaneus (cast)",,,,
1229988435,5/3/2017 13:02:02,5/4/2017 11:35:22, strain,strain or line  ,"b6c3f1, fischer, f344/ducrl, sprague-dawley rat, sprague dawley",,,,
1229988436,5/3/2017 13:02:02,5/4/2017 11:54:57, strain,strain (donor)  ,balb/c,,,,
1229988437,5/3/2017 13:02:02,5/4/2017 11:39:38, strain,strain (host)  ,balb/c,,,,
1229988438,5/3/2017 13:02:02,5/4/2017 11:38:01, strain,xenograft recipient strain  ,balb/c,,,,
1229988439,5/3/2017 13:02:02,5/4/2017 11:31:26, strain,source strain  ,"balb/c, riii",,,,
1229988440,5/3/2017 13:02:02,5/4/2017 11:38:32, tissue,tissue/tumor subtype ,"basal-like adjacent tissue, basal-like tumor, erbb2+ adjacent tissue, luminal b adjacent tissue, luminal b tumor",,,,
1229988441,5/3/2017 13:02:02,5/4/2017 11:36:57, treatment,treatment stage  ,"baseline (prior infliximab infusion), vitellogenic, preablation, elongated cortical rod, 24hrs postablation (previtellogenic)",,,,
1229988442,5/3/2017 13:02:02,5/4/2017 11:29:16, time,time-point  ,"baseline, post-deployment, pre-deployment, pre-infection, post-infection",,,,
1229988443,5/3/2017 13:02:02,5/4/2017 11:36:42, genotype,genotype reference  ,"baumberger & baulcombe 2005. pnas 102(33)11928-33., montgomery et al., 2008. cell 133(1)128-41., wang et al., 2010., pnas 107(1)484-9.",,,,
1229988444,5/3/2017 13:02:02,5/4/2017 11:31:32, strain,parental strain  ,"bdiv and bdix, cross of h4-8 and h4-8b",,,,
1229988445,5/3/2017 13:02:02,5/4/2017 11:34:24, tissue,tissuer type ,"benign, tumor",,,,
1229988446,5/3/2017 13:02:02,5/4/2017 11:21:16, treatment,treatment protocol  ,"biweekly with high dose of peg30-fgf21 q108 (biw, 2.5mpk), twice daily with wild-type fgf21 (bid, 1.25mpk), biweekly with low dose of peg30-fgf21 q108 (biw, 0.75mpk), twice daily with vehicle (saline), hypoxia, followed by variable-length normoxia",,,,
1229988447,5/3/2017 13:02:02,5/4/2017 11:33:48, tissue,sample tissue type ,"blood, skin",,,,
1229988448,5/3/2017 13:02:02,5/4/2017 11:28:14, tissue,tissue-cy5 ,bovine reference rna,,,,
1229988449,5/3/2017 13:02:02,5/4/2017 11:43:57, tissue,origin tissue ,"breast epithelial, peripheral lymph nodes and spleen, breast cancer, lymph node, porcine kidney",,,,
1229988450,5/3/2017 13:02:02,5/4/2017 11:27:33, cell line,cell line origin  ,"breast epithelium, breast cancer, mammary, erythroid myeloid lymphoid (eml), bone metastasis of prostate cancer",,,,
1229988451,5/3/2017 13:02:02,5/4/2017 11:31:08, tissue,tissue-type ,"breast epithlieum, lung, articular cartilage, cholangiocarcinoma, growth plate cartilage",,,,
1229988452,5/3/2017 13:02:02,5/4/2017 11:37:58, tissue,tissue origin of cancer cell ,"breast, cervix",,,,
1229988453,5/3/2017 13:02:02,5/4/2017 11:59:08, strain,strain.rep  ,"bro1, bro2, dah1, als1, ap1",,,,
1229988454,5/3/2017 13:02:02,5/4/2017 11:36:27, cell type,cell type/line  ,"btic, snb19, nsc, c17.2",,,,
1229988455,5/3/2017 13:02:02,5/4/2017 11:23:54, strain,listeria strain  ,"bug2384, bug2466",,,,
1229988456,5/3/2017 13:02:02,5/4/2017 11:36:04, tissue,tissue preparation ,"bulk, microscope dissected, antibody purified, cell line, laser capture microdissected",,,,
1229988457,5/3/2017 13:02:02,5/4/2017 11:26:10, tissue,tissue collection ,"bulk, whole blood drawn in edta tubes, day 7, on day 15, the mice were sacrificed and half of the, cerebellum was harvested for purification of mitochondria, with the left half snap-frozen, homogenized, and aliquoted for western blotting, microarray, and detection of atp and nad+., embryos dissected from fully-developed green seeds",,,,
1229988458,5/3/2017 13:02:02,5/4/2017 11:44:19, strain,yeast strain  ,"by4720-leu3null, by4741, snt2-13myc, ecm5-13myc, ybc2192",,,,
1229988459,5/3/2017 13:02:02,5/4/2017 11:43:53, cell line,cell line/genotype  ,by4741 (wt),,,,
1229988460,5/3/2017 13:02:02,5/4/2017 11:45:29, genotype,background genotype  ,"by4741, wild type, parental, congenic",,,,
1229988461,5/3/2017 13:02:02,5/4/2017 11:34:49, strain,strain (or line)  ,by4742,,,,
1229988462,5/3/2017 13:02:02,5/4/2017 11:27:01, strain,strainorline  ,"by4742, s2, dbaxc57bl/6j, jb371, singapore",,,,
1229988463,5/3/2017 13:02:02,5/4/2017 11:40:51, genotype,rb1 genotype  ,"c1816inst, loh",,,,
1229988464,5/3/2017 13:02:02,5/4/2017 11:39:19, strain,strain of maternal pronucleus  ,"c3h, b6",,,,
1229988465,5/3/2017 13:02:02,5/4/2017 11:42:10, strain,strain donor  ,c3h/hen,,,,
1229988466,5/3/2017 13:02:02,5/4/2017 11:35:09, strain,strain description  ,"c57 black 6, the most common inbred strain of laboratory mouse, unknown strain origin, strain c3h, very related to c57bl/6, strain 129, has widely available embryonic stem cells, derived by inbreeding from selected f2 progeny of b10.a x b10.129",,,,
1229988467,5/3/2017 13:02:02,5/4/2017 11:35:58, gender,strain gender ,c57bl/6,,,,
1229988468,5/3/2017 13:02:02,5/4/2017 11:30:42, strain,congenic strain  ,c57bl/6,,,,
1229988469,5/3/2017 13:02:02,5/4/2017 11:44:47, strain,organ-derived dc strain  ,c57bl/6,,,,
1229988470,5/3/2017 13:02:02,5/4/2017 11:35:51, strain,secondary host strain  ,c57bl/6,,,,
1229988471,5/3/2017 13:02:02,5/4/2017 11:30:08, strain,strain (of recipient mice)  ,c57bl/6,,,,
1229988472,5/3/2017 13:02:02,5/4/2017 11:36:10, strain,strain backgroud  ,c57bl/6,,,,
1229988473,5/3/2017 13:02:02,5/4/2017 11:50:09, strain,strain gender  ,c57bl/6,,,,
1229988474,5/3/2017 13:02:02,5/4/2017 11:23:10, strain,strain recipient  ,c57bl/6,,,,
1229988475,5/3/2017 13:02:02,5/4/2017 11:44:20, strain,mice strain  ,"c57bl/6 cd45+/- (ptprc+/-), c57bl/6",,,,
1229988476,5/3/2017 13:02:02,5/4/2017 11:33:06, genotype,host genotype  ,"c57bl/6 mouse, wild-type, tnfr 1, 2 -/-",,,,
1229988477,5/3/2017 13:02:02,5/4/2017 11:41:05, strain,strain of the clone  ,"c57bl/6-cd45.1, c57bl/6-gfp",,,,
1229988478,5/3/2017 13:02:02,5/4/2017 11:35:51, strain,background mouse strain  ,"c57bl/6, c57bl/6j, 129svjae/c57bl/6, mix of c57bl/6, 129/ola and cba/j, c57b16",,,,
1229988479,5/3/2017 13:02:02,5/4/2017 11:44:20, strain,strain background  ,"c57bl/6, c57bl/6j, by4741, balb/c, offspring of cross between c57bl6/j (male) and cba/ca (female)",,,,
1229988480,5/3/2017 13:02:02,5/4/2017 11:44:42, strain,strain/background  ,"c57bl/6, c57bl/6j, diversity outcross x pymt, molf/ei x pymt, 129",,,,
1229988481,5/3/2017 13:02:02,5/4/2017 11:33:48, strain,background strain  ,"c57bl/6, c57bl/6j, wistar hanover (crlwi[gl/brl/han]igs br), balb/c, c3h/hej",,,,
1229988482,5/3/2017 13:02:02,5/4/2017 11:29:49, strain,strain  ,"c57bl/6, sprague dawley, cd-igs, c57bl/6j, c57bl/j6 and c3h/hej on apoe null age24 weeks genderfemale, c57bl/j6 and c3h/hej on apoe null age24 weeks gendermale",,,,
1229988483,5/3/2017 13:02:02,5/4/2017 11:32:02, strain,host/mouse strain  ,c57bl/6j,,,,
1229988484,5/3/2017 13:02:02,5/4/2017 11:38:09, strain,strain/cell-line  ,c57bl/6j,,,,
1229988485,5/3/2017 13:02:02,5/4/2017 11:40:44, strain,host strain  ,"c57bl/6j, a/j, female cd1 nude mouse, nod/scid, cd1",,,,
1229988486,5/3/2017 13:02:02,5/4/2017 11:38:50, strain,mouse strain  ,"c57bl/6j, c57bl/6, cd1, c57/bl6, balb/c",,,,
1229988487,5/3/2017 13:02:02,5/4/2017 11:38:52, strain,jackson lab. strain  ,c57bl/6j. gendermale. stock number000664,,,,
1229988488,5/3/2017 13:02:02,5/4/2017 11:29:49, cell line,atcc cell line  ,"cal27, a253",,,,
1229988489,5/3/2017 13:02:02,5/4/2017 11:37:35, tissue,# of tissue = 36 tissue ,carotid body,,,,
1229988490,5/3/2017 13:02:02,5/4/2017 11:26:10, tissue,# of tissue = 40 tissue ,carotid body,,,,
1229988491,5/3/2017 13:02:02,5/4/2017 11:26:37, tissue,# of tissue = 42 tissue ,carotid body,,,,
1229988492,5/3/2017 13:02:02,5/4/2017 11:35:03, tissue,# of tissue = 38 tissue ,carotid body,,,,
1229988493,5/3/2017 13:02:02,5/4/2017 11:42:32, disease,clinical disease stage  ,castration-resistant prostate cancer,,,,
1229988494,5/3/2017 13:02:02,5/4/2017 11:33:02, cell line,cell line source ethnicity  ,caucasian,,,,
1229988495,5/3/2017 13:02:02,5/4/2017 11:38:14, strain,host strain background  ,"cb17/icr-prkdcscid/icrcrl (sever combined immunodeficiency micescid mice), ncr nude mice, balb/c nu/nu",,,,
1229988496,5/3/2017 13:02:02,5/4/2017 11:37:40, genotype,nqo1 rs1800566 genotype  ,"cc, ct, na, tt",,,,
1229988497,5/3/2017 13:02:02,5/4/2017 11:36:52, genotype,15q13 genotype rs4779584  ,"cc, ct, tt",,,,
1229988498,5/3/2017 13:02:02,5/4/2017 11:39:54, genotype,16q22 genotype rs2059254  ,"cc, ct, tt",,,,
1229988499,5/3/2017 13:02:02,5/4/2017 11:33:04, genotype,8q24 genotype rs7014346  ,"cc, ct, tt",,,,
1229988500,5/3/2017 13:02:02,5/4/2017 11:41:12, genotype,20q13 genotype rs4925386  ,"cc, ct, tt, nd",,,,
1229988501,5/3/2017 13:02:02,5/4/2017 11:37:06, cell type,cell type (immunophenotype)  ,"cd133/2 positive, cd133/2 negative ",,,,
1229988502,5/3/2017 13:02:02,5/4/2017 11:39:29, cell type,cell type subpopulation  ,"cd25+ treg, cd25- non-treg, cd25-",,,,
1229988503,5/3/2017 13:02:02,5/4/2017 11:33:25, cell type,sorted cell type  ,"cd34+cd45ra-, hematopoietic stem cells (hsc1), multipotent progenitor cells (mpp), common myeloid progenitor cells (cmp), granulocyte-monocyte progenitors (gmp)",,,,
1229988504,5/3/2017 13:02:02,5/4/2017 11:22:01, genotype,genotype of pollen  ,cdka,,,,
1229988505,5/3/2017 13:02:02,5/4/2017 11:38:50, cell line,cell line characteristics  ,"cell line derived from t47d that contain one copy of mmtv promoter, the cell line has been observed to undergone minor changes after long-term culture, except for the presence of dense granules in the nucleoli (uzman, foley et al. 1966). finally, the ccrf-cem cell line has been reported to manifest autocrine catalase activity which participates to its mechanisms of growth and progression (sandstrom and buttke 1993).",,,,
1229988506,5/3/2017 13:02:02,5/4/2017 11:44:21, tissue,tumor tissue source ,"cell line established, cell line1st deg. Culture",,,,
1229988507,5/3/2017 13:02:02,5/4/2017 11:27:16, time,time of growth  ,cells were grown for 72 hrs,,,,
1229988508,5/3/2017 13:02:02,5/4/2017 11:44:42, strain,strain source  ,"charles river laboratories, wistar, harvard medical  school, p53, iberian pork plant",,,,
1229988509,5/3/2017 13:02:02,5/4/2017 11:41:22, strain,animal/plant strain or line  ,"charleston harbor, indian river lagoon, fl",,,,
1229988510,5/3/2017 13:02:02,5/4/2017 11:35:19, treatment,chamber treatment  ,"clean air, diesel exhaust inhalation",,,,
1229988511,5/3/2017 13:02:02,5/4/2017 11:31:22, cell line,cell line or clinical sample  ,"clinical specimen, cell line",,,,
1229988512,5/3/2017 13:02:02,5/4/2017 11:37:02, cell line,cell line manufacturer  ,clontech,,,,
1229988513,5/3/2017 13:02:02,5/4/2017 11:28:37, genotype,cmv genotype/variation  ,cmvf-_2b,,,,
1229988514,5/3/2017 13:02:02,5/4/2017 11:29:33, genotype,brca genotype  ,cmvf-__2b,,,,
1229988515,5/3/2017 13:02:02,5/4/2017 11:27:13, treatment,treatment regimen  ,cog 9404,,,,
1229988516,5/3/2017 13:02:02,5/4/2017 11:35:52, strain,basal strain  ,col,,,,
1229988517,5/3/2017 13:02:02,5/4/2017 11:41:30, strain,strain/ecotype  ,"col-0, colombia, shakdara (sha), bay-0, bur-0",,,,
1229988518,5/3/2017 13:02:02,5/4/2017 11:31:52, genotype,genotype/ecotype  ,"col-0, det2-1, ga1-5",,,,
1229988519,5/3/2017 13:02:02,5/4/2017 11:32:44, tissue,original tissue source ,colon,,,,
1229988520,5/3/2017 13:02:02,5/4/2017 11:29:03, strain,plant strain  ,"columbia-0 pen2-1 pad4-1 sag101-2 mutant expressing mla1-ha, columbia-0 pen2-1 pad4-1 sag101-2 mutant",,,,
1229988521,5/3/2017 13:02:02,5/4/2017 11:23:10, genotype,plant genotype  ,"columbia-0 pen2-1 pad4-1, sag101-2 mutant expressing mla1-ha, ha-ago2-dad (ago2-1)columbia-0 pen2-1 pad4-1 sag101-2 mutant, ha-ago10-ddh (col-0), ha-ago1-dah (col-0)",,,,
1229988522,5/3/2017 13:02:02,5/4/2017 11:32:07, treatment,myo-inositol treatment  ,"complete response, progressive disease, partial response, unknown response",,,,
1229988523,5/3/2017 13:02:02,5/4/2017 11:31:26, time,time course  ,"constant stress, recovery, early log phase, mid log phase, 8 days",,,,
1229988524,5/3/2017 13:02:02,5/4/2017 11:29:49, treatment,treatment gp  ,control adenoviral recombinant,,,,
1229988525,5/3/2017 13:02:02,5/4/2017 11:36:34, tissue,tissue treatment ,"control luteal day 10, hcg (simulated early pregnancy) luteal day 15, hcg (simulated early pregnancy) luteal day 10, hcg (simulated early pregnancy) luteal day 15+trl+r5020, hcg (simulated early pregnancy) luteal day 10+trl+r5020",,,,
1229988526,5/3/2017 13:02:02,5/4/2017 11:54:51, treatment,tissue treatment  ,"control luteal day 10, hcg (simulated early pregnancy) luteal day 15, hcg (simulated early pregnancy) luteal day 10+trl+r5020, hcg (simulated early pregnancy) luteal day 10+trl, hcg (simulated early pregnancy) luteal day 15+trl+r5020",,,,
1229988527,5/3/2017 13:02:02,5/4/2017 11:41:01, time,dark timepoint  ,"control, 1 h, 2 h, 15 min, 4 h",,,,
1229988528,5/3/2017 13:02:02,5/4/2017 11:35:19, time,harvest time  ,"control, 20, 26, 14, day 3",,,,
1229988529,5/3/2017 13:02:02,5/4/2017 11:39:19, time,light timepoint  ,"control, 8 h, 30 min, 1 h, 4 h",,,,
1229988530,5/3/2017 13:02:02,5/4/2017 11:40:57, treatment,environmental treatment group  ,"control, collected on the day of landing emerged during the flight and within 4 hours of, landing",,,,
1229988531,5/3/2017 13:02:02,5/4/2017 11:40:52, treatment,treatment 1  ,"control, laser treated, steroids 0mg/kg, 10 ng/ml tnf, antide on days 1 and 4",,,,
1229988532,5/3/2017 13:02:02,5/4/2017 11:25:31, treatment,transfection or treatment  ,"control, no treatment, dmso",,,,
1229988533,5/3/2017 13:02:02,5/4/2017 11:41:05, treatment,sirna treatment group  ,"control, sisteap1, itm2a, dkk2",,,,
1229988534,5/3/2017 13:02:02,5/4/2017 11:34:13, treatment,in vivo treatment  ,"corn oil, propylene glycol mono-t-butyl ether, methylene chloride, 1,2,3-trichloropropane, naphthalene",,,,
1229988535,5/3/2017 13:02:02,5/4/2017 11:26:44, strain,insect strain  ,corn strain,,,,
1229988536,5/3/2017 13:02:02,5/4/2017 11:31:27, genotype,8q24 genotype rs10505477  ,"ct, tt, cc",,,,
1229988537,5/3/2017 13:02:02,5/4/2017 11:41:51, time,timecollected  ,"ct12, ct16, ct24, ct28, ct32",,,,
1229988538,5/3/2017 13:02:02,5/4/2017 11:35:48, time,sample time point  ,"ct23.5, ct11.5, ct17.5, ct0.5, ct5.5",,,,
1229988539,5/3/2017 13:02:02,5/4/2017 11:30:42, cell line,cell line/cell type  ,"ctb primary cells, hesc h7 cell line, tbpc colony, tbpc monolayer",,,,
1229988540,5/3/2017 13:02:02,5/4/2017 11:34:34, tissue,source tissue ,"cutaneous metastasis of melanoma, cerebellum, frontal cortex, superior temporal gyrus, entorhinal cortex",,,,
1229988541,5/3/2017 13:02:02,5/4/2017 11:28:32, tissue,source  tissue ,"cutaneous metastasis of melanoma, cerebellum, frontal cortex, superior temporal gyrus, entorhinal cortex",,,,
1229988542,5/3/2017 13:02:02,5/4/2017 11:30:23, age,cycle phase/ gestational age ,"cycling endometrium secretory phase, first trimester",,,,
1229988543,5/3/2017 13:02:02,5/4/2017 11:41:11, time,time point post-infection  ,d8,,,,
1229988544,5/3/2017 13:02:02,5/4/2017 11:38:01, treatment,light treatment  ,"dark, light, white light 1h, white light 6h",,,,
1229988545,5/3/2017 13:02:02,5/4/2017 11:35:11, time,time (relative to induction)  ,"day -2, day 0, day 9, day 7, day 3",,,,
1229988546,5/3/2017 13:02:02,5/4/2017 11:29:36, time,time-points collected  ,"day 0 (immediately after sorting), day 7",,,,
1229988547,5/3/2017 13:02:02,5/4/2017 11:36:21, time,time post vbg  ,"day 0, 4 months, 12 months",,,,
1229988548,5/3/2017 13:02:02,5/4/2017 11:45:17, age,age/disease timepoint ,"day 100, end-stage, day 65, day 130, day 150",,,,
1229988549,5/3/2017 13:02:02,5/4/2017 11:38:51, time,age/disease timepoint  ,"day 100, end-stage, day 65, day 130, day 150",,,,
1229988550,5/3/2017 13:02:02,5/4/2017 11:35:51, time,time of differentiation  ,"day 12, day 8, day 4/5, 3 days, 2 days",,,,
1229988551,5/3/2017 13:02:02,5/4/2017 11:48:50, time,sampling time point  ,"day 140, day 28, day 0, day 14, week 12",,,,
1229988552,5/3/2017 13:02:02,5/4/2017 11:28:30, age,age of embryo ,day 19,,,,
1229988553,5/3/2017 13:02:02,5/4/2017 11:22:16, time,time point (visit)  ,"day 2 (v1), baseline (v3), day 6 (v2)",,,,
1229988554,5/3/2017 13:02:02,5/4/2017 11:38:50, time,time after scale removal  ,"day 3, day 7",,,,
1229988555,5/3/2017 13:02:02,5/4/2017 11:35:47, time,time of transfection  ,"day 4, day 0",,,,
1229988556,5/3/2017 13:02:02,5/4/2017 11:29:49, age,neuron age ,day 5 in vitro,,,,
1229988557,5/3/2017 13:02:02,5/4/2017 11:34:13, time,time after adoptive transfer  ,"day 5, day 15, day 0",,,,
1229988558,5/3/2017 13:02:02,5/4/2017 11:32:02, age,age of culture ,"day 5, day 21, day 7",,,,
1229988559,5/3/2017 13:02:02,5/4/2017 11:40:21, time,time of death  ,"day 6 of illness, day 17 of illness",,,,
1229988560,5/3/2017 13:02:02,5/4/2017 11:40:57, time,time of sample collection  ,"day 7 post-infection, day 4 post-infection, day 2 post-infection, 48h post-infection, 12h post-infection",,,,
1229988561,5/3/2017 13:02:02,5/4/2017 11:37:02, time,time (post virus infection)  ,"day 7, day 4, day 2, day1, 0h",,,,
1229988562,5/3/2017 13:02:02,5/4/2017 11:36:21, time,time p.i.  ,"day 8, day 3, day 5",,,,
1229988563,5/3/2017 13:02:02,5/4/2017 11:29:49, age,age (after birth) ,"day6, day0, day24",,,,
1229988564,5/3/2017 13:02:02,5/4/2017 11:24:34, time,time points  ,"day7 post stimulation, day7 p.i., 24 hours, 12 hours, 48 hours",,,,
1229988565,5/3/2017 13:02:02,5/4/2017 11:31:08, age,age of  culture ,"day7, day 7, day 5, day 6, day 2",,,,
1229988566,5/3/2017 13:02:02,5/4/2017 11:42:43, treatment,units of treatment time  ,"days/wk, 6 hr/day, hr/day",,,,
1229988567,5/3/2017 13:02:02,5/4/2017 11:37:28, time,units of treatment time  ,"days/wk, 6 hr/day, hr/day",,,,
1229988568,5/3/2017 13:02:02,5/4/2017 11:24:52, strain,p. syringae pv tomato strain  ,"dc3000 carrying avrrpm1, dc3000 wildtype, dc3000 hrpa mutant",,,,
1229988569,5/3/2017 13:02:02,5/4/2017 11:27:09, cell type,cell type subset  ,"dec205+, cd11b+, cd11b, esam+, cd11b esam-dec205 esam-",,,,
1229988570,5/3/2017 13:02:02,5/4/2017 11:28:14, genotype,th-mycn mouse genotype  ,"deficient caspase-8, wild type caspase-8",,,,
1229988571,5/3/2017 13:02:02,5/4/2017 11:32:01, treatment,sample treatment  ,"dep, fap, dnase digestion, sonication",,,,
1229988572,5/3/2017 13:02:02,5/4/2017 11:22:01, genotype,genotype/varaiation  ,dereg x ldlr-/-,,,,
1229988573,5/3/2017 13:02:02,5/4/2017 11:40:10, treatment,treatment result  ,"developed lipodystrophy, nonlipodystrophic",,,,
1229988574,5/3/2017 13:02:02,5/4/2017 11:32:45, cell type,cell types  ,"dfci 121, dfci 123, primary mouse embryonic fibroblasts e13.5, burkitts lymphoma (raji) and breast adenocarcinoma (mcf-7), hesc derived pancreatic endoderm, isolated conventional and plasmacytoid dendritic cells",,,,
1229988575,5/3/2017 13:02:02,5/4/2017 11:36:05, disease,disease exposure  ,diabetes,,,,
1229988576,5/3/2017 13:02:02,5/4/2017 11:38:26, disease,duration of disease  ,"diagnosed at inclusion, 6 years, 21 years, 16 years, 5 years",,,,
1229988577,5/3/2017 13:02:02,5/4/2017 11:42:01, strain,progeny strain  ,"dicer fl/+ lyszcre+/- (wild type), dicer fl/fl lyszcre+/- (dicer-deficient)",,,,
1229988578,5/3/2017 13:02:02,5/4/2017 11:25:31, treatment,dsrna treatment (knockdown)  ,"dicer-1 dsrna, argonaute 1 dsrna, argonaute 2 dsrna, dicer-2 dsrna, drosha dsrna",,,,
1229988579,5/3/2017 13:02:02,5/4/2017 11:37:06, cell line,huh7 cell line  ,differentiated hepatoma from a male,,,,
1229988580,5/3/2017 13:02:02,5/4/2017 11:35:54, treatment,cardioglycoside treatment  ,"digoxin, strophanthidin, peruvoside, control",,,,
1229988581,5/3/2017 13:02:02,5/4/2017 11:40:54, tissue,gingival tissue phenotype ,"diseased (bop + interproximal ppd of>3 mm + concomitant cal of>2 mm), healthy (no bop + ppd of<5 mm + cal of<3 2 mm",,,,
1229988582,5/3/2017 13:02:02,5/4/2017 11:40:51, tissue,tissue-cy3 ,"distal ileum, inoculated with bmel",,,,
1229988583,5/3/2017 13:02:02,5/4/2017 11:44:20, treatment,dnase treatment  ,"dnase i treated, no, 1.2u-12u per 132 ul, yes",,,,
1229988584,5/3/2017 13:02:02,5/4/2017 11:33:24, age,embryonic age ,"e10.5, e14.5, 10 weeks",,,,
1229988585,5/3/2017 13:02:02,5/4/2017 11:48:50, age,age of source ,e12.5,,,,
1229988586,5/3/2017 13:02:02,5/4/2017 11:41:13, time,time of atoh1 expression  ,"e13.5, e10.5",,,,
1229988587,5/3/2017 13:02:02,5/4/2017 11:42:36, age,source age ,"e13.5, e11.5, 8-week, e3.5, e12.5",,,,
1229988588,5/3/2017 13:02:02,5/4/2017 11:50:33, age,embryo age ,"e14.5, tissue whole embryo excluding head and organs, week 11 of gestation, e17, 1 hour post fertilization, 7 hour post fertilization",,,,
1229988589,5/3/2017 13:02:02,5/4/2017 11:39:28, age,gestational age of pups ,"e17.5, e14",,,,
1229988590,5/3/2017 13:02:02,5/4/2017 11:41:12, time,harvest timepoint  ,"e17.5, zt12, zt16, zt20, zt4",,,,
1229988591,5/3/2017 13:02:02,5/4/2017 11:38:26, strain,b virus strain  ,e2490,,,,
1229988592,5/3/2017 13:02:02,5/4/2017 11:36:04, genotype,e2f1 genotype  ,"e2f1+/+, e2f1-/-",,,,
1229988593,5/3/2017 13:02:02,5/4/2017 11:41:02, tissue,tissue/development stage ,"e4-8, adultmale, adultfemale, l3, e12-16",,,,
1229988594,5/3/2017 13:02:02,5/4/2017 11:53:48, time,relapse time  ,"early (less than 36 months), late (greater than 36 months)",,,,
1229988595,5/3/2017 13:02:02,5/4/2017 11:31:29, age,initial age (infection day) ,eight weeks old,,,,
1229988596,5/3/2017 13:02:02,5/4/2017 11:39:24, time,injection time  ,embryonic day 14,,,,
1229988597,5/3/2017 13:02:02,5/4/2017 11:32:32, tissue,cell line tissue source ,"embyronic hypothalamus, adult hypothalamus",,,,
1229988598,5/3/2017 13:02:02,5/4/2017 11:38:50, cell line,cell line tissue source  ,"embyronic hypothalamus, adult hypothalamus",,,,
1229988599,5/3/2017 13:02:02,5/4/2017 11:35:03, cell type,cell type [c]  ,endothelial,,,,
1229988600,5/3/2017 13:02:02,5/4/2017 11:38:19, tissue,tissue_biological ,"epithelial, endothelial",,,,
1229988601,5/3/2017 13:02:02,5/4/2017 11:35:29, tissue,tissue compartment ,"epithelium, stroma, epithelial, stromal",,,,
1229988602,5/3/2017 13:02:02,5/4/2017 11:36:06, cell line,host cell line  ,"erc, hek293, a385, aag2 cells, vero",,,,
1229988603,5/3/2017 13:02:02,5/4/2017 11:24:52, cell line,hybrid cell line  ,"es-e-hybrid line 3, es-e-hybrid line 22, es-e-hybrid line 10",,,,
1229988604,5/3/2017 13:02:02,5/4/2017 11:41:25, cell line,cell line nih code  ,es03,,,,
1229988605,5/3/2017 13:02:02,5/4/2017 11:32:01, treatment,plant treatment  ,"etoh, dexamethasone",,,,
1229988606,5/3/2017 13:02:02,5/4/2017 11:32:46, strain,evolved strain  ,"evolved mutator derived after 6700 generations, evolved non-mutator yeast after 6700 generations",,,,
1229988607,5/3/2017 13:02:02,5/4/2017 11:39:44, tissue,source tissue type ,ex vivo e__-myc lymphoma,,,,
1229988608,5/3/2017 13:02:02,5/4/2017 11:49:01, tissue,tissue/developmental stage ,"explant tissue subjected to se induction, the advanced phase of embryogenesis related to somatic embryo formation, freshly isolated explants competent to undergo embryogenic transition",,,,
1229988609,5/3/2017 13:02:02,5/4/2017 11:48:22, treatment,treatment/growth condition  ,"expose 0.1% ethanol for 4days between day2 and day6, expose 10-7m retinoic acid for 4days between day2 and day6, expose 10-8m retinoic acid for 4days between day2 and day6",,,,
1229988610,5/3/2017 13:02:02,5/4/2017 11:42:00, treatment,treatments  ,"exposed to mq water, ut-untreated, ra-al-trans retinoic acid induced, 10 min 1mm h2o2, exposed to raw wastewater",,,,
1229988611,5/3/2017 13:02:02,5/4/2017 11:36:04, treatment,treatment/exposure  ,"exposed toa ir, exposed to smoke",,,,
1229988612,5/3/2017 13:02:02,5/4/2017 11:30:43, sex,baby's sex  ,"f, m",,,,
1229988613,5/3/2017 13:02:02,5/4/2017 12:02:25, sex,cell sex  ,"f, m, u, b",,,,
1229988614,5/3/2017 13:02:02,5/4/2017 11:33:52, gender,gender (sex) ,"f, na",,,,
1229988615,5/3/2017 13:02:02,5/4/2017 11:39:48, strain,paternal strain  ,"f1, b6, canton-s, c57bl6/j (b6), castaneus (cast)",,,,
1229988616,5/3/2017 13:02:02,5/4/2017 11:38:16, strain,strain/line  ,"f8 ril from the cross between `chinese long` inbred line 9930 and north american pickling gy14, f7 ril from the cross between `chinese long` inbred line 9930 and north american, pickling gy14, cal 27 cells,nm23-h1 transfected, cal 27 cells, empty vector transfected cells, n2",,,,
1229988617,5/3/2017 13:02:02,5/4/2017 11:35:15, treatment,treatment.type  ,"fec/tx, fec/tx+h",,,,
1229988618,5/3/2017 13:02:02,5/4/2017 11:29:49, gender,gender (rat) ,female,,,,
1229988619,5/3/2017 13:02:02,5/4/2017 11:33:49, sex,sex of donor mice  ,female,,,,
1229988620,5/3/2017 13:02:02,5/4/2017 11:22:00, gender,source gender ,"female fly, male, female",,,,
1229988621,5/3/2017 13:02:02,5/4/2017 11:32:48, sex,sex/age  ,"female, 3-5 days old, m/48, f/62, f/67",,,,
1229988622,5/3/2017 13:02:02,5/4/2017 11:40:55, gender,gender of mice ,"female, male",,,,
1229988623,5/3/2017 13:02:02,5/4/2017 11:39:20, sex,newborn sex  ,"female, male",,,,
1229988624,5/3/2017 13:02:02,5/4/2017 11:51:33, sex,sex/age at diagnosis (years)  ,female/49,,,,
1229988625,5/3/2017 13:02:02,5/4/2017 11:19:22, cell type,cell type derived from  ,"fetal liver, bone marrow, pancreatic islet beta cells, spleen",,,,
1229988626,5/3/2017 13:02:02,5/4/2017 11:41:02, tissue,pig tissue ,"fetal placenta, spleen",,,,
1229988627,5/3/2017 13:02:02,5/4/2017 11:38:26, tissue,tissue_type ,"ffpe tissue sample, smooth muscle, fetal lung, mucosa, fetal intestine, large",,,,
1229988628,5/3/2017 13:02:02,5/4/2017 11:36:11, tissue,tissue archive method ,"ffpe, fresh, fresh frozen",,,,
1229988629,5/3/2017 13:02:02,5/4/2017 11:54:57, tissue,tissue status ,"ffpe, freshly resected tissue sample, involved, juvenile, mature",,,,
1229988630,5/3/2017 13:02:02,5/4/2017 11:43:55, strain,strain fgsc number  ,"fgsc 2489, fgsc 11066",,,,
1229988631,5/3/2017 13:02:02,5/4/2017 11:40:21, tissue,harvested tissue type ,fiber,,,,
1229988632,5/3/2017 13:02:02,5/4/2017 11:40:52, tissue,tissue & age ,"fiber 2 dpa, fiber 10 dpa, fiber 20 dpa, npcs of neocortex from 3 littermates wild-type mouse embryos at e14, npcs of neocortex from 3 littermates ts1cje mouse embryos at e14",,,,
1229988633,5/3/2017 13:02:02,5/4/2017 11:41:30, age,tissue & age ,"fiber 2 dpa, fiber 10 dpa, fiber 20 dpa, npcs of neocortex from 3 littermates wild-type mouse embryos at e14, npcs of neocortex from 3 littermates ts1cje mouse embryos at e14",,,,
1229988634,5/3/2017 13:02:03,5/4/2017 11:26:12, disease,donor disease state  ,"fibrocystic disease, adenocarcinoma",,,,
1229988635,5/3/2017 13:02:03,5/4/2017 11:39:48, time,secondary time course  ,final 24 hours of 8 day treatment,,,,
1229988636,5/3/2017 13:02:03,5/4/2017 11:38:09, time,sample time  ,"five weeks after grafting, before ebv acquisition, mid-exponential phase, following resolution of infectious mononucelosis, day 10",,,,
1229988637,5/3/2017 13:02:03,5/4/2017 11:43:12, strain,strain number  ,"fmf248, klp694, fmf1 (fgsc9075), fgsc2489, spy 1491",,,,
1229988638,5/3/2017 13:02:03,5/4/2017 11:39:44, strain,cmv strain  ,fny,,,,
1229988639,5/3/2017 13:02:03,5/4/2017 11:41:02, tissue,thyroid tissue type ,"follicular thyroid carcinoma, follicular thyroid adenoma",,,,
1229988640,5/3/2017 13:02:03,5/4/2017 11:53:48, time,infection_control time  ,for 7 days,,,,
1229988641,5/3/2017 13:02:03,5/4/2017 11:31:31, tissue,tissue processing ,"formalin-fixed paraffin-embedded (ffpe), frozen",,,,
1229988642,5/3/2017 13:02:03,5/4/2017 11:41:02, cell line,cell line of origin  ,"foxd3 conditional knockout c57bl/6 escs, dual mirna reporter v6.5 escs, fibroblasts from ts patient t7643, embryonic stem cellsescs (r cells), epiblast cellsepic (dy cells)",,,,
1229988643,5/3/2017 13:02:03,5/4/2017 11:39:47, tissue,tissue archive ,fresh frozen,,,,
1229988644,5/3/2017 13:02:03,5/4/2017 11:39:17, tissue,tissue state ,"fresh frozen tissue, basal state, ffpe, ovarian cancer tissue after treatment, ovarian cancer tissue before treatment",,,,
1229988645,5/3/2017 13:02:03,5/4/2017 11:39:44, tissue,tissue (brain region) ,"frontal cortex, temporal cortex, cerebellum",,,,
1229988646,5/3/2017 13:02:03,5/4/2017 11:42:43, tissue,tissue storage ,"frozen, ffpe",,,,
1229988647,5/3/2017 13:02:03,5/4/2017 11:43:05, tissue,tissue preservation ,"frozen, fixed",,,,
1229988648,5/3/2017 13:02:03,5/4/2017 11:35:48, strain,strain/isolate  ,fully-sequenced human fecal isolate of b.theta (vpi-5482),,,,
1229988649,5/3/2017 13:02:03,5/4/2017 11:34:27, genotype,host/mouse genotype  ,"fut2_ko, wild type, fut2(+/-)_ko",,,,
1229988650,5/3/2017 13:02:03,5/4/2017 11:23:11, strain,parasite strain  ,"fv1, 1s, n/a, rh 1-1, uninfected",,,,
1229988651,5/3/2017 13:02:03,5/4/2017 11:31:31, strain,back ground strain  ,"fvb  c57bl/6 crosses, swiss",,,,
1229988652,5/3/2017 13:02:03,5/4/2017 11:37:56, treatment,treatment route  ,gavage,,,,
1229988653,5/3/2017 13:02:03,5/4/2017 11:39:28, genotype,rs1333049 genotype  ,"gc, gg, cc",,,,
1229988654,5/3/2017 13:02:03,5/4/2017 11:42:59, treatment,in vivo treatment with  ,"gdc-0941 alone, gdc-0941 + pd0325901",,,,
1229988655,5/3/2017 13:02:03,5/4/2017 11:43:04, cell line,es cell line type  ,"geminin overexpression, geminin knockdown",,,,
1229988656,5/3/2017 13:02:03,5/4/2017 11:33:43, age,pig age ,"gestation day 75, gestation day 90, 30 days",,,,
1229988657,5/3/2017 13:02:03,5/4/2017 11:28:31, genotype,lrrk2 genotype  ,"gg (wt), ga (g2019s), wt / wt, wt / lrrk2 gs, transgenic ga (g2019s)",,,,
1229988658,5/3/2017 13:02:03,5/4/2017 11:42:00, genotype,10p14 genotype rs706771  ,"gg, ag, aa",,,,
1229988659,5/3/2017 13:02:03,5/4/2017 11:43:05, genotype,rs7956957 genotype  ,"gg, cg, cc",,,,
1229988660,5/3/2017 13:02:03,5/4/2017 11:35:18, genotype,1q41 genotype rs11579490  ,"gg, gt, tt",,,,
1229988661,5/3/2017 13:02:03,5/4/2017 11:32:46, genotype,1q41 genotype rs6691195  ,"gg, gt, tt",,,,
1229988662,5/3/2017 13:02:03,5/4/2017 11:29:36, genotype,rs7575840 genotype  ,"gg, tx",,,,
1229988663,5/3/2017 13:02:03,5/4/2017 11:54:57, disease,disease model  ,"glioblastoma, medulloblastoma, congenital heart disease (chd) with increased pulmonary blood flow (pbf), control, normal",,,,
1229988664,5/3/2017 13:02:03,5/4/2017 11:36:42, tissue,tissue subregion ,"glomerulus, tubules, tubulus",,,,
1229988665,5/3/2017 13:02:03,5/4/2017 11:30:24, cell line,primary cell line  ,"gm00739b, glioblastoma stem-like cells, kidney asmcs derived from the renin cell lineage",,,,
1229988666,5/3/2017 13:02:03,5/4/2017 11:53:48, cell line,coriell cell line  ,"gm07044, gm12157, gm12002, gm12920, gm07038",,,,
1229988667,5/3/2017 13:02:03,5/4/2017 11:32:07, cell line,cell line (coriell id)  ,"gm17201, gm17102, gm17104, gm17735, gm17207",,,,
1229988668,5/3/2017 13:02:03,5/4/2017 11:34:49, strain,strain origin  ,"gmr-gal4 x bloomington4776, bloomington25174, bloomington48881 x bloomington4776, pbre c4 isolated from skin biopsy of erythema migrans, 1408 c1 isolated from skin biopsy of acrodermatitis chronica atrophians",,,,
1229988669,5/3/2017 13:02:03,5/4/2017 11:35:01, tissue,tissue (group) ,"gonadotrope tumor, normal pituitary",,,,
1229988670,5/3/2017 13:02:03,5/4/2017 11:44:19, strain,eri-1 mutant strain  ,gr1373 (mg366). whole c.elegans,,,,
1229988671,5/3/2017 13:02:03,5/4/2017 11:37:02, genotype,genotype = gs(1)n441 (mat  ,"gs(1)n441/fm7c), gs(1)n441)",,,,
1229988672,5/3/2017 13:02:03,5/4/2017 11:27:27, genotype,8q24 genotype rs6983267  ,"gt, gg, tt",,,,
1229988673,5/3/2017 13:02:03,5/4/2017 11:38:39, strain,toxplasma gondii strain  ,"gt1, ctg, none, ptg",,,,
1229988674,5/3/2017 13:02:03,5/4/2017 11:41:37, age,age_at_onset ,"gte6, lt6",,,,
1229988675,5/3/2017 13:02:03,5/4/2017 11:29:57, strain,strain genotype  ,"h minus (cnp1-flag:kanr), h minus (leu1 ade6 cnp20+-flag[kanr]), h minus (lys:cnp1halys+), by4743, h minus (scm3-19-ha[kanr] lys1+cnp1-gfp)",,,,
1229988676,5/3/2017 13:02:03,5/4/2017 11:42:58, genotype,strain genotype  ,"h minus (cnp1-flag:kanr), h minus (leu1 ade6 cnp20+-flag[kanr]), h minus (lys:cnp1halys+), h minus (scm3-19-ha[kanr] lys1+cnp1-gfp), by4743",,,,
1229988677,5/3/2017 13:02:03,5/4/2017 11:44:20, strain,strain 1783  ,h- leu1-32 ura4-d18 ade6-210 ssl3:ura4+ ars1-ssl3-29ts-leu2 rad21-3ha-kanr,,,,
1229988678,5/3/2017 13:02:03,5/4/2017 11:38:01, strain,strain 1785  ,h- leu1-32 ura4-d18 ade6-210 ssl3:ura4+ ars1-ssl3+-leu2 rad21-3ha-kanr,,,,
1229988679,5/3/2017 13:02:03,5/4/2017 11:39:50, strain,m. tuberculosis strain  ,"h37rv, r17.1, chn50.2, r19.5, mad2.2",,,,
1229988680,5/3/2017 13:02:03,5/4/2017 11:43:09, strain,control strain o157  ,h7 edl933,,,,
1229988681,5/3/2017 13:02:03,5/4/2017 11:38:46, genotype,genotype/background  ,"harboring a plasmid encoding for the polyhistidine-tagged sigma factor gene, heterozygous for the krt14-cre transgene and homozygous (ilk-deficient) for the floxed ilk alleles, heterozygous for the krt14-cre transgene and heterozygous (ilk-expressing) for the floxed ilk alleles",,,,
1229988682,5/3/2017 13:02:03,5/4/2017 11:31:32, tissue,tissue sample ,"hcv positive, hcv negative",,,,
1229988683,5/3/2017 13:02:03,5/4/2017 11:39:54, genotype,hd genotype  ,"hd, wild type",,,,
1229988684,5/3/2017 13:02:03,5/4/2017 11:35:04, tissue,tissue age ,"heads after mid-anthesis, five weeks after grafting seven day-old seedlings",,,,
1229988685,5/3/2017 13:02:03,5/4/2017 11:43:38, age,tissue age ,"heads after mid-anthesis, five weeks after grafting seven day-old seedlings",,,,
1229988686,5/3/2017 13:02:03,5/4/2017 11:32:45, disease,disease_status  ,"healthy control, bipolar disorder, healthy, down syndrome, sle",,,,
1229988687,5/3/2017 13:02:03,5/4/2017 11:41:12, disease,disease course  ,"healthy control, secondary progressive multiple sclerosis, n/a, 2 years at time of biopsy, 1 year at time of biopsy",,,,
1229988688,5/3/2017 13:02:03,5/4/2017 11:41:30, disease,disease_onset  ,"healthy, 2, 3, 4, 7",,,,
1229988689,5/3/2017 13:02:03,5/4/2017 11:38:26, disease,diseasestate  ,"healthy, adenocarcinoma, breast cancer, carcinoma, normal",,,,
1229988690,5/3/2017 13:02:03,5/4/2017 11:42:58, treatment,heat treatment  ,"heating at 95c for 30 min, heating at 95c for 60 min, heating at 95c for 0 min, heating at 95c for 10 min",,,,
1229988691,5/3/2017 13:02:03,5/4/2017 11:38:19, cell line,background cell line  ,"hek-293, ahr null hepatocytes (ahr-/- hepa), mda-mb-231, a673 ewing cell line, wild-type 293 cells",,,,
1229988692,5/3/2017 13:02:03,5/4/2017 11:38:19, cell line,cell line specificity  ,"hek293-t-rex inducible cell line expressing znf143-ha, hek293-t-rex inducible cell line expressing znf143",,,,
1229988693,5/3/2017 13:02:03,5/4/2017 11:29:16, cell line,cell line specifics  ,"hela s3 stably expressing h3.1-flag-ha, hela s3 stably expressing h3.3-flag-ha",,,,
1229988694,5/3/2017 13:02:03,5/4/2017 11:45:55, cell line,cell line  ,"hela, hepg2, mcf7, mcf-7, c2c12",,,,
1229988695,5/3/2017 13:02:03,5/4/2017 11:38:50, cell line,insect cell line  ,"helicoverpa zea cell line (hzam1) isolated from pupal ovarian tissue by mcintosh and ignoffo (1983), helicoverpa zea cell line (hzam1)",,,,
1229988696,5/3/2017 13:02:03,5/4/2017 11:43:09, strain,strain details  ,"hg.cast-(d11mit260-d11mit255), hg.cast-(d2mit329-d2mit457), hg.cast-(d17mit196-d17mit190)",,,,
1229988697,5/3/2017 13:02:03,5/4/2017 11:36:05, disease,advanced disease stage  ,"hgd, eac, lgd, im",,,,
1229988698,5/3/2017 13:02:03,5/4/2017 11:46:26, strain,hcmel3 strain  ,hgfxcdk4r24c_c57bl6,,,,
1229988699,5/3/2017 13:02:03,5/4/2017 11:29:35, treatment,treatment dosage  ,"high, low, 0.7 ppm, 60mg/kg/d, 100 nm",,,,
1229988700,5/3/2017 13:02:03,5/4/2017 11:29:34, genotype,infection (e. coli genotype)  ,"hlya1-, cnf1- hlya1-, cnf1-, pbs control, wt",,,,
1229988701,5/3/2017 13:02:03,5/4/2017 11:21:16, cell line,cell line id  ,"hmvecdlyad-der, 262, 334, 391, 395",,,,
1229988702,5/3/2017 13:02:03,5/4/2017 12:18:36, cell type,cell type origin  ,"hodgkin's lymphoma, cultured lncap cells, fibroblast, cervical cancer, myelogenous leukemia",,,,
1229988703,5/3/2017 13:02:03,5/4/2017 11:33:06, sex,sexual_orientation  ,"homosexual, heterosexual",,,,
1229988704,5/3/2017 13:02:03,5/4/2017 11:42:43, age,agenotype ,"homozygous knockout  (sirt1-/-), wild type  (sirt1+/+), heterozygous knockout  (sirt1+/-)",,,,
1229988705,5/3/2017 13:02:03,5/4/2017 11:36:05, time,time_hpi  ,"hour 00, hour 005, hour 045, hour 012, hour 060",,,,
1229988706,5/3/2017 13:02:03,5/4/2017 11:25:46, time,time [post-infection]  ,"hour 72, hour 8, hour 24, hour 0, hour 48",,,,
1229988707,5/3/2017 13:02:03,5/4/2017 11:38:00, strain,strain/genotyp  ,"hpl-2(tm1489), n2 (wt)",,,,
1229988708,5/3/2017 13:02:03,5/4/2017 11:36:01, strain,host mouse strain  ,"hsdathymic nude-foxn1nu (athymic nude mice), c57bl/6j",,,,
1229988709,5/3/2017 13:02:03,5/4/2017 12:10:12, cell line,fibrosarcoma cell line  ,ht1080,,,,
1229988710,5/3/2017 13:02:03,5/4/2017 11:32:57, treatment,treatments prior to dasatinib  ,"hu, ifn, im, hu, ifn, arac, im, hu, ifn, arac, asct, im",,,,
1229988711,5/3/2017 13:02:03,5/4/2017 11:32:01, treatment,tzd treatment  ,"hu, ifn, im, hu, ifn, arac, im, hu, ifn, arac, asct, im",,,,
1229988712,5/3/2017 13:02:03,5/4/2017 11:40:10, treatment,oxygen treatment  ,"hypoxia, normoxia (mock)",,,,
1229988713,5/3/2017 13:02:03,5/4/2017 11:21:16, treatment,patient treatment plan  ,"ic+surgery, crt, ic+crt, ic+rt",,,,
1229988714,5/3/2017 13:02:03,5/4/2017 11:29:43, tissue,tissue histology ,"idc-nst, grade 3, na",,,,
1229988715,5/3/2017 13:02:03,5/4/2017 11:30:14, tissue,tissue_grade ,"iii, iv, ii,v",,,,
1229988716,5/3/2017 13:02:03,5/4/2017 11:32:01, treatment,cytokine treatment  ,"il13, il13 + il4, media, il-33, il-25",,,,
1229988717,5/3/2017 13:02:03,5/4/2017 11:54:57, disease,disease location  ,"ileal and colonic involvement, ileal involvement only, colonic involvement only",,,,
1229988718,5/3/2017 13:02:03,5/4/2017 11:48:50, disease,disease phenotype  ,"illeal crohn's disease, ulcerative colitis, no inflammatory bowel disease, stage iv melanoma",,,,
1229988719,5/3/2017 13:02:03,5/4/2017 11:40:55, tissue,tissue and developmental stage ,immature seed coats dissected from seeds of 50-75 mg fresh weight,,,,
1229988720,5/3/2017 13:02:03,5/4/2017 11:27:16, cell type,background cell type  ,immortalized human bronchial epithelial cell,,,,
1229988721,5/3/2017 13:02:03,5/4/2017 11:35:50, cell line,cell line conditioning  ,"in vivo, in vitro",,,,
1229988722,5/3/2017 13:02:03,5/4/2017 11:30:23, treatment,nature of treatment  ,"in vivo, in vitro con, in vivo con (age-matched), in vitro",,,,
1229988723,5/3/2017 13:02:03,5/4/2017 11:29:42, disease,aggressiveness of disease  ,"indolent, aggressive",,,,
1229988724,5/3/2017 13:02:03,5/4/2017 11:31:26, cell line,cell line subpopulation  ,"invasive, reference",,,,
1229988725,5/3/2017 13:02:03,5/4/2017 11:37:45, genotype,host genotype/variation  ,"irradiated wild-type, irradiated tgfb1 heterozygote, sham-irradiated wild-type, sham-irradiated tgfb1 heterozygote",,,,
1229988726,5/3/2017 13:02:03,5/4/2017 11:23:10, tissue,tissue grade ,"iv, iii, ii, v",,,,
1229988727,5/3/2017 13:02:03,5/4/2017 11:42:58, treatment,treatment_category  ,"ivig responder_acute, ivig responder_after, ivig healthy controls, ivig non responder_acute, ivig non responder_after ivig",,,,
1229988728,5/3/2017 13:02:03,5/4/2017 11:45:29, strain,parent strain  ,"ja122, jir8094",,,,
1229988729,5/3/2017 13:02:03,5/4/2017 11:39:30, strain,strain info  ,"jax stock #000664, say995, say996, say841, ah13",,,,
1229988730,5/3/2017 13:02:03,5/4/2017 12:10:13, tissue,landrace tissue ,jejunum,,,,
1229988731,5/3/2017 13:02:03,5/4/2017 11:41:22, treatment,treatment drug  ,"jq1, dmso, --",,,,
1229988732,5/3/2017 13:02:03,5/4/2017 11:37:14, cell line,cell line name  ,"k-562 (atcc_ ccl-243__｢), a375p, tt-fhago2, mds-l, tt-ago2",,,,
1229988733,5/3/2017 13:02:03,5/4/2017 12:18:36, cell line,leukemia cell line  ,k562,,,,
1229988734,5/3/2017 13:02:03,5/4/2017 11:38:50, genotype,genotype/genetic variation  ,"k5rta, epcam negative, epcam positive, k5rta tetotgfbeta",,,,
1229988735,5/3/2017 13:02:03,5/4/2017 11:40:21, strain,strain by4741-rco1  ,kanmx (mata his3__1 leu2__0 met15__0 ura3__0 rco1:kanmx),,,,
1229988736,5/3/2017 13:02:03,5/4/2017 11:38:14, strain,strain by4741-rpd3  ,kanmx (mata his3__1 leu2__0 met15__0 ura3__0 rpd3:kanmx),,,,
1229988737,5/3/2017 13:02:03,5/4/2017 11:36:04, strain,strain by4741-ume6  ,kanmx (mata his3__1 leu2__0 met15__0 ura3__0 ume6:kanmx),,,,
1229988738,5/3/2017 13:02:03,5/4/2017 11:19:22, strain,strain by4741-pho23  ,kanmx (mata his3_1 leu2_0 met15_0 ura3_0 pho3:kanmx),,,,
1229988739,5/3/2017 13:02:03,5/4/2017 11:36:08, strain,strain by4741-msn2  ,"kanmx/msn4:ura3/rpd3:leu2 (mata his3__1 leu2__0 met15__0 ura3__0 msn2:kanmx msn4:ura3 rpd3:leu2), kanmx/msn4:ura3 (mata his3__1 leu2__0 met15__0 ura3__0 msn2:kanmx msn4:ura3)",,,,
1229988740,5/3/2017 13:02:03,5/4/2017 11:27:09, tissue,tissue/cell ,"kidney, testis, cerebellum, heart, brain",,,,
1229988741,5/3/2017 13:02:03,5/4/2017 11:36:27, strain,strain jam1  ,knockout of s,,,,
1229988742,5/3/2017 13:02:03,5/4/2017 11:43:52, strain,strain tw14  ,knockout of the brpa gene via insertion of a erythromycin cassette,,,,
1229988743,5/3/2017 13:02:03,5/4/2017 11:39:18, strain,strain tw1  ,knockout of the ccpa homolog via insertion of a kanamycin cassette,,,,
1229988744,5/3/2017 13:02:03,5/4/2017 11:44:19, strain,bacterial strain used  ,"l. plantarum 299v msa mutant, l. plantarum 299v wildtype, I. plantarum 299v srt mutant",,,,
1229988745,5/3/2017 13:02:03,5/4/2017 11:36:11, strain,equivalent strain name  ,"l2r (25667r), l2(434) bu, l2rp+",,,,
1229988746,5/3/2017 13:02:03,5/4/2017 11:42:58, disease,disease phase  ,"late period, early period, control",,,,
1229988747,5/3/2017 13:02:03,5/4/2017 11:38:43, cell line,cell line derivation  ,"late stage embryos, 39-year-old parous japanese female diagnosed with endometrial adenocarcinoma stage 2., bone marrow",,,,
1229988748,5/3/2017 13:02:03,5/4/2017 11:34:10, time,time of relapse  ,"late, very early, early",,,,
1229988749,5/3/2017 13:02:03,5/4/2017 11:38:45, tissue,tissue harvested ,"leaf, root, tramp-c2re3 prostate orthotopic tumors, ts/a tumors 21 days after tumor challenge",,,,
1229988750,5/3/2017 13:02:03,5/4/2017 11:38:43, tissue,a.thaliana tissue ,leaves,,,,
1229988751,5/3/2017 13:02:03,5/4/2017 11:22:16, disease,disease extension  ,"left-sided colitis, --, pancolitis",,,,
1229988752,5/3/2017 13:02:03,5/4/2017 11:37:58, treatment,maternal treatment group  ,"leptin, control, restricted",,,,
1229988753,5/3/2017 13:02:03,5/4/2017 11:43:05, strain,strain[background]  ,line-m,,,,
1229988754,5/3/2017 13:02:03,5/4/2017 11:37:55, cell line,cell line/clone  ,"line, clone fips5-7, clone fips2-10, clone fips1-14, clone fips6-3",,,,
1229988755,5/3/2017 13:02:03,5/4/2017 11:39:50, treatment,treatment (short label)  ,"lis.dil, er.char 40%, lis 40%, mdl.diel, mdl.phen",,,,
1229988756,5/3/2017 13:02:03,5/4/2017 11:25:46, tissue,cell tissue ,liver,,,,
1229988757,5/3/2017 13:02:03,5/4/2017 11:34:27, tissue,tissue ,"liver, blood, whole blood, peripheral blood, lung",,,,
1229988758,5/3/2017 13:02:03,5/4/2017 11:37:02, tissue,tissue derived ,"liver, skin, peripheral blood",,,,
1229988759,5/3/2017 13:02:03,5/4/2017 11:42:58, disease,patient disease status  ,"localized neuroblastoma, with a diagnosis of cyanotic tetralogy of fallot congenital heart disease, metastatic neuroblastoma, healthy young donor, normal",,,,
1229988760,5/3/2017 13:02:03,5/4/2017 11:25:46, disease,extent of disease  ,"localized, unknown, metastatic",,,,
1229988761,5/3/2017 13:02:03,5/4/2017 11:28:31, time,time reference  ,"longitudinal, enrollment",,,,
1229988762,5/3/2017 13:02:03,5/4/2017 11:24:53, cell line,cell line traits  ,"loss of p53, loss of hormone receptors er and pr",,,,
1229988763,5/3/2017 13:02:03,5/4/2017 11:33:47, treatment,pbmc treatment  ,"lps, conditioned, untreated, conditioned",,,,
1229988764,5/3/2017 13:02:03,5/4/2017 11:33:48, treatment,treatment condition  ,"lps, control, oxpapc, na, constant dark conditions",,,,
1229988765,5/3/2017 13:02:03,5/4/2017 11:39:20, tissue,tissue enriched for ,"ls1-np-ncr, ls1-np-t, ls1-np-cr",,,,
1229988766,5/3/2017 13:02:03,5/4/2017 11:35:53, disease,lung disease  ,"lung cancer (before surgical resection of lung cancer), none (no current or past lung cancer or non-cancerous nodule), non-cancerous lung nodule, none (after surgical resection of lung cancer)",,,,
1229988767,5/3/2017 13:02:03,5/4/2017 11:28:32, tissue,# of tissue = 1 tissue ,"lung, liver",,,,
1229988768,5/3/2017 13:02:03,5/4/2017 11:41:29, strain,background strain(s)  ,lxt1xbalb/c,,,,
1229988769,5/3/2017 13:02:03,5/4/2017 11:42:36, tissue,tissue_surgery ,"lymph_node, liver",,,,
1229988770,5/3/2017 13:02:03,5/4/2017 11:38:01, gender,gender (1#pfu_2) ,m,,,,
1229988771,5/3/2017 13:02:03,5/4/2017 11:36:27, gender,gender (1#pfu_1) ,m,,,,
1229988772,5/3/2017 13:02:03,5/4/2017 11:30:07, sex,recipient sex  ,"m, f",,,,
1229988773,5/3/2017 13:02:03,5/4/2017 11:34:11, sex,sex/mating type  ,"m, f",,,,
1229988774,5/3/2017 13:02:03,5/4/2017 11:37:06, gender,gender (male/female) ,"m, f, 1/1/2017",,,,
1229988775,5/3/2017 13:02:03,5/4/2017 11:32:52, sex,donor sex  ,"m, f, male, female, unknown",,,,
1229988776,5/3/2017 13:02:03,5/4/2017 11:35:51, treatment,secondary treatment  ,"macrophage conditioned medium, thesc conditioned medium serum starved, serum starvation",,,,
1229988777,5/3/2017 13:02:03,5/4/2017 11:53:43, cell type,cell type (sorted)  ,"macrophages, ntreg, itreg, ex-itreg",,,,
1229988778,5/3/2017 13:02:03,5/4/2017 11:41:22, gender,gender (mouse) ,male,,,,
1229988779,5/3/2017 13:02:03,5/4/2017 11:28:37, gender,gender of the clone ,male,,,,
1229988780,5/3/2017 13:02:03,5/4/2017 11:34:58, gender,gender (pup) ,male,,,,
1229988781,5/3/2017 13:02:03,5/4/2017 11:27:09, gender,xenograft recipient gender ,male,,,,
1229988782,5/3/2017 13:02:03,5/4/2017 11:39:37, gender,mouse model gender ,male,,,,
1229988783,5/3/2017 13:02:03,5/4/2017 11:24:34, age,agender ,male,,,,
1229988784,5/3/2017 13:02:03,5/4/2017 11:29:44, sex,sex of recipient mice  ,male,,,,
1229988785,5/3/2017 13:02:03,5/4/2017 11:39:29, sex,proband sex  ,male,,,,
1229988786,5/3/2017 13:02:03,5/4/2017 11:36:42, strain,strain c57bl/6  gender  ,male  age10 weeks  tissuesubstantia nigra(sn) disected bilaterally from six like-treated mice.,,,,
1229988787,5/3/2017 13:02:03,5/4/2017 11:58:00, gender,strain c57bl/6 gender ,male  age10 weeks  tissuesubstantia nigra(sn) disected bilaterally from six like-treated mice.,,,,
1229988788,5/3/2017 13:02:03,5/4/2017 11:46:57, strain,strain c57bl/6 gender  ,male age10 weeks tissuesubstantia nigra(sn) disected bilaterally from six like-treated mice,,,,
1229988789,5/3/2017 13:02:03,5/4/2017 11:38:45, gender,ma4 gender ,male age10 weeks tissuesubstantia nigra(sn) disected bilaterally from six like-treated mice,,,,
1229988790,5/3/2017 13:02:03,5/4/2017 11:29:44, gender,gender of human sera ,"male, female",,,,
1229988791,5/3/2017 13:02:03,5/4/2017 11:41:02, gender,gender of baby ,"male, female",,,,
1229988792,5/3/2017 13:02:03,5/4/2017 11:40:52, gender,host gender ,"male, female",,,,
1229988793,5/3/2017 13:02:03,5/4/2017 11:32:44, gender,donor gender ,"male, female",,,,
1229988794,5/3/2017 13:02:03,5/4/2017 11:43:38, gender,cell line source gender ,"male, female",,,,
1229988795,5/3/2017 13:02:03,5/4/2017 11:33:29, gender,fetus gender ,"male, female",,,,
1229988796,5/3/2017 13:02:03,5/4/2017 11:32:19, gender,donor's  gender ,"male, female",,,,
1229988797,5/3/2017 13:02:03,5/4/2017 11:44:47, cell line,cell line source gender  ,"male, female",,,,
1229988798,5/3/2017 13:02:03,5/4/2017 11:44:19, sex,genotyped sex  ,"male, female",,,,
1229988799,5/3/2017 13:02:03,5/4/2017 11:39:58, sex,mouse sex  ,"male, female",,,,
1229988800,5/3/2017 13:02:03,5/4/2017 11:44:19, sex,sex (gender)  ,"male, female",,,,
1229988801,5/3/2017 13:02:03,5/4/2017 11:36:58, sex,sex of patient  ,"male, female",,,,
1229988802,5/3/2017 13:02:03,5/4/2017 12:46:58, genotype,genotyped sex  ,"male, female",,,,
1229988803,5/3/2017 13:02:03,5/4/2017 11:38:08, gender,gender ,"male, female, m, f",,,,
1229988804,5/3/2017 13:02:03,5/4/2017 11:44:47, gender,subject gender ,"male, female, m, f",,,,
1229988805,5/3/2017 13:02:03,5/4/2017 11:25:46, sex,sex  ,"male, female, m, f, unknown",,,,
1229988806,5/3/2017 13:02:03,5/4/2017 11:36:42, sex,patient sex  ,"male, female, m, n/a, f",,,,
1229988807,5/3/2017 13:02:03,5/4/2017 11:24:10, gender,patient gender ,"male, female, n1, 1, 2",,,,
1229988808,5/3/2017 13:02:03,5/4/2017 11:34:10, gender,recipient gender ,"male, none, female",,,,
1229988809,5/3/2017 13:02:03,5/4/2017 11:33:48, tissue,tissue origination ,"mammary gland, breast",,,,
1229988810,5/3/2017 13:02:03,5/4/2017 11:40:21, genotype,relevant genotype  ,"mata, sth1td ubr1(delta), h- ura4-d18 leu1-32 ade6-704, rsc3-9myc, rpb1-1",,,,
1229988811,5/3/2017 13:02:03,5/4/2017 11:39:44, strain,strain sr954  ,mata/alpha  ira1:his3/ira1:leu2  ura3___52/ura3___52  leu2:hisg/leu2:hisg  his3:hisg/his3:hisg  prs316___ira1ra,,,,
1229988812,5/3/2017 13:02:03,5/4/2017 11:41:02, strain,strain sr595  ,mata/alpha  ira1:his3/ira1:leu2  ura3-52/ura3-52  leu2:hisg/leu2:hisg  his3:hisg/his3:hisg  prs316,,,,
1229988813,5/3/2017 13:02:03,5/4/2017 11:41:38, strain,strain sr563  ,mata/alpha  ira2:his3/ira2:leu2  ura3-52/ura3-52  leu2:hisg/leu2:hisg  his3:hisg/his3:hisg  prs316,,,,
1229988814,5/3/2017 13:02:03,5/4/2017 11:36:08, strain,strain sr957  ,mata/alpha  ras1:his3/ras1:his3  ras2delta/ras2delta  pde2:kanr/ pde2:kanr  ura3-52/ura3-52 leu2:hisg/leu2:hisg  his3:hisg/his3:hisg  trp1+/trp1:hisg,,,,
1229988815,5/3/2017 13:02:03,5/4/2017 11:23:10, strain,strain sr959  ,mata/alpha  ras1:his3/ras1:his3  ras2delta/ras2delta  pde2:kanr/ pde2:kanr  ura3-52/ura3-52 leu2:hisg/leu2:hisg  his3:hisg/his3:hisg  trp1+/trp1:hisg  prs315,,,,
1229988816,5/3/2017 13:02:03,5/4/2017 11:36:59, strain,strain sr453  ,"mata/alpha  ura3-52/ura3-52  prs316-ras2v19, mata/alpha  ura3___52/ura3___52  prs316___ras2v19",,,,
1229988817,5/3/2017 13:02:03,5/4/2017 11:35:04, strain,strain sr1187  ,mata/alpha ura3-52/ura3-52 prs316,,,,
1229988818,5/3/2017 13:02:03,5/4/2017 11:37:56, strain,strain sr753  ,mata/alpha ura3-52/ura3-52 prs316___ras2a22,,,,
1229988819,5/3/2017 13:02:03,5/4/2017 11:41:39, genotype,pool genotype  ,mata/alpha ura3delta0 leu2delta his3delta1 lys2delta0/lys2 met15delta0/met15 can1delta:leu2-mfa1pr-his3/can1 xxx:kanmx/xxx,,,,
1229988820,5/3/2017 13:02:03,5/4/2017 11:40:29, sex,sexual maturity  ,mature,,,,
1229988821,5/3/2017 13:02:03,5/4/2017 11:40:57, strain,strain/genotype variation  ,"mc58, grb2405cml128 hcm1-3ha:natmx4 (hcm1ha), cml128mata ura3-52 his4 leu2-3,112 trp1 (wt), mjrc07grb2405 teto7-hcm1-3ha:kanmx4 (tethcm1ha)",,,,
1229988822,5/3/2017 13:02:03,5/4/2017 11:35:50, tissue,tissue-of-origin ,"melanoma, colon, renal, non-small cell lung, ovarian",,,,
1229988823,5/3/2017 13:02:03,5/4/2017 11:37:42, cell line,cell lineage  ,"mesoderm, ectoderm, endoderm, inner cell mass, international hapmap project - ceph/utah - european caucasion",,,,
1229988824,5/3/2017 13:02:03,5/4/2017 11:39:23, treatment,peptide treatment  ,"metastin-10, control peptide",,,,
1229988825,5/3/2017 13:02:03,5/4/2017 11:40:44, tissue,tissues ,"microdissected dental tissues from lower incisors, spleen and head kidney, spleen, normal spleen, cultured callus",,,,
1229988826,5/3/2017 13:02:03,5/4/2017 11:38:34, tissue,tissue stage ,"mid-late/late luteal phase, fresh frozen tissue, basal state, ffpe, ovarian cancer tissue after treatment",,,,
1229988827,5/3/2017 13:02:03,5/4/2017 11:41:22, time,sampling time group  ,"mid, early",,,,
1229988828,5/3/2017 13:02:03,5/4/2017 11:35:18, tissue,tissue part ,middle region,,,,
1229988829,5/3/2017 13:02:03,5/4/2017 11:32:43, genotype,genotype(breed)  ,"mix, greyhound, rottweiler, golden ret.",,,,
1229988830,5/3/2017 13:02:03,5/4/2017 11:29:16, strain,strain name  ,"mixed, common referencemixture of by4716 and, rm11-1a rna from glucose and ethanol conditions, 1254, (wild_type), wt, wt (a11311)",,,,
1229988831,5/3/2017 13:02:03,5/4/2017 11:27:01, cell type,tumor cell type  ,"mixed, epithelioid, na, the rat-derived c6 glioma cell line was obtained from the american type culture collection (manassas, va). the cells were routinely maintained in dmem supplemented with l-glutamine, 1% penicillin/streptomycin solution, and 10% fbs in a humidified co2 incubator at 37 __c., neuroblastoma",,,,
1229988832,5/3/2017 13:02:03,5/4/2017 11:32:46, disease,disease_severity  ,"moderate, healthy, severe, mild, unclassified",,,,
1229988833,5/3/2017 13:02:03,5/4/2017 11:33:01, cell line,originating cell line  ,"molt-4, pc-3/m, rxf 393, uacc-62, a549",,,,
1229988835,5/3/2017 13:02:04,5/4/2017 12:03:29, cell type,host cell type  ,"monocyte derived dendritic cells (mddcs), enucleated mii oocytes, t lymphocyte",,,,
1229988836,5/3/2017 13:02:04,5/4/2017 11:32:52, cell line,cell line(s)  ,"mouse es cells and human fibroblast, human fibroblast",,,,
1229988837,5/3/2017 13:02:04,5/4/2017 11:31:32, treatment,antibody treatment  ,"mouse igg, 228b/c, 228b/c + 11h4, none, 11h4",,,,
1229988838,5/3/2017 13:02:04,5/4/2017 11:40:44, cell type,source cell type  ,"mouse mammary epithelial cells, human embryonic stem cells (hescs), circulating tumor cells, csf, mouse embryonic fibroblast (mef)",,,,
1229988839,5/3/2017 13:02:04,5/4/2017 11:36:34, disease,disease category  ,"mpn_pmf, blast phase_pmf, mpn_et, mpn_pv, blast phase_et",,,,
1229988840,5/3/2017 13:02:04,5/4/2017 11:41:22, treatment,vaccine or treatment  ,"mrkad5/hiv, mrkad5 at 20000 virus particles/cell, mock",,,,
1229988841,5/3/2017 13:02:04,5/4/2017 11:36:52, genotype,maternal genotype  ,"msh22, flagstaff 14, ms, lw, rpa-70-egfp/+",,,,
1229988842,5/3/2017 13:02:04,5/4/2017 11:33:49, treatment,rnai treatment  ,"msl2 rnai, control gfp rnai, xrn-1, mes-4, tspan-17 shrna",,,,
1229988843,5/3/2017 13:02:04,5/4/2017 11:30:08, tissue,tissue morphology ,"mucosa, colonic crypt epithelial cells",,,,
1229988844,5/3/2017 13:02:04,5/4/2017 11:34:58, strain,strain_description  ,"mutant strain unable to discharge trichocysts. less background in deciliation experiments, stock 37c09, wild type, wild type mating type vii, wild type mating type viii",,,,
1229988845,5/3/2017 13:02:04,5/4/2017 11:38:14, treatment,transcription factor treatment  ,"myocd, nkx2.5, hand2, gata4, no tf",,,,
1229988846,5/3/2017 13:02:04,5/4/2017 11:26:12, tissue,tissue/cell line [c] ,"myometrium, mda-mb231 cells, prostate gland, endometrium, endometrium/ovary",,,,
1229988847,5/3/2017 13:02:04,5/4/2017 11:33:02, time,sampling date and time  ,n/a,,,,
1229988848,5/3/2017 13:02:04,5/4/2017 11:25:12, time,time interval fromc (months)  ,n/a,,,,
1229988849,5/3/2017 13:02:04,5/4/2017 11:36:10, disease,residual disease  ,"n/a, < 1 cm, no",,,,
1229988850,5/3/2017 13:02:04,5/4/2017 11:41:25, age,age of onset (years) ,"n/a, 25, 22, 14, 17",,,,
1229988851,5/3/2017 13:02:04,5/4/2017 11:29:36, age,age at first birth ,"n/a, 26, 25, 28, 23",,,,
1229988852,5/3/2017 13:02:04,5/4/2017 11:32:19, age,maternal age ,"n/a, 27 ,29, 24, 30",,,,
1229988853,5/3/2017 13:02:04,5/4/2017 11:40:32, age,treatment start age ,"n/a, 44 days",,,,
1229988854,5/3/2017 13:02:04,5/4/2017 11:19:22, treatment,treatment start age  ,"n/a, 44 days",,,,
1229988855,5/3/2017 13:02:04,5/4/2017 12:10:12, age,age at dx (years) ,"n/a, 5, 6.6, 6.4, 3.9",,,,
1229988856,5/3/2017 13:02:04,5/4/2017 11:36:59, age,mean age years (range) ,"n/a, 62.75 (56-68)",,,,
1229988857,5/3/2017 13:02:04,5/4/2017 11:35:51, age,age-at-onset ,"n/a, 65, 45, 48",,,,
1229988858,5/3/2017 13:02:04,5/4/2017 11:32:42, treatment,c systemic treatment  ,"n/a, chemotherapy - tamoxifen, chemotherapy, tamoxifen, no",,,,
1229988859,5/3/2017 13:02:04,5/4/2017 11:44:20, genotype,hcv genotype  ,"n/a, genotype 1b, 1",,,,
1229988860,5/3/2017 13:02:04,5/4/2017 11:40:32, treatment,c local treatment  ,"n/a, mastectomy, breast conserving surgery",,,,
1229988861,5/3/2017 13:02:04,5/4/2017 11:34:24, treatment,lithium treatment  ,"n/a, no, yes",,,,
1229988862,5/3/2017 13:02:04,5/4/2017 11:25:52, treatment,valproate treatment  ,"n/a, no, yes",,,,
1229988863,5/3/2017 13:02:04,5/4/2017 11:37:06, cell line,growth pattern of cell line  ,"n/a, sclc-classic, sclc-variant",,,,
1229988864,5/3/2017 13:02:04,5/4/2017 11:38:19, disease,disease severity  ,"n/a, severe, mild, not applicable, 7 (p)",,,,
1229988865,5/3/2017 13:02:04,5/4/2017 11:45:54, time,time measured post wounding  ,"n/a, two hours, 30 min",,,,
1229988866,5/3/2017 13:02:04,5/4/2017 11:39:21, strain,strain (cy3)  ,n2,,,,
1229988867,5/3/2017 13:02:04,5/4/2017 11:41:02, strain,strain (cy5)  ,"n2, ss186",,,,
1229988868,5/3/2017 13:02:04,5/4/2017 11:39:38, genotype,rb genotype/variation  ,"n750f,wt,loh, ko",,,,
1229988869,5/3/2017 13:02:04,5/4/2017 11:27:33, time,survival time (years)  ,na,,,,
1229988870,5/3/2017 13:02:04,5/4/2017 11:45:29, time,survival time in months  ,na,,,,
1229988871,5/3/2017 13:02:04,5/4/2017 11:38:46, treatment,treatment response  ,"na ,responder, nonresponder, fl_responder, partial response",,,,
1229988872,5/3/2017 13:02:04,5/4/2017 11:37:35, treatment,treatment response in vitro  ,"na, 0, 1",,,,
1229988873,5/3/2017 13:02:04,5/4/2017 11:36:54, time,time to treatment (days)  ,"na, 0, 31, 230, 1624",,,,
1229988874,5/3/2017 13:02:04,5/4/2017 11:31:08, time,timetofirstszmin  ,"na, 0, 330, 57, 115",,,,
1229988875,5/3/2017 13:02:04,5/4/2017 11:31:32, time,time post-treatment  ,"na, 1 day, 7 day, 0 day, control",,,,
1229988876,5/3/2017 13:02:04,5/4/2017 11:32:46, age,age at diagnosis (years) ,"na, 12, 5, 3, 14",,,,
1229988877,5/3/2017 13:02:04,5/4/2017 11:31:27, treatment,time to treatment (days)  ,"na, 1624, 31, 230, 0",,,,
1229988878,5/3/2017 13:02:04,5/4/2017 11:33:49, time,time2lr  ,"na, 2.2, 4.6, 3.1, 4.2",,,,
1229988879,5/3/2017 13:02:04,5/4/2017 11:35:48, time,overall survival time_days  ,"na, 2211, 2225",,,,
1229988880,5/3/2017 13:02:04,5/4/2017 11:36:21, age,age at incident ,"na, 24, 17, 54, 15",,,,
1229988881,5/3/2017 13:02:04,5/4/2017 11:38:10, time,recurrence free time (months)  ,"na, 25, 32.13, 31.97, 38.3",,,,
1229988882,5/3/2017 13:02:04,5/4/2017 11:38:19, age,age  (months) ,"na, 28, 12, 8, 11",,,,
1229988883,5/3/2017 13:02:04,5/4/2017 11:29:33, age,age (months) ,"na, 28, 12, 8, 11",,,,
1229988884,5/3/2017 13:02:04,5/4/2017 11:31:26, time,overall survival time  ,"na, 40, 20, 37, 36",,,,
1229988885,5/3/2017 13:02:04,5/4/2017 11:50:33, age,ageyear ,"na, 49, 48, 46, 42",,,,
1229988886,5/3/2017 13:02:04,5/4/2017 11:27:10, disease,disease activity (das28_v3)  ,"na, 5.13, 3.69, 3.87, 3.26",,,,
1229988887,5/3/2017 13:02:04,5/4/2017 11:59:07, time,dfs time  ,"na, 5.58, 4, 5.83, 4.67",,,,
1229988888,5/3/2017 13:02:04,5/4/2017 11:44:42, time,dss time  ,"na, 5.58, 5, 5.83, 1.96",,,,
1229988889,5/3/2017 13:02:04,5/4/2017 11:36:04, disease,disease activity (das28_v1)  ,"na, 6.04, 5.52, 4.06, 4.33",,,,
1229988890,5/3/2017 13:02:04,5/4/2017 12:46:58, age,ageatsampling ,"na, 66, 42, 38, 62",,,,
1229988891,5/3/2017 13:02:04,5/4/2017 11:38:34, age,age.at.diagnosis ,"na, 68, 70, 78, 73",,,,
1229988892,5/3/2017 13:02:04,5/4/2017 12:10:12, age,age of biopsy ,"na, 73 days, 75 days, 54 days, 3 years",,,,
1229988893,5/3/2017 13:02:04,5/4/2017 11:40:18, age,age at operation ,"na, 74 years, 70 years, 28, 64",,,,
1229988894,5/3/2017 13:02:04,5/4/2017 11:39:48, disease,diseaseduration(years)  ,"na, 8, 10, 11, 9",,,,
1229988895,5/3/2017 13:02:04,5/4/2017 11:37:35, age,age.brain ,"na, 80, 90, 86, 88",,,,
1229988896,5/3/2017 13:02:04,5/4/2017 11:38:19, time,time of followup (mo)  ,"na, 81, 83, 71, 53",,,,
1229988897,5/3/2017 13:02:04,5/4/2017 11:24:53, age,age.blood ,"na, 89, 80, 79, 82",,,,
1229988898,5/3/2017 13:02:04,5/4/2017 11:32:46, tissue,tissue_code ,"na, f, a h, e",,,,
1229988899,5/3/2017 13:02:04,5/4/2017 11:38:32, treatment,treatment compound  ,"na, indomethacin, sildenafil, valproic acid, rofecoxib",,,,
1229988900,5/3/2017 13:02:04,5/4/2017 11:33:00, treatment,treatment agent  ,"na, macrophage differentiation medium, acd3/acd28, il15, lps",,,,
1229988901,5/3/2017 13:02:04,5/4/2017 11:36:22, treatment,intrusion treatment  ,"na, simulated territorial intrusion, control",,,,
1229988902,5/3/2017 13:02:04,5/4/2017 11:41:22, strain,toxoplasma parasite strain  ,"na, type ii (pru a7) +rop16i, type ii (pru a7)",,,,
1229988903,5/3/2017 13:02:04,5/4/2017 11:29:57, treatment,gefitinib treatment  ,"na, y",,,,
1229988904,5/3/2017 13:02:04,5/4/2017 11:41:48, treatment,hormone treatment  ,"na, y",,,,
1229988905,5/3/2017 13:02:04,5/4/2017 11:36:27, cell type,cell type/growth condition  ,"na随ve t-cells from spleen under th17 polarizing conditions, na随ve t-cells from spleen under th2 polarizing conditions, na随ve t-cells from spleen activated by anti-cd3 and anti-cd28, ilc2s were sorted from the mln of il-25-treated mice, bone marrow derived dendritic cells stimulated with lps for 6hrs",,,,
1229988906,5/3/2017 13:02:04,5/4/2017 11:37:39, cell line,tumor cell line  ,"nccit, mc38, be2c, 1273, syo-1",,,,
1229988907,5/3/2017 13:02:04,5/4/2017 11:25:46, strain,reference strains  ,nctc 11168 and rm1221,,,,
1229988908,5/3/2017 13:02:04,5/4/2017 11:32:25, strain,strain id  ,"ncyc110, w303, yps1009, yps163, ncyc3290",,,,
1229988909,5/3/2017 13:02:04,5/4/2017 11:41:02, treatment,treatment of mouse  ,"neu+ tumor bearing, normal",,,,
1229988910,5/3/2017 13:02:04,5/4/2017 11:33:31, disease,disease status  ,"neurologically and neuropathologically normal, healthy, control, prostate cancer, unaffected",,,,
1229988911,5/3/2017 13:02:04,5/4/2017 11:34:22, tissue,tissue type ,"neuronal, tumor, breast cancer cell line, bone marrow, normal",,,,
1229988912,5/3/2017 13:02:04,5/4/2017 11:38:10, strain,rrf-3 mutant strain  ,nl2099 (pk1426). whole c.elegans,,,,
1229988913,5/3/2017 13:02:04,5/4/2017 11:37:42, genotype,hal genotype  ,nn,,,,
1229988914,5/3/2017 13:02:04,5/4/2017 11:41:39, treatment,sirna or shrna treatment  ,no,,,,
1229988915,5/3/2017 13:02:04,5/4/2017 11:37:58, treatment,treatment of estrogen  ,no,,,,
1229988916,5/3/2017 13:02:04,5/4/2017 11:30:14, treatment,treatment (chemo)  ,"no chemo, chemo",,,,
1229988917,5/3/2017 13:02:04,5/4/2017 11:32:01, cell line,cell line resistance  ,"no igf-1r drugs resistant, stably resistant to igf-1r hab ave1642 hab, stably resistant to igf-1r tki nvp-aew541, stably resistant to igf-1r hab cp-751,871",,,,
1229988918,5/3/2017 13:02:04,5/4/2017 11:26:12, treatment,il-2 treatment  ,"no il-2, 50 u/ml il-2 (added at day0+16h)",,,,
1229988919,5/3/2017 13:02:04,5/4/2017 11:41:12, treatment,imatinib treatment  ,"no im, im",,,,
1229988920,5/3/2017 13:02:04,5/4/2017 11:41:02, treatment,treatment_2  ,"no loading, passive loading, fenofibrate, 1_ｵm 5z-7-oxozeaenol for 1 h, none",,,,
1229988921,5/3/2017 13:02:04,5/4/2017 12:03:29, treatment,msc treatment  ,"no msc, msc",,,,
1229988922,5/3/2017 13:02:04,5/4/2017 11:33:00, treatment,treatment description  ,"no special treatment or protocol applies, 1 h with 0.02% ethanol (myers), 60 h with 2.0% equine serum and insulin (wold), transmits 90.0% of vis, blocks 99.9% of all uv below 390 nm, transmits 90.0% of vis, uva, and uvb radiation",,,,
1229988923,5/3/2017 13:02:04,5/4/2017 11:33:30, treatment,treatment before sampling  ,"no treatment, anastrozole 1mg/d for 10 days, before anastrozole treatment",,,,
1229988924,5/3/2017 13:02:04,5/4/2017 11:30:23, treatment,chemical treatment condition  ,"no treatment, vc6tfmb+z, vc6tf+z, vc6tf",,,,
1229988925,5/3/2017 13:02:04,5/4/2017 11:40:54, treatment,chemical treatment conditon  ,"no treatment, vc6tfmps+z, vc6tf+z, f",,,,
1229988926,5/3/2017 13:02:04,5/4/2017 11:29:35, treatment,dopamine-agonists treatment  ,"no, ""-"", yes",,,,
1229988927,5/3/2017 13:02:04,5/4/2017 11:29:49, treatment,chx treatment  ,"no, chx treated, yes, solvent only, 380 ppm co2",,,,
1229988928,5/3/2017 13:02:04,5/4/2017 11:29:49, tissue,somatic tissue ,"no, yes",,,,
1229988929,5/3/2017 13:02:04,5/4/2017 11:39:58, treatment,amykor treatment  ,"no, yes",,,,
1229988930,5/3/2017 13:02:04,5/4/2017 11:19:57, treatment,anti-cd8 treatment  ,"no, yes",,,,
1229988931,5/3/2017 13:02:04,5/4/2017 11:35:03, treatment,tap treatment  ,"no, yes",,,,
1229988932,5/3/2017 13:02:04,5/4/2017 11:33:00, disease,celiac disease  ,"no, yes",,,,
1229988933,5/3/2017 13:02:04,5/4/2017 11:40:21, disease,dead of disease  ,"no, yes",,,,
1229988934,5/3/2017 13:02:04,5/4/2017 11:54:57, treatment,drb treatment  ,"no, yes, last 16 hours",,,,
1229988936,5/3/2017 13:02:04,5/4/2017 11:36:21, time,ph<7.30 at time of diagnosis  ,"no, yes, n/a",,,,
1229988937,5/3/2017 13:02:04,5/4/2017 11:37:02, tissue,tumor tissue ,"no, yes, pcc, primary tumor, high grade glioblastoma, low grade anaplastic mixed glioma",,,,
1229988938,5/3/2017 13:02:04,5/4/2017 11:44:19, strain,mouse model strain  ,"nod balb/c, balb/c",,,,
1229988939,5/3/2017 13:02:04,5/4/2017 11:39:38, disease,source disease status  ,"non-aneurysm, aneurysm, ruptured",,,,
1229988940,5/3/2017 13:02:04,5/4/2017 11:39:32, treatment,treatment_1  ,"non-depolarizing neuromuscular blocking agent (nmba), pioglitazone, aleglitazar, tesaglitazar, 10ng/ml il-1alpha for 1 h",,,,
1229988941,5/3/2017 13:02:04,5/4/2017 11:39:22, treatment,treatment class  ,none,,,,
1229988942,5/3/2017 13:02:04,5/4/2017 11:41:37, strain,viral strain  ,"none - mock, a/swine/alberta/25/2009, a/swine/iowa/15/1930, a/ca/04/2009",,,,
1229988943,5/3/2017 13:02:04,5/4/2017 11:39:54, treatment,iodine treatment  ,"none, 1mm",,,,
1229988944,5/3/2017 13:02:04,5/4/2017 11:29:28, treatment,ecdysone treatment  ,"none, 3 hours, 48 hours",,,,
1229988945,5/3/2017 13:02:04,5/4/2017 11:36:58, treatment,sirna treatment  ,"none, bmal1 sirna, n/a, neg ctr, sirna myb",,,,
1229988946,5/3/2017 13:02:04,5/4/2017 11:39:50, disease,primary disease  ,"none, breast cancer, hodgkin lymphoma, heart transplant",,,,
1229988947,5/3/2017 13:02:04,5/4/2017 11:33:43, treatment,treatment  ,"none, control, untreated, wild-type, dmso",,,,
1229988948,5/3/2017 13:02:04,5/4/2017 11:40:24, disease,etiology of liver disease  ,"none, hepatitis c virus",,,,
1229988949,5/3/2017 13:02:04,5/4/2017 11:39:19, treatment,compound based treatment  ,"none, ima, rap",,,,
1229988950,5/3/2017 13:02:04,5/4/2017 11:29:42, tissue,tissue harvest site ,"none, metastatic site, lymph node, leaf, root",,,,
1229988951,5/3/2017 13:02:04,5/4/2017 11:40:19, disease,meibomian gland disease state  ,"none, moderate, severe",,,,
1229988952,5/3/2017 13:02:04,5/4/2017 11:45:54, disease,disease  ,"none, multiple sclerosis, carcinoma, derived from metastatic site, left supraclavicular lymph node, advanced colorectal (crc), cancer, control",,,,
1229988953,5/3/2017 13:02:04,5/4/2017 11:44:20, treatment,dsrna treatment  ,"none, pc dsrna, trx dsrna, gst drna, nsl1 dsrna",,,,
1229988954,5/3/2017 13:02:04,5/4/2017 11:36:24, treatment,probiotic treatment  ,"none, probiotic treated (1x10^6 cfu/chick), treated one h later with probiotic (1x10^6 cfu/chick)",,,,
1229988955,5/3/2017 13:02:04,5/4/2017 11:39:44, treatment,treatment_molecule  ,"none, roferon",,,,
1229988956,5/3/2017 13:02:04,5/4/2017 11:29:42, treatment,animal treatment  ,"none, temodal (tmz) in orange juice, orange juice, continuous growth hormone treatment",,,,
1229988957,5/3/2017 13:02:04,5/4/2017 11:33:29, treatment,shrna treatment  ,"none, tet1 shrna2863, luc shrna, s6k1 shrna lentivirus, control shrna-treated",,,,
1229988958,5/3/2017 13:02:04,5/4/2017 11:39:19, treatment,prior treatment  ,"none, unknown, --, rad, radiation",,,,
1229988959,5/3/2017 13:02:04,5/4/2017 11:40:29, treatment,uv treatment  ,"none, uvb, uva",,,,
1229988960,5/3/2017 13:02:04,5/4/2017 11:45:29, treatment,ligand treatment  ,"none, vehicle, r5020, ngf, ngf-bdnf",,,,
1229988961,5/3/2017 13:02:04,5/4/2017 11:35:51, strain,strain type  ,"nontypeable haemophilus influenzae (nthi), e, wild, type, mutant, enological strain",,,,
1229988962,5/3/2017 13:02:04,5/4/2017 11:32:07, time,time to next relapse(days)  ,norelapse,,,,
1229988963,5/3/2017 13:02:04,5/4/2017 11:54:57, disease,disease-state  ,"normal (reduction mammoplasty), breast cancer",,,,
1229988964,5/3/2017 13:02:04,5/4/2017 11:41:37, strain,cell strain  ,"normal human astrocytes (nha), mc3t3, 20d17",,,,
1229988965,5/3/2017 13:02:04,5/4/2017 11:32:01, tissue,tissue/origin ,"normal prostate, prostate cancer, normal urinary bladder",,,,
1229988966,5/3/2017 13:02:04,5/4/2017 11:32:32, tissue,tissue typ ,"normal skin, b16-ova grown in cell culture, normal skin inflamed by treatment with oxazolone, b16-ova melanoma tissue from 6 day tumors, b16-ova melanoma tissue from 11 day tumors",,,,
1229988967,5/3/2017 13:02:04,5/4/2017 11:44:52, disease,disease/treatment status  ,"normal, aat treated, diabetic, power mix treated",,,,
1229988968,5/3/2017 13:02:04,5/4/2017 11:36:05, disease,ocular disease  ,"normal, amd",,,,
1229988969,5/3/2017 13:02:04,5/4/2017 11:25:40, disease,disease type  ,"normal, chronic hepatitis c patient, in-transit melanoma, t-all, t-lbl",,,,
1229988970,5/3/2017 13:02:04,5/4/2017 11:38:36, disease,disease_state  ,"normal, hcv-infected, carcinoma, lymphoma, adenocarcinoma",,,,
1229988971,5/3/2017 13:02:04,5/4/2017 11:29:34, disease,disease state  ,"normal, lymphoma, healthy, control, tumor",,,,
1229988972,5/3/2017 13:02:04,5/4/2017 11:39:35, genotype,myostatin genotype  ,"normal, mstn exon 3 floxed",,,,
1229988973,5/3/2017 13:02:04,5/4/2017 11:33:08, tissue,connective tissue type ,"normal, trabecular, papillary",,,,
1229988974,5/3/2017 13:02:04,5/4/2017 11:39:19, tissue,tissuetype ,"normal, tumor, resistanttumor",,,,
1229988975,5/3/2017 13:02:04,5/4/2017 11:26:44, treatment,experimental treatment  ,"normal, untreated, dmso, 30min, benomyl, 25 mcg/ml, 30min, left atrial ligation",,,,
1229988976,5/3/2017 13:02:04,5/4/2017 11:23:10, sex,apparent sex  ,"normale female, apparent impsex female",,,,
1229988977,5/3/2017 13:02:04,5/4/2017 11:33:31, time,time to survival  ,not aplicable,,,,
1229988978,5/3/2017 13:02:04,5/4/2017 11:42:58, time,time to distant metastasis  ,"not applicable, 6 months, 16 months, 19 months, 13 months",,,,
1229988979,5/3/2017 13:02:04,5/4/2017 11:44:36, treatment,patient treatment  ,"not applicable, mtx+et, mtx",,,,
1229988980,5/3/2017 13:02:04,5/4/2017 11:41:02, disease,lyme disease stage  ,"not applicable, none, lyme arthritis, early, disseminated or late",,,,
1229988981,5/3/2017 13:02:04,5/4/2017 11:36:06, age,age at blood draw ,"not available, 58, 61, 68, 59",,,,
1229988982,5/3/2017 13:02:04,5/4/2017 11:33:29, treatment,adjuvant treatment  ,"not known, no, yes",,,,
1229988983,5/3/2017 13:02:04,5/4/2017 11:35:47, time,timepoint 4h treatment  ,"not same day, same end point, same start point",,,,
1229988984,5/3/2017 13:02:04,5/4/2017 11:26:12, treatment,enrichment treatment  ,"np ratio of 151 (1.5 _ｵm  nano3 and 0.1 _ｵm kh2po4), np ratio of 751 (1.5 _ｵm  nano3 and 0.02 _ｵm kh2po4)",,,,
1229988985,5/3/2017 13:02:04,5/4/2017 11:33:59, genotype,genotype (transgenic line)  ,nrlp-egfp,,,,
1229988986,5/3/2017 13:02:04,5/4/2017 11:40:59, cell line,injected cell line  ,"nsc11, u87, nsc11r, u87r",,,,
1229988987,5/3/2017 13:02:04,5/4/2017 11:35:11, cell line,cell line description  ,"ntera-2 cl.d1 [nt2/d1] atcc number crl-1973, embryonal carcinoma cell line derived from a human teratocarcinoma, biphenotypic b myelomonocytic leukemia (mll-af4 rearragenment), a cd4+ (miranda, wolf et al. 1996) and cd34+ presenting cell line (naujokat, sezer et al. 2000), acute myeloid leukemia (mll-af9 rearrangement), human acute monocytic leukemia",,,,
1229988988,5/3/2017 13:02:04,5/4/2017 11:32:59, time,follow-up time (months)  ,"ntl, 11, 14, 12, na",,,,
1229988989,5/3/2017 13:02:04,5/4/2017 11:32:25, strain,strain (mouse)  ,"nu/nu, c57bl/6",,,,
1229988990,5/3/2017 13:02:04,5/4/2017 11:44:20, age,sample age ,"null, 7.416666667, 12.16666667, 7.916666667, 9.833333333",,,,
1229988991,5/3/2017 13:02:04,5/4/2017 11:34:24, tissue,brain tissue ,"ob, dp, white matter, cortex",,,,
1229988992,5/3/2017 13:02:04,5/4/2017 11:36:08, treatment,treatment_protocol  ,"od600 0.5 exposed to benzalkonium chloride 2 _ｵg/ml for 0 min, od600 0.5 exposed to hydrogen peroxide 0.05mm for 0 min, od600 0.5 exposed to peracetic acid 10_ｵg/ml for 0 min, od600 0.5 exposed to hydrogen peroxide 0.2mm for 0 min, od600 0.5 exposed to benzalkonium chloride 1 _ｵg/ml for 0 min",,,,
1229988993,5/3/2017 13:02:04,5/4/2017 11:42:43, gender,gender composition ,"of the 10 in the pool, 2 were women, 8 were men",,,,
1229988994,5/3/2017 13:02:04,5/4/2017 11:25:46, age,age category ,"old, young, adult",,,,
1229988995,5/3/2017 13:02:04,5/4/2017 11:41:02, time,time of sorting  ,on day 5 of culture,,,,
1229988996,5/3/2017 13:02:04,5/4/2017 11:36:21, cell type,tissue or cell type  ,"oocyte, embryo, embryoid body, embryonics stem cell, liver",,,,
1229988997,5/3/2017 13:02:04,5/4/2017 11:41:02, tissue,tissue or cell type ,"oocyte, embryo, embryoid body, liver, embryonics stem cell",,,,
1229988998,5/3/2017 13:02:04,5/4/2017 11:22:16, treatment,route of treatment  ,oral treatment-drug added to drinking water,,,,
1229988999,5/3/2017 13:02:04,5/4/2017 11:54:57, cell line,cell lines  ,"osteoblast, 1_adenocarcinoma, mammary gland 2_hepatoblastoma, liver 3_adenocarcinoma, cervix 4_embryonal carcinoma, testis, 5_glioblastoma, brain 6_melanoma 7_liposarcoma 8_histiocytic lymphomaraji, human malignant melanoma_92-1, human malignant melanoma_c32tg",,,,
1229989000,5/3/2017 13:02:04,5/4/2017 11:29:16, cell type,sarcoma and primary cell type  ,"osteosarcoma, ewing sarcoma, neuroblastoma (metastatic), chondrosarcoma, fibrosarcoma",,,,
1229989001,5/3/2017 13:02:04,5/4/2017 11:41:37, tissue,primary tissue ,"ovary, colon, blood, fat, muscle",,,,
1229989002,5/3/2017 13:02:04,5/4/2017 11:37:55, age,developmental age ,"p1, 120 days of fetal age, 1 day of life, 130 days of fetal age, 145 days of fetal age",,,,
1229989003,5/3/2017 13:02:04,5/4/2017 11:40:22, age,development age ,"p30.5, e18.5",,,,
1229989004,5/3/2017 13:02:04,5/4/2017 11:32:19, genotype,genotype of the cells  ,"p53(246/-), p53(-/-)",,,,
1229989005,5/3/2017 13:02:04,5/4/2017 11:36:24, genotype,genotype p53  ,"p53fl/fl, p53.1224, fl/fl",,,,
1229989006,5/3/2017 13:02:04,5/4/2017 11:31:49, tissue,tissue (donor) ,"p53null mammary fragments, trp53-null mammary fragments",,,,
1229989007,5/3/2017 13:02:04,5/4/2017 11:37:06, disease,disease state (host)  ,"p53null mammary tumors, trp53-null mammary tumors",,,,
1229989008,5/3/2017 13:02:04,5/4/2017 11:38:26, cell line,donor cell line  ,"panc291, panc198, panc219, panc420, panc253",,,,
1229989009,5/3/2017 13:02:04,5/4/2017 11:33:08, strain,virus strain  ,"pandemic influenza (a/h1n1 new subtype), sars-cov (tor2), none, a/california/07/2009 (h1n1), towne/e",,,,
1229989010,5/3/2017 13:02:04,5/4/2017 11:29:49, cell line,cell line population  ,"parental, subclone 4",,,,
1229989011,5/3/2017 13:02:04,5/4/2017 11:40:57, time,full time pregancy  ,"parous, nulliparous",,,,
1229989012,5/3/2017 13:02:04,5/4/2017 11:39:30, treatment,response to treatment  ,"partial response, stable disease, er stress, control",,,,
1229989013,5/3/2017 13:02:04,5/4/2017 11:39:30, strain,parental strains  ,pax7-creer,,,,
1229989014,5/3/2017 13:02:04,5/4/2017 11:40:15, strain,pythium strain  ,pb912 132,,,,
1229989015,5/3/2017 13:02:04,5/4/2017 11:35:00, strain,strain(s)  ,"pbclop11, pbclop10, pbclop17, cf1, cf2, cf3, cf4, cfcz",,,,
1229989016,5/3/2017 13:02:04,5/4/2017 11:41:12, treatment,ca04 or pbs treatment  ,"pbs, ca04 virus",,,,
1229989017,5/3/2017 13:02:04,5/4/2017 11:31:52, cell line,human colon cancer cell line  ,pc/aa/c1/sb10c,,,,
1229989018,5/3/2017 13:02:04,5/4/2017 11:33:43, sex,sexed  ,"pcr, manual",,,,
1229989019,5/3/2017 13:02:04,5/4/2017 11:40:33, treatment,units of treatment repeat  ,"per day, hr/day, days/week, day/wk",,,,
1229989020,5/3/2017 13:02:04,5/4/2017 11:27:01, tissue,tissue source ,"peripheral blood, nci-edrn, r lower, liver, kidney",,,,
1229989021,5/3/2017 13:02:04,5/4/2017 11:32:49, tissue,cell line source tissue ,"peripheral blood, primary human hypopharyngeal squamous cell carcinoma",,,,
1229989022,5/3/2017 13:02:04,5/4/2017 11:31:27, cell line,cell line source tissue  ,"peripheral blood, primary human hypopharyngeal squamous cell carcinoma",,,,
1229989023,5/3/2017 13:02:04,5/4/2017 11:19:57, treatment,acidification treatment  ,"ph 7.6-7.7, ph 8.0-8.2, ph 7.8-7.9",,,,
1229989024,5/3/2017 13:02:04,5/4/2017 11:41:51, genotype,genotype.variation  ,"pik3ca knockdown, control",,,,
1229989025,5/3/2017 13:02:04,5/4/2017 11:42:45, tissue,tissue of origin ,"pineal gland, melanoma, onl of both obs, non-small cell lung, renal",,,,
1229989026,5/3/2017 13:02:04,5/4/2017 11:34:24, tissue,tissue (pup) ,"pituitary, hypothalamus",,,,
1229989027,5/3/2017 13:02:04,5/4/2017 11:29:49, tissue,tissue id ,"placenta 3.1, placenta 1.1, placenta 3.2, placenta 1.2, placenta 1.3",,,,
1229989028,5/3/2017 13:02:04,5/4/2017 11:21:04, cell line,dendritic cell lineages  ,"plasmacytoid dendritic cells (pdc), myeloid dendritic cells (mdc1), epidermal langerhans cells",,,,
1229989029,5/3/2017 13:02:04,5/4/2017 11:38:09, cell line,cell line (derived)  ,"plc8024, mhcc97h",,,,
1229989030,5/3/2017 13:02:04,5/4/2017 11:35:22, strain,strain/cell line background  ,pmid 17311920,,,,
1229989031,5/3/2017 13:02:04,5/4/2017 11:38:08, age,age (pn postnatal days) ,"pn14, pn1, pn7",,,,
1229989032,5/3/2017 13:02:04,5/4/2017 11:38:16, age,age (at weaning) ,pnd 22,,,,
1229989033,5/3/2017 13:02:04,5/4/2017 11:33:59, age,age sacrificed ,pnd 8,,,,
1229989034,5/3/2017 13:02:04,5/4/2017 11:40:15, age,age (pup) ,pnd70,,,,
1229989035,5/3/2017 13:02:04,5/4/2017 11:28:32, cell line,cell line source  ,"polyclonal cell line gm13130, american type culture collection (atcc) number crl_1550, normal, non-pregnant female, polyclonal cell line gm12878, american type culture collection (atcc) number htb_33",,,,
1229989036,5/3/2017 13:02:04,5/4/2017 11:33:57, treatment,treatment/sample type  ,"pooled rna from c. neoformans grown under 9 different culture conditions, harvested from h99-inoculated rabbit at day7, harvested from h99-inoculated rabbit at day1",,,,
1229989037,5/3/2017 13:02:04,5/4/2017 12:18:35, cell line,cell line ebv-status  ,positive for ebv,,,,
1229989038,5/3/2017 13:02:04,5/4/2017 11:34:47, genotype,sdad2 genotype  ,"positive, negative",,,,
1229989039,5/3/2017 13:02:04,5/4/2017 11:32:48, genotype,spea2 genotype  ,"positive, negative",,,,
1229989040,5/3/2017 13:02:04,5/4/2017 11:27:09, treatment,treatment state  ,"post-deep brain stimulation on electrical stimulation, pre-deep brain stimulation, post-deep brain stimulation following 1 hour off electrical stimulation, none",,,,
1229989041,5/3/2017 13:02:04,5/4/2017 11:27:10, disease,disease development  ,"post-treatment non-lesional, lesional, normal, pre-treatment non-lesional",,,,
1229989042,5/3/2017 13:02:04,5/4/2017 11:36:27, time,training timepoint  ,"post, pre",,,,
1229989043,5/3/2017 13:02:04,5/4/2017 11:40:16, time,time of surgery  ,"post;, pre;",,,,
1229989044,5/3/2017 13:02:04,5/4/2017 11:34:24, tissue,tissue region ,"posterior right site of the cerebrum, layer 3, layer 6, layer 2, layer 5",,,,
1229989045,5/3/2017 13:02:04,5/4/2017 11:40:38, treatment,treatment_response  ,"pr, cr, vgpr, cured, not cured",,,,
1229989046,5/3/2017 13:02:04,5/4/2017 11:41:30, strain,infection (influenza strain)  ,"pr8, vn62, x31, mock, none",,,,
1229989047,5/3/2017 13:02:04,5/4/2017 11:39:24, genotype,prdm1 genotype  ,"prdm1ca/+, prdm1beh/beh, villin-cre, prdm1ca/beh, prdm1+/+",,,,
1229989048,5/3/2017 13:02:04,5/4/2017 11:42:45, time,time post-vaccination  ,"pre-challenge, 51-53 hours, 76-78 hours, 4-6 hours, 26-28 hours",,,,
1229989049,5/3/2017 13:02:04,5/4/2017 11:34:10, treatment,dasatinib treatment  ,"pre-treatment, post-treatment",,,,
1229989050,5/3/2017 13:02:04,5/4/2017 11:23:10, time,sample collection time  ,"pre-treatment, post-treatment, follow up, 8 months post-vaccination (pre-siv challenge), 10 days post-siv challenge",,,,
1229989051,5/3/2017 13:02:04,5/4/2017 11:44:39, treatment,treatment status  ,"pre-treatment, previously treated, pre-interferon, post-interferon, unknown",,,,
1229989052,5/3/2017 13:02:04,5/4/2017 11:42:43, tissue,tissue subtype ,"primary hepatocellular carcinoma, non-tumor cirrhosis, micro-dissected for >80% tumor cell content, micro-dissected for >80% non-malignant cell content, tumor (t)",,,,
1229989053,5/3/2017 13:02:04,5/4/2017 11:40:10, tissue,donor tissue ,"primary human breast cancer, caucasion male foreskin",,,,
1229989054,5/3/2017 13:02:04,5/4/2017 11:39:48, cell type,primary cell type  ,"primary macrophages (derived from blood monocytes), human foreskin fibroblast (hff)",,,,
1229989055,5/3/2017 13:02:04,5/4/2017 11:27:17, cell line,rcc cell line type  ,"primary rcc cell line, none, metastatic rcc cell line",,,,
1229989056,5/3/2017 13:02:04,5/4/2017 11:33:31,time,timepoint,"prior to artemisinin combination therapy (act), pre-treatment, 24h, 2h, baseline",,,,
1229989057,5/3/2017 13:02:04,5/4/2017 11:32:44, strain,b.bifidum strain  ,prl2010,,,,
1229989058,5/3/2017 13:02:04,5/4/2017 11:34:47, disease,status of disease  ,progressive,,,,
1229989059,5/3/2017 13:02:04,5/4/2017 11:36:59, cell line,cell line type  ,"prostate cancer cell line, small cell lung carcinoma,melanoma cell line, less-aggressive cell line, immortalised",,,,
1229989060,5/3/2017 13:02:04,5/4/2017 11:32:07, tissue,tissue site ,"prostate, lymph node, bone, liver, ge junction",,,,
1229989061,5/3/2017 13:02:04,5/4/2017 11:26:10, treatment,treatment arm  ,"prostvac, control, ixabepilone, paclitaxel, 13-cis-retinoic acid",,,,
1229989062,5/3/2017 13:02:04,5/4/2017 11:41:00, treatment,cancer treatment  ,"pt dxed in 2002, pt dxed in 2007",,,,
1229989063,5/3/2017 13:02:04,5/4/2017 11:39:13, tissue,tissue/sector ,"purple, red",,,,
1229989064,5/3/2017 13:02:04,5/4/2017 11:32:25, genotype,hdh genotype  ,"q7/q7, q111/q111, q7/q111",,,,
1229989065,5/3/2017 13:02:04,5/4/2017 11:37:35, genotype,rnasel r462q genotype  ,"qq, rr, rq, na",,,,
1229989066,5/3/2017 13:02:04,5/4/2017 11:41:02, cell line,source cell line  ,"r1, h9, a431, mnng/hos, bg01v",,,,
1229989067,5/3/2017 13:02:04,5/4/2017 11:41:02, treatment,growth condition and treatment  ,"radish sprout seeds were sterilized (5 min 70% ethanol, 10 min 1% naocl with 0.1% tween), then washed five times with sterile water and subsequently incubated in sterile ms medium without glucose in sterile plastic boxes (1 l total volume, passively aerated). after germination, seedlings were tested for sterility by plating a sample on lb agar. after 5 days of growth, the shoots were inoculated 10 min with 1 l __ concentrated ringer solution containing 103 cfu/ml ehec. the superfluous medium was decanted and cfu/g was periodically determined as followsinfected shoots were washed and bacterial numbers of the washing liquid were determined by serial dilution platings. after 120 hours, the transition from exponential to stationary phase could be determined. bacteria were harvested by gently shaking the seedlings in cold __-concentrated ringer (+1% tween-20tenfold diluted lysogeny broth was used as reference medium. cells were harvested after 3.5 h at about 3.1 x 108 cfu/ml.for nitrite, we added 200 mg/l sodium nitrite to 10-fold diluted lb and adjusted it to ph 6. harvest was after 6.5 h at 2.9 x 108 cfu/ml.for spinach medium, whole spinach leaves were homogenized (agienda agricola pistelle, kaufland, germany) on ice using an ultraturrax d50. the mush was centrifuged (1 h, 30,000神g, 5_皇), decanted, filtered (2.5 _ｵm pore size), centrifuged (2 h, 30,000神g, 5_皇), decanted and sterile filtered (0.2 _ｵm). after 5 h of growth, we harvested the cells at 6.0 x 108 cfu/ml.",,,,
1229989068,5/3/2017 13:02:04,5/4/2017 11:44:20, strain,strain for c57bl/6  ,rag-2-ko,,,,
1229989069,5/3/2017 13:02:04,5/4/2017 11:35:51, strain,immune strain/background  ,"rag2, fvb",,,,
1229989070,5/3/2017 13:02:04,5/4/2017 11:30:14, disease,disease progression status  ,"rapid progessor, elite/viremic controller, viremic non-progessor",,,,
1229989071,5/3/2017 13:02:04,5/4/2017 11:40:38, genotype,genotype rb  ,"rbfl/+, rb+/+, fl/fl",,,,
1229989072,5/3/2017 13:02:04,5/4/2017 11:39:19, disease,disease status of patient  ,"rcdii, celiac disease, crohn's disease",,,,
1229989073,5/3/2017 13:02:04,5/4/2017 11:40:22, genotype,a.thaliana genotype  ,"rdr1/2/6 mutant, rdr1 mutant, wild type (col)",,,,
1229989074,5/3/2017 13:02:04,5/4/2017 11:29:03, treatment,chip dna treatment  ,"recjf, exoi",,,,
1229989075,5/3/2017 13:02:04,5/4/2017 11:32:46, cell line,reference cell lines  ,"reference pool of lncap, du145, pc3, and cwr22 cell lines",,,,
1229989076,5/3/2017 13:02:04,5/4/2017 11:38:19, cell line,origin of a cell line  ,"referencekolossov e. et al., j exp med 203(10)2315-2327, 2006., referencemeissner a. et al., nat. biotechnol. 25(10)1177-1181, 2007., james thomson, university of wisconsin, es cell international, singapore, clontech (cat. no. 636532, lot 7120603a)",,,,
1229989077,5/3/2017 13:02:04,5/4/2017 11:39:54, tissue,tissue section ,"region 3, region 2, region 4, region 1, region 5",,,,
1229989078,5/3/2017 13:02:04,5/4/2017 11:30:40, cell line,human leukemia cell line  ,reh,,,,
1229989079,5/3/2017 13:02:04,5/4/2017 11:31:31, strain,strain jlrela  ,rela kockout,,,,
1229989080,5/3/2017 13:02:04,5/4/2017 11:41:01, disease,disease group  ,"remission, failure of treatment, new, non-metastatic, nonatopic control",,,,
1229989081,5/3/2017 13:02:04,5/4/2017 11:38:52, time,time of sample harvesting  ,"reperfusion, normoxia, ischemia",,,,
1229989082,5/3/2017 13:02:04,5/4/2017 11:22:00, cell type,test cell type  ,repo-gal4/uas-uprt,,,,
1229989083,5/3/2017 13:02:04,5/4/2017 11:38:58, treatment,small molecule treatment  ,"repsox at 24 hours, repsox at 48 hours, repsox at 1 week, repsox at 10 hours, repsox during derivation",,,,
1229989084,5/3/2017 13:02:04,5/4/2017 11:35:09, tissue,tissue condition ,"resting (uninjured) muscle, 48h after barium chloride-induced muscle injury, 12h after barium chloride-induced muscle injury",,,,
1229989085,5/3/2017 13:02:04,5/4/2017 11:22:00, tissue,tissue location ,"right, tongue, left, unknown, internode",,,,
1229989086,5/3/2017 13:02:04,5/4/2017 11:29:45, tissue,tissue collection method ,"rnalater, snap frozen, dnagard, laser capture microdissection",,,,
1229989087,5/3/2017 13:02:04,5/4/2017 11:31:30, treatment,rna treatment  ,"rrna depleted, tobacco acid pyrophosphatase (tap), no rna treatment, none, oxidised",,,,
1229989088,5/3/2017 13:02:04,5/4/2017 11:37:02, treatment,treatment_given  ,"rt, --, rt + rt",,,,
1229989089,5/3/2017 13:02:04,5/4/2017 11:36:59, treatment,treatment*  ,"s, rt, s, s, crt, ic, s, rt, surgery",,,,
1229989090,5/3/2017 13:02:04,5/4/2017 11:40:25, strain,pathogen strain  ,"s. aureus usa300, tt01",,,,
1229989091,5/3/2017 13:02:04,5/4/2017 11:26:11, time,time point after hepatectomy  ,"s48h, 2h, 48h, 0h, 6h",,,,
1229989092,5/3/2017 13:02:04,5/4/2017 11:38:01, strain,background strains  ,"s96 and yjm 789, c57bl/6 female mouse and a sb/le male",,,,
1229989093,5/3/2017 13:02:04,5/4/2017 11:31:26, treatment,b240 or saline treatment  ,"saline, lactobacillus pentosus b240",,,,
1229989094,5/3/2017 13:02:04,5/4/2017 11:42:43, treatment,timepoint 4h treatment  ,"same end point, not same day, same start point",,,,
1229989095,5/3/2017 13:02:04,5/4/2017 11:24:52, strain,bacterial strain  ,"sanger476, -, o18k1h7, usa300, imdo 130201",,,,
1229989096,5/3/2017 13:02:04,5/4/2017 11:35:51, strain,strain/model  ,scid beige mouse,,,,
1229989097,5/3/2017 13:02:04,5/4/2017 11:36:58, strain,recipient strain  ,"scid, cb-17 scid/scid, c57bl6_h-2b, na, lethally irradiated syngeneic mice",,,,
1229989098,5/3/2017 13:02:04,5/4/2017 11:35:16, genotype,genotype/variataion  ,"scramble shrna control, creb knock-down, luciferase, shrna control, crtc1-maml2/maml2, knock-downmaml2 knock-down",,,,
1229989099,5/3/2017 13:02:04,5/4/2017 11:25:31, treatment,oligo treatment  ,scrambled control,,,,
1229989100,5/3/2017 13:02:04,5/4/2017 11:43:42, tissue,8 weeks. tissue ,scraped off oxyntic mucosa.,,,,
1229989101,5/3/2017 13:02:04,5/4/2017 11:23:37, treatment,immunogen treatment  ,"sea water, pic, mdp",,,,
1229989102,5/3/2017 13:02:04,5/4/2017 11:38:39, time,hatching time  ,"sept, dec",,,,
1229989103,5/3/2017 13:02:04,5/4/2017 11:34:26, genotype,genotype/variaion  ,"sgpp1-/-, sgpp1+/+",,,,
1229989104,5/3/2017 13:02:04,5/4/2017 11:41:23, treatment,cell treatment  ,"shrna infected cells, cultured with anticd3 cd28 beads and collected at various time points, purified by cell sorting (cd4+ gfp+), purified by cell sorting (cd4+ gfp-), lmna knock-down (cultured)",,,,
1229989105,5/3/2017 13:02:04,5/4/2017 11:33:48, disease,subject's disease state  ,"sickle cell disease, control",,,,
1229989106,5/3/2017 13:02:04,5/4/2017 11:26:12, treatment,treatment2_in vivo treatment  ,"silica, air control, iraqi sand",,,,
1229989107,5/3/2017 13:02:04,5/4/2017 11:40:10, treatment,vaccine treatment  ,"siv dna vaccine, no vaccine (control), siv dna vaccine with rantes adjuvant",,,,
1229989108,5/3/2017 13:02:04,5/4/2017 11:33:59, strain,siv strain  ,"sivsm, sivmac239, uninfected control (sivsm), uninfected control (sivmac239)",,,,
1229989109,5/3/2017 13:02:04,5/4/2017 11:35:14, cell line,ovarian cancer cell line  ,"sk-ov-3, tov-21g, ovcar-3, sk-ov-3 p38dn",,,,
1229989110,5/3/2017 13:02:04,5/4/2017 11:36:23, tissue,tissue lineage ,"skin, blood",,,,
1229989111,5/3/2017 13:02:04,5/4/2017 11:21:16, cell type,other cell types  ,"skin, few fibrous strands",,,,
1229989112,5/3/2017 13:02:04,5/4/2017 11:37:40, tissue,tissue.origin ,"skin, lung",,,,
1229989113,5/3/2017 13:02:04,5/4/2017 11:35:11, tissue,tissue harvest methods ,"slices from each of the lobes were pooled together for microarray analysis, the organ was longitudinally bisected, a slice was removed for histology and the remainder of the organ was minced and used for microarray analysis, the gland was transversely sectioned and the bottom portion was used for microarray analysis, lung samples were obtained by placing a suture loosely around the left bronchus at the site where the bronchus enters the left lung lobe.  a second suture was placed around the right bronchus and pulled tightly to tie off the right lung lobes.  the right lung lobes were removed and placed in rnalater, and the left lung infused under hydrostatic pressure (~30 cm) with neutral buffered formalin.   samples placed in rnalater were incubated overnight at 4_皇 and frozen the next day at < 70_皇., the nose was dissected to isolate the level ii region of both nostrils.  the maxillo turbinate and olfactory epithelium were discarded and the lateral meatus and nasoturbinate were retained for cell isolation.  the dissected nasal sections were rinsed with cold phosphate buffered saline to remove the blood.  after rinsing, a 5 ml buffered mixture of proteases (collagenase, 80 u/ml, sigma-aldrich",,,,
1229989114,5/3/2017 13:02:04,5/4/2017 11:35:51, treatment,dna treatment  ,"sonicated and immunoprecipitated with anti-5-methyl cytidine antibody (diagnode, li姓ge, belgium), sonicated, sonicated and immunoprecipitated with anti-5-methyl cytidine antibody (diagenode, li姓ge, belgium)",,,,
1229989115,5/3/2017 13:02:04,5/4/2017 11:30:24, cell type,t cell type  ,"sorted cd4+ conventional t cells from spleen and lymph nodes, sorted cd4+ regulatory t cells from spleen and lymph nodes, teff, treg, tfh",,,,
1229989116,5/3/2017 13:02:04,5/4/2017 11:42:43, tissue,tissue/cell type ,"soybean root/hypocotyls - p.sojae mycelium from minimal medium, peripheral blood leucocytes (pbl), osteosarcoma, ovarian somatic cells (osc), testicular germ cells, macs-sorted",,,,
1229989117,5/3/2017 13:02:04,5/4/2017 11:38:50, cell type,melanoma cell type  ,"spheroid cells, adherent cells",,,,
1229989118,5/3/2017 13:02:04,5/4/2017 11:47:15, tissue,4 months tissue ,spinal cord,,,,
1229989119,5/3/2017 13:02:04,5/4/2017 11:35:50, tissue,secondary lymphoid tissue ,spleen and lymph nodes,,,,
1229989120,5/3/2017 13:02:04,5/4/2017 11:41:02, tissue,fresh tissue ,splenocytes,,,,
1229989121,5/3/2017 13:02:04,5/4/2017 11:30:13, disease,source disease  ,squamous cell carcinoma,,,,
1229989122,5/3/2017 13:02:04,5/4/2017 11:34:49, treatment,rnase treatment  ,"ssrnase (rnase one), dsrnase (rnase v1), none",,,,
1229989123,5/3/2017 13:02:04,5/4/2017 11:24:34, time,nitrogen starvation time  ,"st2d, st10d, t0, st10d+1h",,,,
1229989124,5/3/2017 13:02:04,5/4/2017 11:40:52, cell line,stable cell line  ,stable cell lines inducibly expressing flag/ha-tagged  rbm10,,,,
1229989125,5/3/2017 13:02:04,5/4/2017 11:27:01, time,explant timepoint  ,stage 9/10,,,,
1229989126,5/3/2017 13:02:04,5/4/2017 11:38:39, disease,advanced disease state  ,"stage iii, stage I, stage ii, stage iv",,,,
1229989127,5/3/2017 13:02:04,5/4/2017 11:33:08, tissue,tissue region enriched for ,"starch, lipid",,,,
1229989128,5/3/2017 13:02:04,5/4/2017 11:26:11, treatment,treatment group  ,"statin alone, fenofibric acid+statin, control, fenofibric acid, untreated",,,,
1229989129,5/3/2017 13:02:04,5/4/2017 11:26:12, tissue,host tissue ,"stomach, root, hind foot pads, hyphae, serum",,,,
1229989130,5/3/2017 13:02:04,5/4/2017 11:38:34, strain,strain/genotype  ,"strain dp1, mtb1254 rv3662c-3665c ko, wt, pol1-3flag strain congenic to w303-1a in which the weak rad5 mutant allele in the original w303 has been corrected., __sml1, pol1-3flag strain congenic to w303-1a in which the weak rad5 mutant allele in the original w303 has been corrected., __mec1 __sml1, pol1-3flag strain congenic to w303-1a in which the weak rad5 mutant allele in the original w303 has been corrected.",,,,
1229989131,5/3/2017 13:02:04,5/4/2017 11:36:27, strain,bacteria strain  ,streptcoccus suis 2 strain sc19,,,,
1229989132,5/3/2017 13:02:04,5/4/2017 11:38:45, strain,infected with bacterial strain  ,streptcoccus suis 2 strain sc19,,,,
1229989133,5/3/2017 13:02:04,5/4/2017 11:30:13, tissue,mammary tissue ,"stroma (fat pad), parenchyma",,,,
1229989134,5/3/2017 13:02:04,5/4/2017 11:38:08, treatment,treatment delivery  ,"subcutaneous with osmotic pump, untreated",,,,
1229989135,5/3/2017 13:02:04,5/4/2017 12:10:12, cell line,human cell line  ,"supt1, lovo epithelial cells atcc ccl-229, kmb17",,,,
1229989143,5/3/2017 13:02:05,5/4/2017 11:29:49, tissue,tissue_source ,"surgical specimen, chtn specimen",,,,
1229989144,5/3/2017 13:02:05,5/4/2017 11:36:05, disease,disease resistance  ,"susceptible, resistant",,,,
1229989145,5/3/2017 13:02:05,5/4/2017 12:10:13, disease,disease-resistance  ,"susceptible, resistant",,,,
1229989146,5/3/2017 13:02:05,5/4/2017 11:39:37, genotype,transgene genotype  ,"t transgene, homozygous, t and s transgenes, homozygous",,,,
1229989147,5/3/2017 13:02:05,5/4/2017 11:21:16, time,partial hepatectomy time point  ,"t=0, t=1h, t=6h, t=12h, t=24h",,,,
1229989148,5/3/2017 13:02:05,5/4/2017 11:24:10, time,timepoint (hrs)  ,"t=42, t=18, t=0, 3",,,,
1229989149,5/3/2017 13:02:05,5/4/2017 11:41:51, time,biopsy time  ,"t1, 3month, 0month, ts, t2",,,,
1229989150,5/3/2017 13:02:05,5/4/2017 11:44:36, cell line,parental cell line  ,"t47d-y, mda-mb-231, skbr-3, t47d-yb, hek 293 flp-in t-rex",,,,
1229989151,5/3/2017 13:02:05,5/4/2017 11:54:57, time,time point (min)  ,"t60, t90, t390, t210",,,,
1229989152,5/3/2017 13:02:05,5/4/2017 11:44:20, time,time of sampling  ,"taken relapse after treatment, taken at diagnosis, diagnosis, relapse",,,,
1229989153,5/3/2017 13:02:05,5/4/2017 11:33:06, treatment,adjuvant patient treatment  ,tamoxifen,,,,
1229989154,5/3/2017 13:02:05,5/4/2017 11:53:48, treatment,preoperative treatment  ,"taxol x 12 fac x 4, fac x 6, fec x 6, paclitaxel x(12 )  + fec x(4 ), fec x(6 )",,,,
1229989155,5/3/2017 13:02:05,5/4/2017 11:34:21, treatment,treatments comments  ,"taxol x 12 fac x 4, paclitaxel x 12, fac x 4, taxol x 12 fec x 4, paclitaxel x 12, fec x 4, taxol 80 mg/m2 x12 , fec x4",,,,
1229989156,5/3/2017 13:02:05,5/4/2017 11:33:49, genotype,tbx1 genotype  ,"tbx1-/-, tbx1+/-, tbx1+/+",,,,
1229989157,5/3/2017 13:02:05,5/4/2017 11:31:32, treatment,treatment category  ,test sample,,,,
1229989158,5/3/2017 13:02:05,5/4/2017 11:31:52, tissue,tissuet type ,testis,,,,
1229989159,5/3/2017 13:02:05,5/4/2017 11:28:35, treatment,hormonal treatment  ,"testosterone supplementation by implant, none, 11-ketotestosterone supplementation by implant",,,,
1229989160,5/3/2017 13:02:05,5/4/2017 11:37:49, treatment,tet1/tet2 treatment  ,"tet1 and tet2 knocked out, wt, tet1, tet2 and tet3 knocked out, heterozygous / tet1 and tet2 knocked out on one chromosome",,,,
1229989161,5/3/2017 13:02:05,5/4/2017 11:36:08, treatment,treatment code  ,"tfac, tfec, txfac, th/fac, fac",,,,
1229989162,5/3/2017 13:02:05,5/4/2017 11:29:36, tissue,tissue extraction ,the entire region from just above the eye to below pharyngeal arch 6 was dissected out and subjected to facs and yfp+ cells were pooled from 10 embryos,,,,
1229989163,5/3/2017 13:02:05,5/4/2017 11:32:22, cell line,cell line provider  ,the european collection of cell cultures (ecacc),,,,
1229989164,5/3/2017 13:02:05,5/4/2017 11:23:54, tissue,tissue source site ,"the ontario tumor bank network,canada, the groene hart hospital,the neterlands",,,,
1229989165,5/3/2017 13:02:05,5/4/2017 11:41:02, strain,strain phenotype  ,"thiamethoxam-resistant (th-r), thiamethoxam-susceptible (th-s), biofilm-negative, biofilm-positive, causing sheep abortion",,,,
1229989166,5/3/2017 13:02:05,5/4/2017 11:34:24, tissue,tissue (organ) ,"thymus, cord blood",,,,
1229989167,5/3/2017 13:02:05,5/4/2017 11:42:43, tissue,tissue/cell line ,"tissue, cell line, hek293, monolayer cells, fibroblast",,,,
1229989168,5/3/2017 13:02:05,5/4/2017 11:41:30, tissue,tissue or cells ,"tissue, cells, homogenized retina, facs sorted retina, cultured retinal progenitor cells",,,,
1229989169,5/3/2017 13:02:05,5/4/2017 11:26:10, strain,hcmv strain  ,towne/e,,,,
1229989170,5/3/2017 13:02:05,5/4/2017 11:29:35, strain,human cytomegalovirus strain  ,towne/e,,,,
1229989171,5/3/2017 13:02:05,5/4/2017 11:37:06, treatment,treatment of the mice  ,treated with ecg for 48h and hcg for 12h,,,,
1229989172,5/3/2017 13:02:05,5/4/2017 11:33:00, time,time and stimulation  ,"tref, t1sa, t1sp, t5sa, t5sp",,,,
1229989173,5/3/2017 13:02:05,5/4/2017 11:33:47, genotype,genotype/ variation  ,"trib1-/- unstimulated, wild-type unstimulated",,,,
1229989174,5/3/2017 13:02:05,5/4/2017 11:29:36, genotype,genotype abbreviation  ,"trphet, trpnull",,,,
1229989175,5/3/2017 13:02:05,5/4/2017 11:37:05, genotype,12q13 genotype rs11169544  ,"tt, ct, cc",,,,
1229989176,5/3/2017 13:02:05,5/4/2017 11:33:31, genotype,3q26 genotype rs12638862  ,"tt, ct, cc",,,,
1229989177,5/3/2017 13:02:05,5/4/2017 11:32:01, genotype,8q23 genotype rs16892766  ,"tt, gt, gg",,,,
1229989178,5/3/2017 13:02:05,5/4/2017 11:29:49, tissue,tissue isolated ,tumor developed in recipient mice,,,,
1229989179,5/3/2017 13:02:05,5/4/2017 11:39:30, tissue,tissue sub-type ,"tumor whole tissue, normal whole tissue, normal stroma, tumor stroma, normal epithelium",,,,
1229989180,5/3/2017 13:02:05,5/4/2017 11:36:06, cell type,b cell type  ,"tumorous, normal, naive (facs sorted primary human), plasma cell (facs sorted primary human), memory (facs sorted primary human)",,,,
1229989181,5/3/2017 13:02:05,5/4/2017 11:32:43, cell type,cell type  ,"tumorous, normal, naive (facs sorted primary human), plasma cell (facs sorted primary human), memory (facs sorted primary human)",,,,
1229989182,5/3/2017 13:02:05,5/4/2017 11:40:21, tissue,treated tissue ,"two fully expanded leaves, root (soil surrounding the root system)",,,,
1229989183,5/3/2017 13:02:05,5/4/2017 11:28:14, tissue,tissue bank ,"umary, blsa",,,,
1229989184,5/3/2017 13:02:05,5/4/2017 11:45:29, tissue,tissuebank ,"umary, blsa, shri, mrc, jhu",,,,
1229989185,5/3/2017 13:02:05,5/4/2017 11:29:42, tissue,tissue estradiol conc. ,"under detection limit, 550pg/g, 9pg/g, 10.5pg/g, 300pg/g",,,,
1229989186,5/3/2017 13:02:05,5/4/2017 11:59:08, sex,sexual differentiation  ,undifferentiated,,,,
1229989187,5/3/2017 13:02:05,5/4/2017 11:29:33, tissue,tissue/cell  type ,"undifferentiated es (cell culture), embryonic bodies (cell culture), cardiac bodies (cell culture), whole heart",,,,
1229989188,5/3/2017 13:02:05,5/4/2017 11:29:35, tissue,tissue separation ,"unfractionated peripheral blood dna, lymphoid peripheral blood dna, myeloid peripheral blood dna",,,,
1229989189,5/3/2017 13:02:05,5/4/2017 11:35:48, tissue,tissue origin ,"uninvolved lung, lung adenocarcinoma, bone marrow, peripheral blood, breast",,,,
1229989190,5/3/2017 13:02:05,5/4/2017 11:40:28, time,time clin rec  ,"unknown, 0, 16, 151, 18",,,,
1229989191,5/3/2017 13:02:05,5/4/2017 11:32:43, time,time met rec  ,"unknown, 0, 16, 55, 151",,,,
1229989192,5/3/2017 13:02:05,5/4/2017 11:39:48, time,time bcr  ,"unknown, 0, 2, 16, 17",,,,
1229989193,5/3/2017 13:02:05,5/4/2017 11:36:42, time,time clinical recurrence  ,"unknown, 0, n/a, 55.06849315, 12",,,,
1229989194,5/3/2017 13:02:05,5/4/2017 11:36:42, time,time metastatic recurrence  ,"unknown, 0, n/a, 55.06849315, 81.10684932",,,,
1229989195,5/3/2017 13:02:05,5/4/2017 11:29:45, time,time no bcr  ,"unknown, 16, 17, 2, n/a",,,,
1229989196,5/3/2017 13:02:05,5/4/2017 11:39:48, time,time f/u  ,"unknown, 164, 12, 16, 65",,,,
1229989197,5/3/2017 13:02:05,5/4/2017 11:39:27, treatment,lps treatment (time)  ,"untreated, 24 hours, 2 hours, 6 hours, 30 mins",,,,
1229989198,5/3/2017 13:02:05,5/4/2017 11:47:07, time,drug treatment time point  ,"untreated, 4hr, 6hr, 8hr, 2hr",,,,
1229989199,5/3/2017 13:02:05,5/4/2017 11:40:33, treatment,drug treatment time point  ,"untreated, 8hr, 2hr, 4hr, 6hr",,,,
1229989200,5/3/2017 13:02:05,5/4/2017 11:37:45, treatment,ddc treatment  ,"untreated, ddc-treated",,,,
1229989201,5/3/2017 13:02:05,5/4/2017 11:34:33, treatment,globin treatment  ,"untreated, globinclear",,,,
1229989202,5/3/2017 13:02:05,5/4/2017 11:35:58, treatment,hnf4 si rna treatment  ,"untreated, treated",,,,
1229989203,5/3/2017 13:02:05,5/4/2017 11:37:49, treatment,lenolidamide treatment  ,"untreated, treated",,,,
1229989204,5/3/2017 13:02:05,5/4/2017 11:41:13, cell line,responder cell line  ,upn727,,,,
1229989205,5/3/2017 13:02:05,5/4/2017 11:37:02, tissue,tissue_depot ,"uw, n/a, brain, na, abdomen",,,,
1229989206,5/3/2017 13:02:05,5/4/2017 11:30:40, genotype,braf genotype  ,"v600e mutationwildtype, wildtype",,,,
1229989207,5/3/2017 13:02:05,5/4/2017 11:33:29, treatment,in vitro treatment  ,"vehicle control, estradiol + progesterone (e2p4), estradiol (e2), none, il-7/il-25/il-33 5 days+ etoh 2 days",,,,
1229989208,5/3/2017 13:02:05,5/4/2017 11:40:07, treatment,drug treatment  ,"vehicle, chronic low levodopa, chronic high levodopa, dmso, jq1",,,,
1229989209,5/3/2017 13:02:05,5/4/2017 11:38:10, strain,strain of mouse  ,"vm, cd1",,,,
1229989210,5/3/2017 13:02:05,5/4/2017 11:33:02, tissue,prostate tissue ,"vp lobe, dlp lobe",,,,
1229989211,5/3/2017 13:02:05,5/4/2017 11:38:24, time,agent time  ,"weaning - 8 weeks, 10 hr, 6 hr, 16 hr, 3 hr",,,,
1229989212,5/3/2017 13:02:05,5/4/2017 11:35:51, age,age unit ,"week, day",,,,
1229989213,5/3/2017 13:02:05,5/4/2017 11:44:53, age,ageunit ,"week, day, weeks",,,,
1229989214,5/3/2017 13:02:05,5/4/2017 11:37:30, time,units of harvest time point  ,"week, weeks, hr, days, h past seeding",,,,
1229989215,5/3/2017 13:02:05,5/4/2017 11:35:50, age,units of age ,"weeks, pnd, days, weeks at start of exposure, years",,,,
1229989216,5/3/2017 13:02:05,5/4/2017 11:32:59, tissue,tissue_detail ,"whole blood, muscle - skeletal, lung, artery - tibial, thyroid",,,,
1229989217,5/3/2017 13:02:05,5/4/2017 11:34:11,strain,strain crl,wi,,,,
1229989218,5/3/2017 13:02:05,5/4/2017 11:23:10, genotype,host soybean genotype  ,"widltype, nfr",,,,
1229989219,5/3/2017 13:02:05,5/4/2017 11:28:13, strain,strain/condition  ,wild type + empty vector in xylose,,,,
1229989220,5/3/2017 13:02:05,5/4/2017 11:35:09, genotype,genotype/varitaion  ,"wild type, 臉sml0013:km mutant, f/f, stably expressing hbz, snai1 knockout",,,,
1229989221,5/3/2017 13:02:05,5/4/2017 11:33:59, genotype,genotype/variaton  ,"wild type, eし-myc wrn dhel/dhel, eし-myc, delta kpst mutant, bca81",,,,
1229989222,5/3/2017 13:02:05,5/4/2017 11:36:06, genotype,bacterial genotype  ,"wild type, gala7 mutant, hpap mutant",,,,
1229989223,5/3/2017 13:02:05,5/4/2017 11:36:27, genotype,gp130 genotype  ,"wild type, gp130-deficient",,,,
1229989224,5/3/2017 13:02:05,5/4/2017 11:34:47, genotype,genotype/treatment  ,"wild type, homozygote",,,,
1229989225,5/3/2017 13:02:05,5/4/2017 11:40:14, genotype,ndrg1 genotype  ,"wild type, knock-out",,,,
1229989226,5/3/2017 13:02:05,5/4/2017 11:29:49, genotype,offspring genotype  ,"wild type, pigr+/-, pigr-/-, 5ht1a knockout",,,,
1229989227,5/3/2017 13:02:05,5/4/2017 11:40:28, genotype,genotype/variation (host)  ,"wild type, tgfb1 heterozygote",,,,
1229989228,5/3/2017 13:02:05,5/4/2017 11:32:22, genotype,genotype (brdt)  ,"wild type, th2b+/tag, ko-/-, th2b kd, ko+/+",,,,
1229989229,5/3/2017 13:02:05,5/4/2017 11:39:29, genotype,genotype  ,"wild type, wt, wild-type, wildtype, b73xh99 f1 hybrid",,,,
1229989230,5/3/2017 13:02:05,5/4/2017 11:27:17, genotype,genotype/variation  ,"wild type, wt, wild-type, wildtype, refpool",,,,
1229989231,5/3/2017 13:02:05,5/4/2017 11:33:08, strain,donor strain  ,"wild-type j1 strain sv/129 es cells, 129",,,,
1229989232,5/3/2017 13:02:05,5/4/2017 11:35:19, genotype,genotype/variations  ,"wild-type mice, siah1a-/-:siah2-/- (ko) mice, tg2576 appswe-transgenic mice",,,,
1229989233,5/3/2017 13:02:05,5/4/2017 11:36:22, genotype,maternal genotype/variation  ,wildtype,,,,
1229989234,5/3/2017 13:02:05,5/4/2017 11:39:44, genotype,parental genotype/variation  ,wildtype,,,,
1229989235,5/3/2017 13:02:05,5/4/2017 11:39:48, genotype,paternal genotype/variation  ,wildtype,,,,
1229989236,5/3/2017 13:02:05,5/4/2017 11:37:49, genotype,genotype/varation  ,"wildtypewild typerdo5-1, transgenic mice, bearing a wild-type, allele of ar with 24 cags (ar-24q), transgenic mice carrying a full-length human ar with 97 cags (ar-97q)",,,,
1229989237,5/3/2017 13:02:05,5/4/2017 11:27:27, genotype,pathogen genotype/variation  ,"wildtype, 臉abvf19-8, wild type, abpf2 deletion mutant",,,,
1229989238,5/3/2017 13:02:05,5/4/2017 11:36:52, disease,disease state (phenotype)  ,"wildtype, affected",,,,
1229989239,5/3/2017 13:02:05,5/4/2017 11:34:21, genotype,idh1/2 genotype  ,"wildtype, idh1mutant, idh2mutant",,,,
1229989240,5/3/2017 13:02:05,5/4/2017 11:34:02, genotype,mouse genotype  ,"wildtype, in vitro, kraslsl-g12d, bl6.wt, wild-type",,,,
1229989241,5/3/2017 13:02:05,5/4/2017 11:30:24, strain,strain (rat)  ,wistar,,,,
1229989242,5/3/2017 13:02:05,5/4/2017 11:32:46, strain,rat strain  ,"wistar, da (dark agouti) inbred",,,,
1229989243,5/3/2017 13:02:05,5/4/2017 11:34:24, treatment,art treatment  ,"with, without",,,,
1229989244,5/3/2017 13:02:05,5/4/2017 11:34:02, disease,disease progression  ,"without metastases, bone metastasis, no bone metastasis, progressor, with metastases",,,,
1229989245,5/3/2017 13:02:05,5/4/2017 11:42:10, cell type,cultured cell type  ,"wt culture cell, snd1 culture cell, vnd6 culture cell",,,,
1229989246,5/3/2017 13:02:05,5/4/2017 11:44:42, tissue,tissue [transplant] ,"wt fetal liver cells engrafted in bm of an irradiated mice, pax5ko fetal liver cells engrafted in bm of an irradiated mice",,,,
1229989247,5/3/2017 13:02:05,5/4/2017 11:29:33, genotype,genotypes  ,"wt pkbalpha, ko pkbalpha, ko/rescued, pkbalpha, te, ct101, c24, col-0",,,,
1229989248,5/3/2017 13:02:05,5/4/2017 11:39:18, genotype,esr1 genotype  ,"wt, ex3aerko (esr1 null), kiko (dna binding deficient), aerko (esr1 null), eaae",,,,
1229989249,5/3/2017 13:02:05,5/4/2017 11:41:02, genotype,atf2 genotype  ,"wt, ko",,,,
1229989250,5/3/2017 13:02:05,5/4/2017 11:42:10, genotype,meis1 genotype  ,"wt, ko",,,,
1229989251,5/3/2017 13:02:05,5/4/2017 11:33:06, genotype,genotype variation  ,"wt, ko, luxs negative, nrf-/-, nrf+/+",,,,
1229989252,5/3/2017 13:02:05,5/4/2017 11:59:08, genotype,tet2 genotype  ,"wt, mutant",,,,
1229989253,5/3/2017 13:02:05,5/4/2017 11:34:10, genotype,precipitated ctcf genotype  ,"wt, mzf8, mzf7, mzf9, r339w/mzf3*",,,,
1229989254,5/3/2017 13:02:05,5/4/2017 11:35:19, tissue,tissue genotype/variation ,"wt, p53 mutant",,,,
1229989255,5/3/2017 13:02:05,5/4/2017 11:35:13, genotype,tissue genotype/variation  ,"wt, p53 mutant",,,,
1229989256,5/3/2017 13:02:05,5/4/2017 11:34:21, genotype,nod2 genotype  ,"wt/wt, r702w/wt, insc/r702w, insc/insc",,,,
1229989257,5/3/2017 13:02:05,5/4/2017 11:26:12, age,age (mouse) ,"xenograft cells injected at 6-10 weeks, 4 months",,,,
1229989258,5/3/2017 13:02:05,5/4/2017 11:37:06, tissue,sample tissue of origin ,"xenograft splenocyte, bone marrow, peripheral blood",,,,
1229989259,5/3/2017 13:02:05,5/4/2017 11:38:19, cell type,cell type (human)  ,xenograft tumors (ht29 cells),,,,
1229989260,5/3/2017 13:02:05,5/4/2017 11:29:33, sex,sex chromosome complement  ,"xx, xo, xy, xy-, xxsry",,,,
1229989261,5/3/2017 13:02:05,5/4/2017 11:35:24, sex,sex chromosome ploidy  ,"xy, xx, xo",,,,
1229989262,5/3/2017 13:02:05,5/4/2017 11:29:48, genotype,mecp2 genotype  ,y/-.,,,,
1229989263,5/3/2017 13:02:05,5/4/2017 11:33:05, time,timeunit  ,years,,,,
1229989264,5/3/2017 13:02:05,5/4/2017 11:28:30, treatment,ntg treatment  ,yes,,,,
1229989265,5/3/2017 13:02:05,5/4/2017 11:35:18, treatment,tamoxifen-citrate treatment  ,yes,,,,
1229989266,5/3/2017 13:02:05,5/4/2017 11:34:26, treatment,l-dopa treatment  ,"yes, -, no",,,,
1229989267,5/3/2017 13:02:05,5/4/2017 11:40:38, strain,autoimmune strain  ,"yes, no",,,,
1229989268,5/3/2017 13:02:05,5/4/2017 11:38:46, treatment,bisulfite treatment of rna  ,"yes, no",,,,
1229989269,5/3/2017 13:02:05,5/4/2017 11:37:42, treatment,nrti treatment status  ,"yes, no",,,,
1229989270,5/3/2017 13:02:05,5/4/2017 11:34:24, disease,diseased  ,"yes, no",,,,
1229989271,5/3/2017 13:02:05,5/4/2017 11:39:35, treatment,doxycycline treatment  ,"yes, no, false, true",,,,
1229989272,5/3/2017 13:02:05,5/4/2017 11:39:38, treatment,dox treatment  ,"yes, no, untreated, treated, dox+",,,,
1229989273,5/3/2017 13:02:05,5/4/2017 11:41:30, age,age group ,"young, adult, old, nonagenarian, ped",,,,
1229989274,5/3/2017 13:02:05,5/4/2017 11:29:44, age,age_group ,"young, aged",,,,
1229989275,5/3/2017 13:02:05,5/4/2017 11:48:54, age,sample age group ,"young, middle-age, old",,,,
1229989276,5/3/2017 13:02:05,5/4/2017 11:31:32, strain,fish strain  ,"zebrafish tab strain, ab tubingen, abc",,,,
1229989277,5/3/2017 13:02:05,5/4/2017 11:38:01, time,time (of harvest)  ,zt1,,,,
1229989278,5/3/2017 13:02:05,5/4/2017 11:29:42, time,time of day  ,"zt10, zt6, leaves collected in the hour before lights were turned on (pre-dawn), leaves collected in the hour in the middle of the photoperiod (pm), leaves collected in the hour before lights were turned on (am)",,,,
1229989279,5/3/2017 13:02:05,5/4/2017 11:36:58, time,time of cacrifice  ,zt12 on 3.5 days post copulation,,,,
1229989280,5/3/2017 13:02:05,5/4/2017 11:32:01, time,circadian time  ,"zt14, 4, 8, 16, 20",,,,
1229989281,5/3/2017 13:02:05,5/4/2017 11:38:10, time,time of sacrifice  ,"zt14, zt16, zt18, zt20, zt10",,,,
1229989282,5/3/2017 13:02:05,5/4/2017 11:23:54, tissue,tissue factor ,,,,,
1229989283,5/3/2017 13:02:05,5/4/2017 11:54:57, tissue,tissue pair ,,,,,
1229989284,5/3/2017 13:02:05,5/4/2017 11:36:21, tissue,tissue weigth ,,,,,
1229989285,5/3/2017 13:02:05,5/4/2017 11:43:53, tissue,tissue/cell lines ,,,,,
1229989286,5/3/2017 13:02:05,5/4/2017 11:22:00, tissue,tissue/cell preparation ,,,,,
1229989287,5/3/2017 13:02:05,5/4/2017 11:26:36, gender,adnp+/- gender ,,,,,
1229989288,5/3/2017 13:02:05,5/4/2017 11:40:25, gender,mc3 gender ,,,,,
1229989289,5/3/2017 13:02:05,5/4/2017 11:37:02, gender,mc2 gender ,,,,,
1229989290,5/3/2017 13:02:05,5/4/2017 11:41:02, gender,mc5 gender ,,,,,
1229989291,5/3/2017 13:02:05,5/4/2017 11:39:27, gender,mc4 gender ,,,,,
1229989292,5/3/2017 13:02:05,5/4/2017 11:44:20, gender,mc1 gender ,,,,,
1229989293,5/3/2017 13:02:05,5/4/2017 11:27:33, gender,mc6 gender ,,,,,
1229989294,5/3/2017 13:02:05,5/4/2017 11:37:42, gender,ma2 gender ,,,,,
1229989295,5/3/2017 13:02:05,5/4/2017 11:42:00, gender,strain c57bl/6  gender ,,,,,
1229989296,5/3/2017 13:02:05,5/4/2017 11:19:22, gender,ma5 gender ,,,,,
1229989297,5/3/2017 13:02:05,5/4/2017 11:35:03, gender,ma3 gender ,,,,,
1229989298,5/3/2017 13:02:05,5/4/2017 11:30:14, gender,ma1 gender ,,,,,
1229989299,5/3/2017 13:02:05,5/4/2017 11:24:52, gender,ma6 gender ,,,,,
1229989300,5/3/2017 13:02:05,5/4/2017 12:03:29, age,age ___ 65 ,,,,,
1229989301,5/3/2017 13:02:05,5/4/2017 11:19:57, age,age 4-7 years ,,,,,
1229989302,5/3/2017 13:02:05,5/4/2017 11:22:16, age,age at blood withdrawal ,,,,,
1229989303,5/3/2017 13:02:05,5/4/2017 11:30:40, age,age at dx in days ,,,,,
1229989304,5/3/2017 13:02:05,5/4/2017 11:36:21, age,age(years)/gender ,,,,,
1229989305,5/3/2017 13:02:05,5/4/2017 11:47:47, age,age/sex ,,,,,
1229989306,5/3/2017 13:02:05,5/4/2017 11:33:06, age,control case age ,,,,,
1229989307,5/3/2017 13:02:05,5/4/2017 11:36:27, age,ma1 age ,,,,,
1229989308,5/3/2017 13:02:05,5/4/2017 11:26:11, age,ma2 age ,,,,,
1229989309,5/3/2017 13:02:05,5/4/2017 11:36:54, age,ma3 age ,,,,,
1229989310,5/3/2017 13:02:05,5/4/2017 11:31:29, age,ma4 age ,,,,,
1229989311,5/3/2017 13:02:05,5/4/2017 11:34:54, age,ma5 age ,,,,,
1229989312,5/3/2017 13:02:05,5/4/2017 11:35:01, age,ma6 age ,,,,,
1229989313,5/3/2017 13:02:05,5/4/2017 11:37:35, age,mc1 age ,,,,,
1229989314,5/3/2017 13:02:05,5/4/2017 11:33:57, age,mc2 age ,,,,,
1229989315,5/3/2017 13:02:05,5/4/2017 12:17:09, age,mc3 age ,,,,,
1229989316,5/3/2017 13:02:05,5/4/2017 11:38:08, age,mc4 age ,,,,,
1229989317,5/3/2017 13:02:05,5/4/2017 11:36:22, age,mc5 age ,,,,,
1229989318,5/3/2017 13:02:05,5/4/2017 11:32:42, age,mc6 age ,,,,,
1229989319,5/3/2017 13:02:05,5/4/2017 11:41:24, age,medicago (truncatula)  - age ,,,,,
1229989320,5/3/2017 13:02:05,5/4/2017 11:39:32, age,not current age ,,,,,
1229989321,5/3/2017 13:02:05,5/4/2017 11:39:19, strain,1996). strain cd4ko (rrp6  ,,,,,
1229989322,5/3/2017 13:02:05,5/4/2017 11:40:22, strain,ehec strain  ,,,,,
1229989323,5/3/2017 13:02:05,5/4/2017 11:41:51, strain,fibroblast cell strain  ,,,,,
1229989324,5/3/2017 13:02:05,5/4/2017 11:39:50, strain,strain (e. coli)  ,,,,,
1229989325,5/3/2017 13:02:05,5/4/2017 11:43:38, strain,strain (yeast)  ,,,,,
1229989326,5/3/2017 13:02:05,5/4/2017 11:44:36, strain,strain 877 = mata wpl-9pk  ,,,,,
1229989327,5/3/2017 13:02:05,5/4/2017 11:43:09, strain,strain by4741 ptc3  ,,,,,
1229989328,5/3/2017 13:02:05,5/4/2017 11:36:16, strain,strain by4741 ptc5  ,,,,,
1229989329,5/3/2017 13:02:05,5/4/2017 11:36:08, strain,strain by4741 ptc51  ,,,,,
1229989330,5/3/2017 13:02:05,5/4/2017 11:22:17, strain,strain with gal  ,,,,,
1229989331,5/3/2017 13:02:05,5/4/2017 11:41:29, strain,strain y2197  ,,,,,
1229989332,5/3/2017 13:02:05,5/4/2017 11:38:10, strain,strain y2460  ,,,,,
1229989333,5/3/2017 13:02:05,5/4/2017 11:38:34, strain,strain y2468  ,,,,,
1229989334,5/3/2017 13:02:05,5/4/2017 11:31:27, strain,strain y2699  ,,,,,
1229989335,5/3/2017 13:02:05,5/4/2017 11:44:37, strain,strain y3071  ,,,,,
1229989336,5/3/2017 13:02:05,5/4/2017 11:40:59, strain,strain y3272  ,,,,,
1229989337,5/3/2017 13:02:05,5/4/2017 11:31:47, strain,strain y3351  ,,,,,
1229989338,5/3/2017 13:02:05,5/4/2017 11:31:49, strain,strain y3403  ,,,,,
1229989339,5/3/2017 13:02:05,5/4/2017 11:39:21, strain,strain y3586  ,,,,,
1229989340,5/3/2017 13:02:05,5/4/2017 11:40:55, strain,strain y3650  ,,,,,
1229989341,5/3/2017 13:02:05,5/4/2017 11:37:45, strain,strain y3724  ,,,,,
1229989342,5/3/2017 13:02:05,5/4/2017 11:58:56, strain,test strain  ,,,,,
1229989343,5/3/2017 13:02:06,5/4/2017 11:37:03, strain,vaccine strain  ,,,,,
1229989344,5/3/2017 13:02:06,5/4/2017 11:27:41, cell type,source of cell type  ,,,,,
1229989345,5/3/2017 13:02:06,5/4/2017 11:46:36, treatment,drug treatment time  ,,,,,
1229989346,5/3/2017 13:02:06,5/4/2017 11:41:13, treatment,ionizing radiation treatment  ,,,,,
1229989347,5/3/2017 13:02:06,5/4/2017 11:32:19, treatment,s2 treatment  ,,,,,
1229989348,5/3/2017 13:02:06,5/4/2017 11:31:08, treatment,tamoxifen treatment  ,,,,,
1229989349,5/3/2017 13:02:06,5/4/2017 11:39:53, treatment,time of treatment with fk866  ,,,,,
1229989350,5/3/2017 13:02:06,5/4/2017 11:31:03, treatment,treatment variable  ,,,,,
1229989351,5/3/2017 13:02:06,5/4/2017 11:38:32, cell line,cell line (sorted)  ,,,,,
1229989352,5/3/2017 13:02:06,5/4/2017 11:36:27, cell line,cell line lineage  ,,,,,
1229989353,5/3/2017 13:02:06,5/4/2017 11:33:08, cell line,cell line stably expresses  ,,,,,
1229989354,5/3/2017 13:02:06,5/4/2017 11:36:22, cell line,cell line stably expressing  ,,,,,
1229989355,5/3/2017 13:02:06,5/4/2017 11:41:51, cell line,cell line/type  ,,,,,
1229989356,5/3/2017 13:02:06,5/4/2017 11:32:19, cell line,or cell line  ,,,,,
1229989357,5/3/2017 13:02:06,5/4/2017 11:29:35, cell line,virus isolation cell line  ,,,,,
1229989358,5/3/2017 13:02:06,5/4/2017 11:36:58, sex,"""=- sex""",,,,,
1229989359,5/3/2017 13:02:06,5/4/2017 11:42:11, sex,ctl bone 64 years  sex  ,,,,,
1229989360,5/3/2017 13:02:06,5/4/2017 11:36:08, sex,w sex  ,,,,,
1229989361,5/3/2017 13:02:06,5/4/2017 11:27:16, disease,disease/cell type  ,,,,,
1229989362,5/3/2017 13:02:06,5/4/2017 12:03:29, disease,hiv disease status  ,,,,,
1229989363,5/3/2017 13:02:06,5/4/2017 11:30:40, time,age at the time of surgery  ,,,,,
1229989364,5/3/2017 13:02:06,5/4/2017 11:42:45, time,circadian time point  ,,,,,
1229989365,5/3/2017 13:02:06,5/4/2017 11:28:13, time,cold ischemia time  ,,,,,
1229989366,5/3/2017 13:02:06,5/4/2017 11:34:49, time,conjugation time  ,,,,,
1229989367,5/3/2017 13:02:06,5/4/2017 11:33:25, time,continuous light time  ,,,,,
1229989368,5/3/2017 13:02:06,5/4/2017 11:43:31, time,drug treatment time  ,,,,,
1229989369,5/3/2017 13:02:06,5/4/2017 11:31:48, time,os time (years)  ,,,,,
1229989370,5/3/2017 13:02:06,5/4/2017 11:33:25, time,split ratio time 1  ,,,,,
1229989371,5/3/2017 13:02:06,5/4/2017 11:40:38, time,time (months) overall survival  ,,,,,
1229989372,5/3/2017 13:02:06,5/4/2017 11:46:15, time,time after inoculation  ,,,,,
1229989373,5/3/2017 13:02:06,5/4/2017 11:33:08, time,time at 4__c  ,,,,,
1229989374,5/3/2017 13:02:06,5/4/2017 11:39:50, time,time fter actd  ,,,,,
1229989375,5/3/2017 13:02:06,5/4/2017 11:30:42, time,time of hcmv infection  ,,,,,
1229989376,5/3/2017 13:02:06,5/4/2017 11:41:38, time,time of treatment with fk866  ,,,,,
1229989377,5/3/2017 13:02:06,5/4/2017 11:32:42, time,time point (post-inoculation)  ,,,,,
1229989378,5/3/2017 13:02:06,5/4/2017 11:21:04, time,time post-dox  ,,,,,
1229989379,5/3/2017 13:02:06,5/4/2017 11:32:44, time,time post-inoculation  ,,,,,
1229989380,5/3/2017 13:02:06,5/4/2017 11:34:34, time,time sampled  ,,,,,
1229989381,5/3/2017 13:02:06,5/4/2017 11:22:16, time,time to death (mos)  ,,,,,
1229989382,5/3/2017 13:02:06,5/4/2017 11:44:36, time,time to outcomel  ,,,,,
1229989383,5/3/2017 13:02:06,5/4/2017 11:38:14, time,time_to_death (yr)  ,,,,,
1229989384,5/3/2017 13:02:06,5/4/2017 11:39:23, time,time_to_progression  ,,,,,
1229989385,5/3/2017 13:02:06,5/4/2017 11:38:46, time,time_to_relapse (yr)  ,,,,,
1230008427,5/3/2017 13:43:22,5/4/2017 09:11:16, genotype,host genotype/variation  ,"irradiated wild-type, irradiated tgfb1 heterozygote, sham-irradiated wild-type, sham-irradiated tgfb1 heterozygote",,"",genotype,""
1230008451,5/3/2017 13:43:34,5/4/2017 09:11:16, age,age of the mice ,1 month old,,"",time,""
1230008521,5/3/2017 13:44:04,5/4/2017 09:11:16, treatment,l-dopa treatment  ,"yes, -, no",,"",treatment,""
1230008613,5/3/2017 13:44:42,5/4/2017 09:11:17, disease,celiac disease  ,"no, yes",,"",disease,""
1230008630,5/3/2017 13:44:53,5/4/2017 09:11:18, cell line,cell line specifics  ,"hela s3 stably expressing h3.1-flag-ha, hela s3 stably expressing h3.3-flag-ha",,"",cell_line,""
1230008724,5/3/2017 13:45:39,5/4/2017 09:11:18, tissue,# of tissue = 36 tissue ,carotid body,,"",tissue,""
1230008785,5/3/2017 13:46:06,5/4/2017 09:11:19, strain,strain 1785  ,h- leu1-32 ura4-d18 ade6-210 ssl3:ura4+ ars1-ssl3+-leu2 rad21-3ha-kanr,,"",strain,""
1230009081,5/3/2017 13:47:54,5/4/2017 09:11:20, tissue,tissue/cell line [c] ,"myometrium, mda-mb231 cells, prostate gland, endometrium, endometrium/ovary",,"",tissue,""
1230009336,5/3/2017 13:50:00,5/4/2017 09:11:20, sex,apparent sex  ,"normale female, apparent impsex female",,"",gendersex,""
1230010160,5/3/2017 13:51:47,5/4/2017 09:11:21, genotype,14q22 genotype rs11623717  ,"aa, ag, gg",,"",genotype,""
1230010181,5/3/2017 13:51:55,5/4/2017 09:11:22, disease,patient disease status  ,"localized neuroblastoma, with a diagnosis of cyanotic tetralogy of fallot congenital heart disease, metastatic neuroblastoma, healthy young donor, normal",,"",disease,""
1230021864,5/3/2017 13:56:37,5/4/2017 09:11:23, treatment,lps treatment (time)  ,"untreated, 24 hours, 2 hours, 6 hours, 30 mins",,"",time,""
1230022160,5/3/2017 14:00:05,5/4/2017 09:11:23, strain,strain c57bl/6 gender  ,male age10 weeks tissuesubstantia nigra(sn) disected bilaterally from six like-treated mice,,"",gendersex,The value contains the gender information.
1230022241,5/3/2017 14:00:41,5/4/2017 09:11:24, gender,gender ,"male, female, m, f",,"",gendersex,""
1230077406,5/3/2017 14:34:40,5/4/2017 09:11:25, cell line,cell line number  ,"69, 11, 64, 71, 12",,"",cell_line,""
1230077417,5/3/2017 14:34:52,5/4/2017 09:11:25, treatment,s2 treatment  ,,,"",treatment,""
1230077434,5/3/2017 14:35:20,5/4/2017 09:11:26, cell line,cell line (sorted)  ,,,"",cell_line,""
1230077482,5/3/2017 14:35:56,5/4/2017 09:11:27, tissue,tissue harvest site ,"none, metastatic site, lymph node, leaf, root",,"",tissue,""
1230077484,5/3/2017 14:36:01,5/4/2017 09:11:30, age,age (days) ,"69, 70, 56, 9, 74",,"",time,""
1230078302,5/3/2017 14:40:34,5/4/2017 09:11:29, time,treatment time-point  ,"24h, 8h, ctrl, 15h, 2h",,"",time,""
1230078580,5/3/2017 14:41:20,5/4/2017 09:11:31, tissue,tissue/developmental stage ,"explant tissue subjected to se induction, the advanced phase of embryogenesis related to somatic embryo formation, freshly isolated explants competent to undergo embryogenic transition",,"",tissue,""
1230078586,5/3/2017 14:41:37,5/4/2017 09:11:31, sex,sex  ,"male, female, m, f, unknown",,"",gendersex,""
1230078596,5/3/2017 14:41:47,5/4/2017 09:11:32, strain,control strain o157  ,h7 edl933,,"",strain,""
1230078636,5/3/2017 14:42:33,5/4/2017 09:11:33, disease,source disease status  ,"non-aneurysm, aneurysm, ruptured",,"",disease,""
1230078668,5/3/2017 14:43:05,5/4/2017 09:11:34, strain,jackson lab. strain  ,c57bl/6j. gendermale. stock number000664,,"",strain,""
1230078974,5/3/2017 14:44:46,5/4/2017 09:11:34, genotype,20q13 genotype rs4925386  ,"cc, ct, tt, nd",,"",genotype,""
1230079147,5/3/2017 14:45:17,5/4/2017 09:11:35, treatment,treatment time (hours)  ,"24hrs, 8, 6hrs, 4, control",,"",time,""
1230079290,5/3/2017 14:48:39,5/4/2017 09:11:36, treatment,antibody treatment  ,"mouse igg, 228b/c, 228b/c + 11h4, none, 11h4",,"",treatment,""
1230079330,5/3/2017 14:49:42,5/4/2017 09:11:36, genotype,15q13 genotype rs4779584  ,"cc, ct, tt",,"",genotype,""
1230079335,5/3/2017 14:49:52,5/4/2017 09:11:37, genotype,nod2 genotype  ,"wt/wt, r702w/wt, insc/r702w, insc/insc",,"",genotype,""
1230079356,5/3/2017 14:50:20,5/4/2017 09:11:38, treatment,dox treatment  ,"yes, no, untreated, treated, dox+",,"",treatment,""
1230079396,5/3/2017 14:51:24,5/4/2017 09:11:39, strain,parental strain  ,"bdiv and bdix, cross of h4-8 and h4-8b",,"",strain,""
1230079401,5/3/2017 14:51:35,5/4/2017 09:11:40, disease,hiv disease status  ,,,"",disease,""
1230079435,5/3/2017 14:51:56,5/4/2017 09:11:41, age,age at primary diagnosis ,"68, 54, 49, 58, 72",,"",time,""
1230079453,5/3/2017 14:52:03,5/4/2017 09:11:41, gender,host gender ,"male, female",,"",gendersex,""
1230079566,5/3/2017 14:52:52,5/4/2017 09:11:42, cell type,cell type (human)  ,xenograft tumors (ht29 cells),,"",cell_line,""
1230079578,5/3/2017 14:52:59,5/4/2017 09:11:43, age,age induced (days) ,"7, 8, 9, 5",,"",time,""
1230079590,5/3/2017 14:53:05,5/4/2017 09:11:43, sex,sex chromosome ploidy  ,"xy, xx, xo",,"",gendersex,""
1230079603,5/3/2017 14:53:11,5/4/2017 09:11:44, treatment,period of salt treatment  ,"6 hours, 1 hour, 3 hours, 12 hours, 0 hour",,"",time,""
1230079733,5/3/2017 14:54:18,5/4/2017 09:11:45, tissue,tissue-of-origin ,"melanoma, colon, renal, non-small cell lung, ovarian",,"",tissue,""
1230079840,5/3/2017 14:55:08,5/4/2017 09:11:47, disease,disease progression (event)  ,"1, 0",,"",time,""
1230079867,5/3/2017 14:55:16,5/4/2017 09:11:47, treatment,enrichment treatment  ,"np ratio of 151 (1.5 _ｵm  nano3 and 0.1 _ｵm kh2po4), np ratio of 751 (1.5 _ｵm  nano3 and 0.02 _ｵm kh2po4)",,"",treatment,""
1230079977,5/3/2017 14:55:59,5/4/2017 09:11:48, cell line,cell line source  ,"polyclonal cell line gm13130, american type culture collection (atcc) number crl_1550, normal, non-pregnant female, polyclonal cell line gm12878, american type culture collection (atcc) number htb_33",,"",cell_line,""
1230080000,5/3/2017 14:56:11,5/4/2017 09:11:05, strain,strain tw1  ,knockout of the ccpa homolog via insertion of a kanamycin cassette,,"",strain,""
1231035974,5/4/2017 09:28:08,5/4/2017 13:03:22, cell line,ips cell line  ,41,,"",cell_line,""
1231036063,5/4/2017 09:28:34,5/4/2017 12:46:33, cell line,cell line source age  ,56,,"",time,"Since the value is a number, the term fits better into this category."
1231036195,5/4/2017 09:29:27,5/4/2017 12:02:25, cell line,cell line initiation date  ,"1982, 1988, 1980, 1981",,"",time,""
1231036259,5/4/2017 09:29:53,5/4/2017 13:03:22, cell type,cancer cell type  ,"aggressive, non-aggressive, metastatic, parental",,"",cell_line,""
1231036417,5/4/2017 09:30:37,5/4/2017 13:29:57, cell type,cell type(s)  ,"all, keratinocytes and fibroblasts, neurons (neun+), non-neurons (neun-, predominantly glia), bmsc, nrvcm",,"",cell_line,""
1231036446,5/4/2017 09:30:49,5/4/2017 12:55:12, cell type,cell type (human)  ,xenograft tumors (ht29 cells),,"",cell_line,""
1231036748,5/4/2017 09:33:05,5/4/2017 12:12:13, cell line,cell line initiation date  ,"1982, 1988, 1980, 1981",,"",time,""
1231036766,5/4/2017 09:33:14,5/4/2017 13:03:21, cell line,cell line karyotype  ,"46,xx, 46,xy, 49,xxxxy, 47,xxx",,"",cell_line,""
1231036778,5/4/2017 09:33:24,5/4/2017 09:33:44, cell line,cell line passage  ,"49-50, 40, 7",,"",cell_line,""
1231036813,5/4/2017 09:33:50,5/4/2017 13:29:57, cell type,pancreatic cell type  ,"adult pancreatic endocrine cells, adult pancreatic exocrine-duct cells",,"",cell_line,""
1231036850,5/4/2017 09:34:02,5/4/2017 13:03:22, cell type,targeted cell type  ,b cell,,"",cell_line,""
1231036870,5/4/2017 09:34:12,5/4/2017 11:58:56, cell line,cell line reference  ,"andrews pw (1984) retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. dev biol 103285-293, brown et al. 1997, sugarman bj, et al. (1985) recombinant human tumor necrosis factor-alphaeffects on proliferation of normal and transformed cells in vitro. science 230943-945. pubmed3933111",,"",cell_line,""
1231036912,5/4/2017 09:34:39,5/4/2017 12:37:32, cell line,cell line origin  ,"breast epithelium, breast cancer, mammary, erythroid myeloid lymphoid (eml), bone metastasis of prostate cancer",,"",cell_line,""
1231037062,5/4/2017 09:35:59,5/4/2017 12:53:50, disease,disease exposure  ,diabetes,,"",disease,""
1231037087,5/4/2017 09:36:09,5/4/2017 12:57:05, disease,duration of disease  ,"diagnosed at inclusion, 6 years, 21 years, 16 years, 5 years",,"",time,""
1231037095,5/4/2017 09:36:18,5/4/2017 09:37:49, disease,disease_onset  ,"healthy, 2, 3, 4, 7",,"",,""
1231037111,5/4/2017 09:36:31,5/4/2017 12:53:50, disease,diseasestate  ,"healthy, adenocarcinoma, breast cancer, carcinoma, normal",,"",disease,""
1231037132,5/4/2017 09:36:42,5/4/2017 09:39:58, disease,disease phase  ,"late period, early period, control",,,,
1231037163,5/4/2017 09:36:47,5/4/2017 12:18:34, disease,disease extension  ,"left-sided colitis, --, pancolitis",,"",disease,""
1231037814,5/4/2017 09:41:44,5/4/2017 12:55:12, disease,lung disease  ,"lung cancer (before surgical resection of lung cancer), none (no current or past lung cancer or non-cancerous nodule), non-cancerous lung nodule, none (after surgical resection of lung cancer)",,"",disease,""
1231038061,5/4/2017 09:43:51,5/4/2017 12:46:33, disease,disease_severity  ,"moderate, healthy, severe, mild, unclassified",,"",disease,""
1231038715,5/4/2017 09:46:46,5/4/2017 13:22:45, sex,sexual differentiation  ,undifferentiated,,"",gendersex,""
1231038736,5/4/2017 09:46:54,5/4/2017 12:08:20, sex,sex chromosome complement  ,"xx, xo, xy, xy-, xxsry",,"",gendersex,""
1231038771,5/4/2017 09:47:03,5/4/2017 13:29:57, sex,sex chromosome ploidy  ,"xy, xx, xo",,"",gendersex,""
1231038808,5/4/2017 09:47:12,5/4/2017 09:48:54, sex,ctl bone 64 years  sex  ,,,"",,""
1231038857,5/4/2017 09:47:20,5/4/2017 13:03:22, sex,w sex  ,,,"",gendersex,""
1231038909,5/4/2017 09:47:29,5/4/2017 13:03:22, sex,sex  ,"male, female, m, f, unknown",,"",gendersex,""
1231039419,5/4/2017 09:49:15,5/4/2017 13:22:45, gender,host gender ,"male, female",,"",gendersex,""
1231039707,5/4/2017 09:50:17,5/4/2017 13:29:57, gender,gender and age ,2 year old caucasian female,,"",disease,""
1231040219,5/4/2017 09:51:55,5/4/2017 12:51:18, genotype,apoe genotype  ,"3,4, 3,3, 4,4, 3/3, 2,4",,"",genotype,""
1231040407,5/4/2017 09:52:31,5/4/2017 12:57:05, genotype,genotype icsbp1  ,"33, 13, 11",,"",genotype,""
1231040457,5/4/2017 09:52:41,5/4/2017 13:03:22, genotype,per3 genotype  ,"4\4, 5\5",,"",genotype,""
1231040490,5/4/2017 09:52:50,5/4/2017 13:29:57, genotype,backgroud genotype  ,717-1b4,,"",genotype,""
1231040525,5/4/2017 09:53:00,5/4/2017 13:29:57, genotype,genotype/varat  ,"垣asc1, wt",,"",genotype,""
1231040679,5/4/2017 09:53:27,5/4/2017 12:55:12, genotype,rs5995355 genotype  ,"ag, gg, aa",,"",genotype,""
1231041019,5/4/2017 09:55:00,5/4/2017 13:29:57, sex,sex of donor mice  ,female,,"",gendersex,""
1231041031,5/4/2017 09:55:10,5/4/2017 12:46:33, sex,newborn sex  ,"female, male",,"",gendersex,""
1231041061,5/4/2017 09:55:19,5/4/2017 12:51:18, sex,sex/age at diagnosis (years)  ,female/49,,"","gendersex
time",""
1231041128,5/4/2017 09:55:35,5/4/2017 13:22:45, sex,baby's sex  ,"f, m",,"",gendersex,""
1231041150,5/4/2017 09:55:44,5/4/2017 12:57:05, sex,cell sex  ,"f, m, u, b",,"",gendersex,""
1231041166,5/4/2017 09:55:52,5/4/2017 09:57:55, gender,gender (1#pfu_2) ,m,,"",gendersex,""
1231041339,5/4/2017 09:56:42,5/4/2017 12:46:33, strain,background strain(s)  ,lxt1xbalb/c,,"",strain,""
1231041360,5/4/2017 09:56:48,5/4/2017 12:12:13, strain,strain c57bl/6 gender  ,male age10 weeks tissuesubstantia nigra(sn) disected bilaterally from six like-treated mice,,,,
1231041376,5/4/2017 09:56:57,5/4/2017 13:22:45, strain,strain sr957  ,mata/alpha  ras1:his3/ras1:his3  ras2delta/ras2delta  pde2:kanr/ pde2:kanr  ura3-52/ura3-52 leu2:hisg/leu2:hisg  his3:hisg/his3:hisg  trp1+/trp1:hisg,,"",strain,""
1231041397,5/4/2017 09:57:05,5/4/2017 12:57:05, strain,strain sr453  ,"mata/alpha  ura3-52/ura3-52  prs316-ras2v19, mata/alpha  ura3___52/ura3___52  prs316___ras2v19",,"",strain,""
1231041419,5/4/2017 09:57:13,5/4/2017 09:58:25, strain,strain/genotype variation  ,"mc58, grb2405cml128 hcm1-3ha:natmx4 (hcm1ha), cml128mata ura3-52 his4 leu2-3,112 trp1 (wt), mjrc07grb2405 teto7-hcm1-3ha:kanmx4 (tethcm1ha)",,"",strain,""
1231041687,5/4/2017 09:58:44,5/4/2017 13:22:45, strain,strain name  ,"mixed, common referencemixture of by4716 and, rm11-1a rna from glucose and ethanol conditions, 1254, (wild_type), wt, wt (a11311)",,"",strain,""
1231041809,5/4/2017 09:59:22,5/4/2017 12:12:34, strain,reference strains  ,nctc 11168 and rm1221,,"",strain,""
1231041836,5/4/2017 09:59:33,5/4/2017 12:12:34, strain,strain id  ,"ncyc110, w303, yps1009, yps163, ncyc3290",,"",strain,""
1231043324,5/4/2017 10:10:14,5/4/2017 12:51:18, treatment,treatment_time[hr]  ,6,,"",time,""
1231043355,5/4/2017 10:10:26,5/4/2017 10:10:42, treatment,euthanasia day post treatment  ,42,,"",,""
1231043419,5/4/2017 10:10:49,5/4/2017 12:37:32, treatment,treatment adchem  ,": adchemanthracycline, : adhtamoxifen, : no treatment",,"",treatment,""
1231043448,5/4/2017 10:10:59,5/4/2017 13:29:57, treatment,ms treatment  ,"""-"", copaxone, betaferon, tysabri, rebif44",,"",treatment,""
1231043463,5/4/2017 10:11:09,5/4/2017 12:55:12, treatment,response to tzd treatment  ,"""=+ (responder)"", ""=- (non responder)""",,"",treatment,""
1231043480,5/4/2017 10:11:20,5/4/2017 13:22:45, treatment,days after treatment  ,"0 d, 1 d, 23 d, 3, 7",,"",time,""
1231043588,5/4/2017 10:11:44,5/4/2017 12:55:12, treatment,treatment response in vivo  ,"0, 1",,"",treatment,""
1231043623,5/4/2017 10:11:56,5/4/2017 13:03:22, treatment,hcg treatment time  ,"0 hr, 3 hr, 9 hr, 14 hr",,"",time,""
1231043738,5/4/2017 10:12:50,5/4/2017 10:13:04, treatment,rai stage before treatment  ,"0, 2, 4, 3, 1",,"",,""
1231043766,5/4/2017 10:13:04,5/4/2017 13:29:57, treatment,h2o2 treatment level  ,"0mm, 1mm, 50mm, 5mm, 25mm",,"",treatment,""
1231043802,5/4/2017 10:13:14,5/4/2017 12:18:35, treatment,b12 treatment  ,"0nm, 500nm, 50um",,"",treatment,""
1231059797,5/4/2017 10:42:03,5/4/2017 13:29:57, tissue,day of tissue dissection ,"10, 15, 12, 18",,"",time,""
1231059826,5/4/2017 10:42:15,5/4/2017 12:53:50, tissue,number of pooled tissues ,"1, 4, 3",,"",tissue,""
1231059837,5/4/2017 10:42:24,5/4/2017 12:32:51, tissue,tissue ph ,"6.46, 6.43, 6.28, 6.38, 6.06",,"",tissue,""
1231059850,5/4/2017 10:42:34,5/4/2017 12:37:32, tissue,tissue derivation ,"adenoid cystic carinoma of the parotid gland, pancreatic tumor, tongue, breast cancer, hodgkin lymphoma",,"",tissue,""
1231059864,5/4/2017 10:42:43,5/4/2017 13:22:45, tissue,original tissue ,"adult dermal fidroblast, breast, peripheral blood",,"",tissue,""
1231059881,5/4/2017 10:42:51,5/4/2017 12:55:12, tissue,fetal vs adult tissue ,"adult, fetal",,"",tissue,""
1231060746,5/4/2017 10:47:17,5/4/2017 12:32:51, time,induction time (h)  ,24,,"",time,""
1231060787,5/4/2017 10:47:35,5/4/2017 12:51:18, age,age at rc ,51.33,,"",time,""
